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ABSTRACT
Propanil (3,4-DCPA)-induced alterations of macrophage function
Irina V. Ustyugova
The pesticide 3,4-dichloropropionanilide (propanil or alternatively, DCPA) is a postemergent herbicide predominantly used for the control of weeds on commercial rice crops
worldwide. The US Environmental Protection Agency report on “Pesticides Industry Sales and
Usage in 2001” ranked propanil as the 17th most used herbicide in the US. It is applied on the
fields via groundboom sprayers or aerial equipment suppressing photosynthesis and carbon
fixation of a growing plant. The primary target of herbicide exposure is personnel working in
the manufacturing and application who are required to wear personal protective equipment to
minimize the exposure. The common routes of this exposure are inhalational and dermal, and to
a lesser extent, oral. A number of toxic side effects are induced by propanil include hemolytic
anemia, methemoglobinemia, and myelotoxicity. The majority of current knowledge about
propanil’s toxic effects comes from animal studies. Liver and spleen were found to be the
primary target organs, with many cell populations of the immune system affected, including T
and B lymphocytes, NK cells and macrophages.
Macrophages play essential roles in both innate and adaptive immune responses. They
recognize and destroy pathogens through phagocytosis and generation of reactive oxygen and
nitrogen species (ROS and RNS). Macrophages can also function as antigen presenting cells in
the initiation of an adaptive immune response and secrete a number of cytokines and
inflammatory mediators thereby modulating the immune reaction at the inflamed site.
Previous studies have demonstrated that propanil was able to suppress interleukin (IL)1β, IL-6 and TNF-α cytokine production by LPS-activated murine macrophages. The analysis of
nuclear factor-κB (NF-κB), responsible for TNF-α production, detected a decreased nuclear
localization of NF-κB accompanied by a reduced, but not entirely abrogated binding to DNA
activity.
The first study of this dissertation demonstrated the ability of propanil to inhibit TNF-α
production by LPS-stimulated human monocytic cells line and suppress phagocytosis of
fluorescent beads and Listeria monocytogenes. The ability to directly kill this bacterium and
produce ROS and RNS was also assessed. The results demonstrate that DCPA has profound
effects on macrophage function, and provide insight into the potential mechanisms of
immunosuppression by DCPA. The second study focused on the mechanism of dramatic
suppression of an inflammatory mediator secreted by activated macrophages, prostaglandin E2
(PGE2). Enzymatic activity and expression level of the proteins involved in PGE2 production
were studied. However, the exact mechanism of propanil’s action is still unknown. The third
study describes a novel behavior on NF-κB, called oscillations, in continuously LPS-stimulated
macrophages. Binding activity of NF-κB was studied by two independent methods, and a
mathematical model describing the oscillatory behavior was created based on experimental data.
It demonstrated that propanil exposure potentiated the NF-κB activation process changing the
oscillation behavior which could influence the transcription activity of the NF-κB-inducible
genes.
Taken together our findings indicate that propanil exposure affects a number of important
macrophage functions, such as phagocytosis, ROS and RNS production and inflammatory
mediator’s secretion. Our studies also demonstrated a potential mechanism for the inhibition of

a number of inflammatory cytokines through changes in NF-κB binding activity and oscillatory
behavior.
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CHAPTER 1.
LITERATURE REVIEW
I.

Propanil
General Usage
Propanil (3,4-dichloropropionanilide) is a post-emergent herbicide used for the selective

post-emergent control of grass-type weeds in rice, barley, oats and spring wheat crops. In the
United States (US) the vast majority of propanil (99%) is applied on rice crops and the remaining
1 % is applied on other small grains. Approximately 7 million pounds of propanil are used
annually to treat 2 million acres of agricultural land. The US Environmental Protection Agency
(U.S. EPA) estimates that approximately 50-70% of rice crops in California and the midsouthern states (Arkansas, Louisiana, Missouri, Mississippi and Texas) are treated with propanil
(U.S.EPA, 2002a). A recent EPA report on “Pesticides Industry Sales and Usage” ranked
propanil as the 17th most used herbicide in the US (U.S. EPA, 2004). Its usage is restricted to
agricultural areas only. The application on the fields is conducted via groundboom sprayers or
aerial equipment.
Propanil is available in different formulations with various concentrations of active
ingredient ranging from 16.6-58% in emulsifiable concentrate liquid, up to 59.6-81% in a water
dispersable granule. Other formulations, such as a soluble concentrate liquid and a flowable
concentrate are also available. The maximum application rate for rice during a growing season is
8 lbs of active ingredient (a.i.) per acre (A), which is applied in two 4 lbs a.i./A applications.
The first application is made 15 days after planting the rice and requires an average temperature
of 70°F to be effective. Two days later, the rice field is flushed (the temporary flood). A second
treatment is applied 21-30 days later and the field is flooded again (the permanent flood) and
1

stays flooded for 40-60 days. Approximately 90 days following the permanent flood, the rice is
mechanically harvested (U.S. EPA, 2002a).
Small grains are also treated with propanil, however, a lower concentration of 1.4 lbs
a.i./A is used. In order to prevent residue accumulation and propanil incorporation into the
grains, the use of the herbicide after 4/5 leaf stage is prohibited (EPA, 2002a).

Mode of action
Propanil is a contact herbicide, applied on growing plants. It acts primarily in the leaves.
Upon application it is moved from the leaves to the growing shoots, then back to other leaves.
Higher plants, such as rice, can inactivate propanil by hydrolyzing it into 3,4-dichloroaniline
(DCA) and propionic acid by an enzyme called acylamidase (Adachi, 1966; Ishizuka and Mitsui,
1966). Studies by Still and Kuzirian (1967) demonstrated that tissue homogenates and enzyme
preparations from leaves of susceptible plants had much lower acylamidase activity than rice
plants. As a result, barnyard grass exhibits an overall growth inhibition within 24 hr after the
spraying with propanil (Matsunaka, 1968).
The principal mode of propanil’s action is an inhibition of photosynthesis and carbon
dioxide fixation (Matsunaka, 1968). In plants photosynthesis occurs in two stages. In the first
phase light-dependent reactions or photosynthetic reactions capture the energy of light and use it
to make high-energy molecules. During the second phase, the light-independent reaction uses
the high-energy molecules to capture carbon dioxide and make the precursors of carbohydrates.
In the light reaction one molecule of the pigment chlorophyll absorbs one photon and loses one
electron. This electron starts the electron transport chain reaction that leads to the reduction of
NADP (nicotinamide adenine dinucleotide phosphate) into reduced NADPH. In addition, it
2

serves to create a photon gradient across the chloroplast membrane; its dissipation is used for
adenosine 5'-triphosphate (ATP) synthesis, source of energy (reviewed in Calvin, 1989).
Propanil inhibits the electron transport chain reaction and carbon fixation resulting in overall
growth inhibition of the plant (Bartha and Pramer, 1970).

Metabolism in the Environment
The half-life of propanil in soil is 1 to 3 days where it is likely to be rapidly degraded by
microorganisms. Bacteria expressing acylamidase enzyme hydrolyze propanil to DCA and
propionic acid, in a manner similar to plants. Propionic acid, in turn, is metabolized by soil
microorganisms to carbon dioxide and water (Bartha and Pramer, 1970). Pseudomonas strists
and Fusarium solani are able to convert propanil to its metabolites in soil (Bartha and Pramer,
1970).
In water under aerobic conditions the half-life (t½) of propanil is estimated to be 2 days,
and under anaerobic conditions the t½ is up to 3 days (Wauchope et al., 1992). In experiments
where 50 ppm of propanil were added to dark non-sterile water, no traces of herbicides were
found 120 hr after treatment. Pseudomonas putida and Streptococcus avium in the water sample
were presumed to be as the bacteria responsible for this breakdown of the propanil (Zeyer and
Kearney, 1984).
The U.S. Geological Survey National Water Quality Assessment Program (NAQWQA)
reported the presence of propanil in 2.6% of the 1560 water samples from 62 agricultural
streams. The maximum concentration of propanil found was 2.05 ppb. Its metabolite, DCA,
was detected in 68 samples out of 219 samples obtained from creeks, bayouts and rivers in the
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states of Mississippi, Missouri, Tennessee, Arkansas and north Louisiana. DCA concentration
was measured as 8.9 ppb (EPA, 2002b).
Propanil is classified as a medium mobility compound for sand, sandy loam, and clay
loam soils. Aquatic field dissipation studies demonstrated that the parent compound and its
major metabolite (DCA) were associated generally with the sediment rather with the aqueous
phase. Residues were detected to the top 2 inches of the sediment (U.S.EPA, 2003). These data
suggest that propanil could possibly reach groundwater, but due to fast degradation by
microorganisms, it does not accumulate.
However, monitoring of a groundwater contamination in the states of California,
Arkansas, Missouri and Mississippi demonstrated the presence of propanil, but as expected, at
lower levels than that present in surface water samples. Only 2 wells out of 124 tested in
Missouri contained propanil (0.06-0.07 ppb), placing groundwater exposure at lower risk (U.S.
EPA, 2002b). The amount of propanil and DCA found in surface water ranges from 6 to 72
μg/L. Chronic exposure to propanil over the course of a person’s life time is called “a drinking
water level of comparison” (DWLOC). It describes the safe level of chronic exposure to a
certain contaminant. DWLOC should be higher than the environmentally occurring dose of
pesticide. For adults, DWLOC is set at 86-100 μg/L, which is higher then 6-72 μg/L range. For
children of 1-6 years of age, DWLOC is lower, 26 μg/L, which falls into the range of
environmentally occurring exposure (6-72 μg/L) and raises a concern for water consumption by
children of this age group (U.S. EPA, 2002b).

4

Routes of Exposure
The primary target of herbicide exposure is personnel working in manufacturing and
application.

Occupational risk to workers was assayed by the EPA, mixers and loaders,

applicators (drivers, pilots), crop advisors (scouts), hoers and irrigators are the groups primarily
exposed. Personal protective equipment (PPE) is required to be worn during herbicide handling
to minimize the exposure. PPE for propanil handling includes long sleeve shirt, long pants,
waterproof gloves, shoes, socks and protective eye wear. Workers can be exposed to propanil
residues by entering previously treated areas. For these cases a restricted-entry interval (REI)
was established to minimize the exposure, and the current REI for propanil is 24 hours (U.S.
EPA, 2003).
The major common routes of occupational exposure to propanil are inhalational and
dermal which places propanil into category IV for acute toxicity via those two routes. Oral
exposure is less common with toxicity category of III. No dermal sensitization was observed,
however primary eye irritation in rabbits was detected (toxicity category II). No carcinogenic or
mutagenic capabilities have been described for propanil so far. EPA has classified propanil into
the category “Suggestive evidence of carcinogenic potential by all routes of exposure, but not
sufficient to assess human carcinogenic potential.”(U.S. EPA, 2002a).

Metabolism and Pharmocokinetics
In the mammalian body, propanil rapidly undergoes metabolic conversion by
acylamidase enzyme into 3,4-dichloroaniline (DCA) in the liver. Other metabolites of propanil
are 2-hydroxypropanil and 6-hydroxypropanil (McMillan et al., 1990a).

DCA can be N-

hydroxylated and undergo rapid redox cycling within the erythrocytes, resulting in the oxidation
5

of Fe2+ in hemoglobin to Fe3+, forming methemoglobin (MetHb). MetHb can not bind O2 and
therefore the O2 carrying capacity of the blood in decreased (McMillan et al., 1990a). The
resulting methemoglobinemia causes the development of hemolytic anemia, which is
characterized by decreases of hemoglobin, red blood cell (RBC) count, and packed cell volume.
RBC’s histopathological evaluation revealed the presence of Heinz bodies and hemosiderin
deposits in the spleen and kidneys (U.S. EPA, 2002b). Not only propanil but its metabolites, 2hydroxypropanil and 6-hydroxypropanil, were found to cause methemoglobinemia and
hemolytic anemia (McMillan et al., 1990a; McMillan et al., 1991b).
Experimental data on acute toxicity suggested that the timing of anemic effects in
Sprague-Dawley rats was dependent on a propanil dose. Rats treated with 300 mg/kg propanil
demonstrated a peak in MetHb formation at 4.5 hours after treatment. Presence of MetHb was
detectable for 24 hr following exposure. A lower dose of 100 mg/kg resulted in maximum
MetHb formation by 1.5 hours and was detectable for 12 hrs, demonstrating transient presence of
propanil in the blood (McMillan et al., 1990b).
Studies on pharmacokinetics of propanil in Sprague-Dawley rats demonstrated that the
majority of herbicide (78-90%) was excreted in the urine and 2-13% in the feces. A single oral
dose of 2.5 mg/kg was eliminated from the body within 24 hrs (U.S. EPA, 2002b). The rapid
elimination of propanil from the body does not raise a concern of tissue and organs
accumulation.

Acute and Chronic Toxicity
Currently, a number of animal studies describing acute and chronic toxicity of propanil
exposure are available. The reported LD50 value for oral propanil exposure in rats ranges from
6

1080 mg/kg and up to 2500 mg/kg (U.S. National Library of Medicine. Hazardous Substances
Databank, 1995). The initial signs of distress were impaired coordination of movements, CNS
depression and cyanosis of the ears and skin. Death of an animal occurred within 3-day period
(Singleton and Murphy, 1973). Propanil is practically nontoxic via the dermal route, with a
reported LD50 of greater than 5000 mg/kg in rabbits, but it is moderately toxic via the inhalation
route, with a reported 4-hour LC50 of 1.12 mg/L (Stevens et al., 1991).
Chronic propanil exposure in a two-year rat study where animals were fed 80 mg/kg/day
demonstrated a decrease in overall growth and a relative increase in the weight of the spleen and
liver in female rats and of the testes in males. A higher dose of 240 mg/kg/day given to mice for
a 90-day period also caused increases in liver and spleen weights, cyanosis and
methemoglobinemia. Histopathological analysis of liver and spleen in mice revealed incidences
of necrotic lesions (Ambrose et al., 1972). A shorter 3-week study in rats with 180 mg/kg/day
exposure also demonstrated a reduction in feed consumption, growth, and hemoglobin levels.
Altogether, these data demonstrate that spleen and liver are target organs for short- and longterm propanil exposure.

Human exposure to propanil
Limited studies on propanil toxicity demonstrated a number of symptoms caused by
exposure to herbicide during its manufacturing. Factory workers who were exposed through
dermal and inhalational route developed a number of symptoms, including acne, rash/skin
irritation, eye irritation and cyanosis. 11 (11%) of 102 workers have been hospitalized for illness
related to chemical exposure and were diagnosed with methemoglobinemia (Morse et al., 1979).
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People living next to the rice crops can also be exposed to propanil as a result of drift
where wind speed, direction and distance from the field are important (McClure et al., 2001).
However, the levels of drifted herbicide originating from the treated fields were 106 lower than
the LC50 established in a rat inhalation model (Barnes et al., 1987). Another two-year study
analyzed the blood samples from children and adults living within 125 meters of the rice field.
Blood samples collected at three time intervals: preseason, prior to propanil application, 5-7 days
after spraying and postseason, following harvest. Samples were analyzed for changes in the
percentages of leukocytes, leukocyte cell numbers, their ability to proliferate in response to
mitogen stimulation, as well as cytokine production and natural killer cell (NK) activity. None
of the parameters measured in the families living adjacent to the fields were different from
unexposed control families (McClure et al., 2001). These studies did not detect changes in the
immune parameters of exposed people but the fact that propanil’s metabolites can be detected in
the body months later after the exposure raise a great concern.
The major metabolite of propanil, DCA, has been found to form hemoglobin adducts in
humans (Pastorelli et al., 1998). DCA reacts with hemoglobin, producing a stable adduct which
can be detected by gas chromatography-mass spectrometry (GC-MS) as an indicator of exposure
(Sabbioni and Neumann, 1990; Pastorelli et al., 1995). Two agricultural workers were tested
before, within 2 days and 4 months after the exposure.

The detectable levels of DCA-

hemoglobin adducts were observed not only 2 days after exposure (36-fold increase), but 4
months later (4-fold increase) compared to background levels. Urine samples collected at 2 days
after exposure varied from 1.07 to 3.5 nmol/ml of urine. No detectable levels of DCA were
found in the urine at 4 months after the exposure, thus hemoglobin adduct detection are a better
marker for herbicide exposure (Pastorelli et al., 1998).
8

DCA is a common metabolite of several herbicides used in agriculture. Detection of
DCA in the urine of non-occupationally exposed people living in a rural area of central Italy was
an indicator of exposure to a panel of herbicides, including propanil. 125 people (87.1%) out of
153 tested had DCA detected in their urine ranging from 0.01 to 6.19 μg/L (Turci et al., 2001).
Another study of 5 non-occupationally exposed people, reported the urine levels of DCA of
0.11–0.56 μg/l (Wittke et al., 2006). This demonstrates that even non-occupationally exposed
populations carry low levels of propanil’s metabolite in the body which raises a concern for
people living in agricultural areas.

Immunotoxicity
The effects of propanil on a number of immune organs and responses have been studied
intensively in mouse and rat models. Acute in vivo exposure of mice to 400mg/kg of propanil
causes a significant inhibition of contact hypersensitivity response (CHR), blastogenic response
to T- and B-cell-specific mitogens, antibody response sheep red blood cells (SRBC), as well as
mixed lymphocyte reaction (MLR).

A significant reduction in the thymus weight and an

elevated absolute weight and relative spleen weight were measured in animals treated with 200
and 400 mg/kg of herbicide (Barnett and Gandy, 1989). DCA at a dose of 150 mg/kg also causes
a significant increase in spleen weight and cellularity, but has minimal effects on the T-cell
dependent antibody response or cytotoxic T cell lymphocyte (CTL) activity. Both propanil and
DCA impaired NK cell functions at doses of 100mg/kg and 75 mg/kg respectively (Barnett et al.,
1992).

Overall, immunotoxicity of propanil results in suppression of T-dependent and T-

independent antibody responses, major changes in primary (thymus) and secondary (spleen)
lymphoid organs, which affects many cell populations of immune system such as T and B
9

lymphocytes, NK cells and macrophages. More details on the immunotoxicity of propanil are
described in the review submitted to Journal of Toxicology and Environmental Health Part B
(Appendix 1).

Innate immunity
The innate immune system provides the first line of defense against invading pathogens
through physical barriers such as the skin and mucous membranes, chemical barriers such as
enzymes and pH, and a range of cell types including monocytes, macrophages,
polymorphonuclear monocytes (PMN), and natural killer cells (NK). The innate immune system
is responsible for not only rapidly eliminating pathogens, but also initiating adaptive immune
responses through cell adhesion molecules and cytokines. Immunotoxic effects on cells of the
innate immune system could therefore compromise both the ability of an organism to control
initial infections and to generate an appropriate protective adaptive immune response. There are
limited studies that examined the effect of propanil on NK cell function. More extensive studies
have been conducted to characterize the immunotoxic effects of propanil on macrophages and on
their function, as detailed below.

10

II.

Macrophage differentiation and activation

Macrophage development
Macrophage development takes place in the bone marrow and passes through the
following

steps:

hematopoietic

stem

cell

(HSC)

→

committed

stem

cell

(granulocyte/macrophage-restricted progeny) → monoblast → pro-monocyte → monocyte (bone
marrow) → monocyte (peripheral blood) → macrophage (tissue) (reviewed in Gordon and
Taylor, 2005). The initial stages of hematopoeisis in the bone marrow proceeds rapidly within
1.5-3 days. The progression from HSC to committed progenitor is controlled by interleukin (IL)3, a growth factor for myeloid-restricted progeny.

These IL-3-responsive progenitors will

differentiate and become responsive to granulocyte/macrophage-colony stimulating factor (GMCSF) and macrophage-CSF (M-CSF), giving rise to granulocyte/macrophage-restricted progeny.
GM-CSF and M-CSF are the major growth factors responsible for continued proliferation and
viability of macrophage precursors in the bone marrow (reviewed in Gordon and Taylor, 2005).
The blood monocyte, the next developmental stage, circulate in the blood up to 70 hours
and comprise between 1-6% of the circulating leukocytes (Whitelaw D.M., 1966). They possess
chemotactic and migratory activities and express receptors for IgG Fc-domains (FcγR) and iC3b
complement (Fearon, 1983; McKenzie and Schreiber, 1998). Monocytes are able to cross the
endothelial barrier using selectins, integrins and other receptors of the immunoglobulin
superfamily. Upon migration into the tissues they undergo further differentiation to become
multifunctional tissue macrophages. Depending on the tissue type that the macrophage resides
in, the different populations are identified (Table 1).
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Table 1. Tissue-specific macrophage populations
Tissue

Macrophage

Bone
Osteoclast
Central Nervous System
Microglia
Intestine
Mucosa Associated Lymphoid Tissue (MALT)
Liver
Kupffer cell
Lung
Alveolar Macrophage
Peritoneal cavity
Peritoneal Macrophage
Tumor
Tumor-associated macrophage
Adapted from Jackson and Evans, 2000.
The renewal of tissue macrophages occurs through local proliferation of progenitor cells,
with a life span between 6 and 16 days. These tissue macrophages can also be classified as
resident macrophages, which are immunologically quiescent, consume low oxygen, express low
levels of major histocompatibility complex (MHC) class II gene and produce little or almost no
cytokines (Liu and Pope, 2004).

Monocyte migration
In the case of inflammation, monocytes are attracted to the sites of immune reaction by
activated endothelial, epithelial and mesenchymal cells. This migration is accompanied by a
dramatic increase in a number of monocytes along with serum levels of M-CSF and results in the
final differentiation of monocytes to macrophages. The recruitment of monocytes is a multi-step
process, including tethering, rolling, activation, and firm adhesion, and migration across
endothelium (diapedesis) (reviewed in Worthylake and Burridge, 2001; Johnson-Ledger et al.,
2000; McEver, 2002).

Monocytes express leukocyte (L)-selectin, membrane glycoprotein

adhesion molecule, which binds to endothelial (E)-selectin, platelet (P)-selectin and
glycosylation-dependent cell adhesion molecule 1 (GlyCAM-1) on endothelial cells. The ligand
for P- and E-selectin is expressed constitutively on monocytes and its ligation enhances tether
12

strength and stabilizes rolling on endothelial cells under blood shear flow conditions
(Ramachandran et al., 2001; Zimmerman, 2001). Firm adherence to endothelium is mediated by
integrin molecules, including lymphocyte function-associated antigen-1 (LFA-1), macrophage-1
antigen (Mac-1), and very late activation antigen-1 (VLA-1). These integrins interact with
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)
on the endothelial cells, resulting in firm adhesion and promotes activation. Integrin ligation
may also result in increased transcription and expression of cytokines, such as IL-1β, TNF-α and
IL-8, which may contribute to the persistent inflammation (Rossetti et al., 2002). Diapedesis, or
passage of monocytes across the endothelial lining, occurs via interaction between vascular
endothelial (VE)-cadherins and platelet/endothelial cell adhesion molecule-1 (PECAM),
expressed on both monocytes and endothelial cells (Johnson-Ledger C., Aurrand-Lions et al.,
2000). Stages of monocyte migration and the molecules involved are summarized in Table 2.
Table 2. Monocyte migration
Stage

Monocyte

Endothelial cell

Tethering

L-selectin
PSGL-1
Rolling
L-selectin
PSGL-1
Firm adhesion
LFA-1, Mac-1
VLA-1
Diapedesis
VE-cadherin
PECAM-1
Adapted from Liu and Pope, 2004.

GlyCAM-1
E, P-selectin
GlyCAM-1
E, P-selectin
ICAM-1, 2
VCAM-1
VE-cadherin
PECAM-1

Macrophage activation
Inflammatory macrophages, which have migrated into the tissues and encountered an
infection, are also called activated macrophages. They exhibit enhanced expression of MHC II
13

molecule, are able to present antigen to CD4+ T helper cells and have increased oxygen
consumption. At the same time, activated macrophages lose their ability to proliferate. The fully
activated macrophages possess high oxygen consumption through upregulation of NADPH
oxidase, are able to kill facultative and intracellular parasites, lyse tumor cells and secrete a
larger variety of inflammatory mediators, such as TNF-α, IL-1, IL-6, reactive oxygen and
nitrogen species. Macrophages also serve as a major source of metabolites of arachidonic acid,
including prostaglandins (PGs), thromboxanes and leukotrienes; all of which are important for
normal physiology and inflammation.

A detailed list of macrophage products secreted in

response to activation is listed in Table 3. Inflammatory mediators will be discussed in Chapter
III.
Table 3. Secretory products generated by activated macrophages
Group of products

Individual products

Cytokines

Reactive oxygen species

IL-1α and β; IL-6; TNF-α
Macrophage Inflammatory proteins (MIP-1, -2, -3)
Platelet Derived Growth Factor (PDGF)
Fibroblast Growth Factor (FGF)
Transforming Growth Factor-β (TGF-β)
Granulocyte-Colony Stimulating Factor (G-CSF)
Macrophage-Colony Stimulating Factor (M-CSF)
Classical Pathway: C1, 2, 3, 4, 5
Alternative Pathway: factor B, D, P, I, H
Prostaglandins (PGE2, PGF2α)
Prostacyclin
Tromboxanes
Leukotrienes (LTB4, LTC4)
Superoxide, hydrogen peroxide, hydroxyl radical

Reactive nitrogen species

Nitric oxide, nitrites, nitrates

Complement components
Bioactive lipids

Adapted from Sasmono and Hume, 2002
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Effects of propanil on cytokine production
Propanil is known to suppress a number of immune cell types, including T and B cells.
To determine the ability of propanil to alter the activation process of macrophages, IL-6 and
TNF-α cytokine production was studied. A series of studies determined the effect of in vivo
exposure to propanil on murine macrophages. Peritoneal exudate cells (PEC) were obtained 3
and 7 days after i.p. propanil exposure (200 mg/kg), re-stimulated ex vivo with
lipopolysaccharide (LPS), and the culture supernatants assayed for IL-6 and TNF-α (Xie et al.,
1997a). Both IL-6 and TNF-α production were inhibited at both 3 and 7 days post-exposure
compared to cells from the vehicle-treated controls. Oral administration of a high dose of
propanil (400 mg/kg) resulted in the inhibition of IL-6 production by PEC at 3 and 7 days postexposure; however, a lower dose (40 mg/kg) had no effect (Xie et al., 1997a). TNF-α production
was reduced significantly 3 and 7 days post-exposure at both the 40 mg/kg and 400 mg/kg doses,
demonstrating a more dramatic reduction of TNF-α after oral administration of propanil.
Studies of PEC exposed in vitro to propanil and simultaneously stimulated with LPS
demonstrated a dose-dependent suppression of IL-6 and TNF-α production after 24 h in culture.
Doses of 33 µM and 66 µM propanil inhibited IL-6 production by 25% and 58%, respectively
(Xie et al., 1997a). TNF-α production was also reduced by 30% and 60% of control with the
same propanil doses (Xie et al., 1997a). Furthermore, mRNA levels of both cytokines were
reduced in a dose-dependent manner without affecting mRNA stability suggesting that propanil
affects these cytokines at the level of transcription (Xie et al., 1997a).
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Activation stimuli
Activation of macrophages allows for an initiation of the immune response. Firstly, they
initiate an innate immune response by recognizing and bacteria, pathogenic protozoa, fungi and
helminthes. Recognition is mediated via pattern recognition receptors (PPR), primary toll-like
Figure 1. LPS signaling.

receptors (TLRs), or via the Fcγ and complement
receptors (CR).

LPS
CD14

TLRs are components of the innate immune
system

TLR4
MyD88

and

structurally

represented

by

transmembrane receptors with extracellular leucine-

IRAK

rich domains that recognize pathogen associated

TRAF6

molecular patterns (PAMP) (reviewed in Medzhitov,
MKKs

IKK

2001).

TLR-2 is critical for recognition of

peptidoglycan from gram-positive organisms, where
SAPK/JNK
c-Jun/AP-1

p38
MAPKAP K2

NF-κB

TLR-4 and surface protein CD14 recognize LPS
from gram negative organisms (reviewed in Takeba

and Akira, 2004). The cytoplasmic tails of TLRs possess common toll/IL-1 receptor (TIR)
domains, which are also shared with type 1 IL-1R.

Upon binding to TLR, myeloid

differentiation factor 88 (MyD88) is recruited to its TIR domain (Figure 1). Bound MyD88 IL-1
receptor-associated kinase (IRAK) and TNF-α receptor associated factor (TRAF)-6, resulting
NF-κB activation. The MAP kinase pathways, such as c-Jun N-terminal kinase (JNK) and p38,
can also be activated (Medzhitov, 2001).
Macrophages can also be activated by immune complexes composed of IgG antibodies
directed against microorganisms or to auto antigens. Opsonized bacteria or particles are bound
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through Fcγ receptors or complement receptors promoting phagocytosis, generation of ROS and
RNS, and activation of the mitogen activated protein (MAP) kinase pathway. FcγRI (CD64),
RIIA (CD32) and RIIIA (CD16) activation signals are mediated through immunoreceptor
tyrosine-based activation motifs (ITAMs). IgG-containing immune complexes also may activate
complement components resulting in soluble phase (C5a) or complement components bound to
an immune complex, such as iC3b (Liu and Pope, 2004).
Macrophage activation can also be induced through receptor ligation by inflammatory
cytokines, such as IFN-γ and TNF-α produced by other leukocytes in the area of inflammation.
IFN-γ, produced by T helper 1 cells, NK and CD8+cells, upregulates the expression of costimulatory molecule B7 on macrophages, a ligand for CD28, providing a costimulatory signal
for T cell activation (Harding et al., 1992). IFN-γ also promotes phagocytosis, induces bacterial
opsonization by IgG and increases FcγRI receptor expression (Bosisio et al., 2002). The routes
of activation, types of stimuli and receptors involved in macrophage activation are summarized
in Table 4.
Table 4. Macrophage activation
Acivation type
Innate

Macrophage
receptor
TLRs

Stimuli

Macrophage product

Humoral

FcγRs, CRs

Microbial
organisms
Immune complexes

TNF-α, IL-1, IL-6,
IL-12, ROS, RNS
ROS, RNS

Cytokine receptors

IFN-γR, TNFR

IFN-γ, TNF-γ

ROS, RNS, enhances
TNF-α, IL-1, IL-6,
IL-12

Adapted from Liu and Pope, 2004
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III.

Inflammatory mediators

Respiratory burst
Once macrophages have arrived at a site of infection or inflammation, they release
mediators which control the accumulation and activation of other cells. Among a number of
mediators produced by macrophages, reactive oxygen and nitrogen species are the major
bactericidal agents. They are generated in response to phagosome formation, which is created by
prominent membrane ruffles that extend around the bacteria, resulting in its engulfment.
Macrophages possess preformed lysosomes, which originate from the Goldgi apparatus and
contain anti-microbial proteins and peptides, such as acid hydrolases, lysozymes and proteases.
This preformed lysosome fuses with the phagosome, forming a phagolysosome, which is
acidified by hydrogen ion transporters and prevents bacteria from proliferating and impairs their
function. Another weapon of activated macrophages are ROS, produced within minutes after
exposure to bacteria. ROS are highly reactive molecules that can react with proteins, lipids and
other biological molecules preventing pathogenic organisms from proliferation and destroying
them.
The enzyme responsible for ROS production is NADPH oxidase. This multicomponent
enzyme is located in the plasma membrane and is composed of four oxidase-specific proteins
(p22phox, p47phox, p67phox, and gp91phox) and a GTPase (Rac1/2) (reviewed in Babior, 2000a).
The assembly and activation of the NADPH oxidase have been shown to be preceded by an
increase in intracellular Ca2+, activation of IP3-mediated signaling and protein kinase C (PKC)
activation (Qualliotine-Mann et al., 1993).

NADPH oxidase becomes activated upon

translocation of cytosolic p47phox, p67phox and GTPase to the phagosome, where they assemble
around a membrane-bound cytochrome b558 complex that contains gp91phox and p22phox. This
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process is tightly regulated and involves phosphorylation and numerous conformational changes,
which results in reduction of extracellular molecular oxygen to superoxide (•O2-) using cytosolic
NADPH as the electron donor (reviewed in Jones et al., 2000). The •O2- generated is toxic but
short lived and normally converted to long lasting hydrogen peroxide (H2O2) and O2. Hydrogen
peroxide is a more reactive oxidant than •O2- and rapidly diffuses across cell membranes. It is
able to oxidize cellular membranes and enzymes, causing DNA damage by the interaction with
Fe2+ to form a toxic ferryl radical and inhibit membrane transport processes (Weiss and Peppin,
1986; Imlayet al., 1988). A hydroxyl radical (•OH) is also a very potent oxidant implicated in
oxidation of bacterial proteins, DNA and lipids (Czapski, 1984).
Another important anti-bacterial product of activated macrophages is nitric oxide (NO).
It is synthesized from L-arginine and NADPH by inducible nitric oxide synthase (iNOS). NO is
a short-lived free radical which can

Figure 2. ROS and RNS generation.
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LPS-mediated activation of the innate immune pattern recognition receptors (PRR)
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stimulates iNOS mRNA transcription within 2-4 hours, and iNOS translation within 6 hours. It
is independent of elevated intracellular Ca2+ levels and can function even with low Ca2+
concentration in the cell. Once induced, iNOS in mouse macrophages can produce NO for as
long as 5 days when induction stimuli and L-arginine substrate are present (Vodovotz et al.,
1994). LPS activation of TLR4 leads to NF-κB activation, triggering iNOS transcription (Xie et
al., 1994). IFN-γ triggers iNOS transcription by activating the JAK/STAT pathway, leading to
synthesis of the transcription factor interferon response factor 1 (IRF-1), which stimulates iNOS
transcription (Kamijo et al., 1994). IFN-γ also provides a synergistic boost to LPS induction of
iNOS transcription because IRF-1 interacts with NF-κB, altering the conformation of the iNOS
promoter (Saura et al., 1999). Expression of the iNOS gene in macrophages is regulated mainly
at the transcriptional level, particularly by NF-κB, which binds to multiple sites on the iNOS
gene promoter (Xie et al. 1993).
NO can inhibit bacterial DNA synthesis by multiple mechanisms, these include inhibiting
bacterial ribonucleotide reductase, causing double-stranded breaks in bacterial DNA, modifying
cysteine residues in bacterial proteins, oxidizing bacterial lipids, and interacting with heme iron
and iron-sulfur clusters in bacterial enzymes. NO mobilizes zinc in bacteria, which suggests that
DNA-binding proteins containing zinc are targets of NO (Schapiro et al., 2003). It can also
increase the susceptibility of bacteria to oxidative DNA damage by blocking respiration
(Woodmansee and Imlay, 2003).

Peroxynitrite can oxidize bacterial lipids and produce

nitrotyrosine of bacterial polypeptides, but the biological significance of these modifications is
also unclear.
When generated within the phagolysosome, the ROS and RNS are antimicrobial;
however, they can have other physiological and pathophysiologic functions when generated
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within the cytoplasm or released from the cell.

Intracellular release of ROS seems to be

important for signal transduction and results in the expression of many proinflammatory genes.
The activation of NF-κB signaling pathway by respiratory burst components (H2O2) has been
demonstrated by Kaul and Forman (1996). When released from the cell, ROS may contribute to
atherosclerosis, DNA mutation, malignancy, as well as apoptosis and necrosis (Babior, 2000b).

Prostaglandins
Prostaglandins (PG) are one of many products secreted by activated macrophages.
Derived from arachidonic acid, they mediate a wide range of physiological functions, such as
control of blood pressure, contraction of smooth muscle, and modulation of inflammation
(Wilkinson, 1994).

They dilate blood vessels and increase their permeability to fluid and

proteins (Williams and Morley, 1973). This results in a rise in temperature and swelling of the
affected area. Prostaglandins also increase the sensitivity of nerve endings to pain.
Prostaglandins are produced by the 85kDa enzyme cytosolic phospholipase A2 (cPLA2)
which catalyzes hydrolysis of

Figure 3. Prostaglandins production.
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Two signals are responsible for this activation, an increase in intracellular Ca2+ and PKC21

dependant phosphorylation of cPLA2 (Kramer and Sharp, 1997). Next, activated cPLA2 converts
membrane phospholipids to arachidonic acid, which has a short t½ and can be metabolized by
two major routes, the cyclooxygenase and lipoxygenase pathways. The cyclooxygenase (COX)
pathway produces prostaglandins, prostacyclin and thromboxanes; the lipoxygenase (LOX)
pathway produces leukotriens and lipoxins (Smith et al., 2000) (Figure 3).

COX enzyme

converts AA to prostaglandin H2 (PGH2), which diffuses from the COX protein and is converted
in a tissue-specific fashion to the various prostaglandins, such as PGE2, PGF2α, PGD, PGI2 and
tromboxane (TxA2) (Funk, 2001; Cao and Prescott, 2002). Cyclooxygenase enzyme exists in
two isoforms, COX-1 and COX-2, which share only 60% homology at the amino acid level
(Williams and Shacter, 1997).

COX-1 is expressed constitutively in most tissues, and is

responsible for the production of PGs that control normal physiological functions including
maintenance of the gastric mucosa and platelet aggregation.

COX-2 is not constitutively

expressed, but is rapidly induced by inflammatory and mitogenic stimuli (Williams et al, 1999).
Several transcription factors, such as AP-1, NF-IL6, NF-κB and NF-AT have been shown to
stimulate COX-2 transcription (reviewed in Wu, 2005).
There are several strategies for inhibiting PG synthesis. Non-steroidal anti-inflammatory
drugs (NSAIDs) will reduce levels of PGs by inhibiting the activity of COX isozymes. Due to
the small differences in the amino acid sequences near the catalytic site, COX-1 and COX-2 can
be inhibited by different NSAIDs (Gierse et al, 1996; Kurumbail et al, 1996; Meade et al, 1996).
Aspirin and piroxicam inhibit both enzymes non-specifically, where as CAY10404 affects only
COX-2 activity and is proven to be the most specific inhibitor with a Selectivity Index (SI) of
(COX-1 IC50/COX-2 IC50) > 500,000 (Parashar et al, 2005). In comparison, the SI of celecoxib,
the second selective COX-2 inhibitor, is about 400 (Habeeb et al, 2000).
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IV. Activation of signaling pathways
NF-κB Activation Pathway
A number of signaling pathways are triggered when macrophages become activated. The
best characterized one is the NF-κB signaling pathway. It can be activated by a wide variety of
agents, including cytokines like TNF-α, IL-1, IL-2, IL-12, H2O2, LPS, various stress conditions,
environmental hazards, and many viruses. Activation of NF-κB requires phosphorylation and
degradation of these inhibitors (IκBs), thereby allowing the rapid translocation of NF-κB from
the cytoplasm to the nucleus where it binds target DNA sequences (Figure 4). Phosphorylation
Figure 4. NF‐κB activation
pathway.
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1998; Li et al., 1998; Delhase and Karin, 1999; Karin, 1999a;
Karin, 1999b). Even though IKKα and IKKβ have 52% identity
in chemical structures, phosphorylation of IKKβ results in
activation of IKK complex.

Concurrent phosphorylation of

IKKα is thought to be not essential for stimulation of IκB kinase activity (Li et al., 1999; Takeda
et al., 1999; Tanaka et al., 1999).

NF-κB Family Proteins
Signals induced by many stimuli including LPS and other bacterial cell wall components,
growth factors and cytokines result in the activation of NF-κB signaling pathway. The term NFκB applies to a family of proteins, consisting of NF-κB1 (p105/p50) and NF-κB2 (p100/p52),
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which are transcribed as precursors (p105 and p100, respectively) and then proteolytically
processed to yield the DNA binding subunits (p50 and p52) (reviewed in Ghosh et al., 1998).
RelA (p65) (Figure 5), cRel and RelB proteins are not proteolytically processed and contain a
transcriptional activation domain (TD) in their C-termini (Attar et al., 1998). Each protein of
Rel/NF-κB family contains a homologous N-terminal segment of approximately 300 amino acids
in length. This Rel homology domain (RHD) is responsible

Figure 5. NF‐κB proteins
structure.
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Role of IκBs in the NF-κB Activation Pathway
IκBα is the best characterized NF-κB inhibitor. This protein binds to the p65 (RelA)
subunit of NF-κB through the association of ankyrin repeat domains of IκBα with the nuclear
localization signal (NLS) of p65. The NLS of the p50 subunit remains exposed (Figure 6, from
Chen et al., 2003) allowing the NF-κB:IκBα complex to efficiently enter the nucleus in resting
Figure 6. IκBα protein
structure.

cells. However, this complex is immediately expelled as a result of a
potent nuclear export sequence (NES) on IκBα and p65. Upon
stimulation with LPS, IKK phosphorylates IκBα on the amino
terminus at serine residues 32 and 36 (Beg et al., 1993; Chen et al.,
1995). Phosphorylation of these serine residues is a necessary step for
inducible IκBα polyubiquitination and degradation.

The principal

sites of ubiquitination are lysine 21 and 22 (Scherer et al., 1995; Aoki et al., 1996; Rodriguez et
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al., 1996). Targeted by ubiquitin, IkBα undergoes rapid degradation by nonlysosomal, ATPdependent 26S proteolytic complex composed of a 700-kDa proteosome (Palombella et al,
1994).

This degradation is followed by induction of IκBα mRNA through a mechanism

dependent on the binding of NF-κB to the κB sequences present in the promoter of the IκBα
gene (Sun et al., 1993; de Martin et al., 1993). This newly synthesized IκBα, possessing an
intrinsic NLS, enters the nucleus and binds NF-κB, thereby enhancing its dissociation from the
DNA and causing re-exportation to the cytoplasm by means of NES present on IκBα (ArenzanaSeisdedos et al., 1997).
IκBβ, together with IκBα, is a major regulator of NF-κB activity through the interaction
with the same Rel proteins, RelA(p65)/p50 heterodimer as well as p65/p65 homodimer. Unlike
IκBα, IκBβ does not have a functional NES, its transcription is not regulated by NF-κB, and this
protein is degraded more slowly (Chen at al., 2003). In resting cells, the NF-κB:IκBβ complexes
are retained in cytoplasm without shuttling in and out of the nucleus, because both NLSs of NFκB dimers are masked by IκBβ. Unlike IκBα, IκBβ has a unique 47-amino acid insertion, which
is bound by small Ras-like G-protein, κB-Ras (Fenwick et al., 2000). This κB-Ras is able to
efficiently mask one of p65 NLS of p65/p65 homodimer or p50 NLS of p65/p50 heterodimer,
thereby preventing shuttling of the complex in and out of the nucleus (Chen et al., 2003). In
order to be degraded, IκBβ has to be phosphorylated on Serines 19 and 23 as well as on its Cterminal proline, glutamic acid, serine and threonine-rich (PEST) region (Weil et al., 1997). It
has been demonstrated that PEST phosphorylation cooperates with κB-Ras binding and the IκBβ
insert in regulating cytosolic retention of IκBβ:NF-κB complexes. It is also thought that PEST
sequence must be dephosphorylated by an unknown phosphatase, which will allow the release of
κB-Ras and consequent IκBβ degradation by 26S proteosome (Chen et al., 2003).
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IκBε, the third major IκB protein, has been found specifically associated with cRel, p65
homodimers or cRel/p65 heterodimers in cell extracts.

It is able to shuttle between the

cytoplasm and the nucleus. Nuclear import is mediated by its ankyrin repeat domain, but it is
much less efficient than that of IκBα. Nuclear export of IκBε is mediated by a short leucinerich NES-like sequence, located at the C-terminal (Lee and Hannink, 2002). Unlike IκBα and
IκBβ, IκBε does not contain a C-terminal PEST sequence. Phosphorylation occurs at serine
residues 18 and 22, which signals to slow degradation by proteosome (Whiteside et al., 1997; Li
et al., 1997).

Role of p65 phosphorylation in NF-κB transcriptional activity
NF-κB transcriptional activity is not only regulated by cytoplasmic IκBs degradation and
nuclear translocation, it can also be regulated by posttranslational modifications, such as
phosphorylation. Upon LPS stimulation, IKKβ phosphorylates the transcriptional activation
domain (TD) of p65 on Serine 536, increasing p65 transcriptional activity (Yang et al., 2003).
Another kinase, protein kinase A (PKAC) stimulates transcriptional activity of p65 by
phosphorylating it on Serine 276 (Zhong et al., 1997). PKAC can be found in some fractions of
NF-κB/IκB complexes and is kept inactive by IκB, which masks the ATP-binding domain of
PKAC. When IκB is degraded, PKAC becomes activated and phosphorylates Serine 276 of p65.
It also promotes interaction with the transcriptional coactivator CBP/p300 (Zhong et al., 1998).
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NF-κB oscillations
Under continuous stimulation of the cell, IκBα goes through the degradation and
resynthesis cycles, which results in oscillations of NF-κB binding activity (Hoffmann, et al
2002). These oscillations were observed in Hela cells (TNF-α stimulation) and macrophages
(LPS stimulation). Upon activation, signal transduction leads to phosphorylation of IKK, which,
in turn, phosphorylates all three IκB isoforms (Ghosh et al., 1998). Phosphorylation of IκBs
signals their ubiquitination and proteolytic degradation, which frees NF-κB in the cytoplasm,
allowing it to translocate to the nucleus. Subsequently, NF-κB binds to DNA and stimulates
expression of IκBα protein, which is NF-κB inducible (Sun et al., 1993). However, two other
isoforms, IκBβ and IκBε, are not resynthesized as quickly as IκBα, and their protein levels
remain low, because their transcription does not depend on NF-κB. Next, newly resynthesized
IκBα decreases NF-κB binding activity, by binding to it in the nucleus and removing it from
DNA, which causes the first dip in oscillations (Arenzana-Seisdedos et al., 1997. At the same
time, continuous stimulation of the cell results in another round of IκBα’s phosphorylation,
triggering its degradation and producing another peak in oscillations (Zandi et al., 1998).
However, protein levels of IκBβ and IκBε stay low and do not get resynthesized as fast as IκBα.
This leads to damping of steady oscillations as a result of the action of IκBβ and IκBε
(Hoffmann et al., 2002).
To characterize the functional role of each IκB isoform in NF-κB oscillations, Hoffman
and co-workers created knock-out cell lines from mouse embryonic fibroblasts containing only
one of IκBs molecules (Hoffmann et al., 2002). The IκBα (IκBβ-/-, IκBε-/-) cells displayed
undamped continuous oscillations upon sustained TNF stimulation, where as IκBβ (IκBα-/-,
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IκBε-/-) and IκBε (IκBα-/-IκBβ-/-) cells produced a steady increase in NF-κB binding activity
without oscillations. Thus, in a wild-type cells, IκBα create the oscillatory behavior of NF-κB,
but the presence of IκBβ and IκBε molecules causes damping of these oscillations (Hoffmann et
al., 2002).
The oscillations may differ in their amplitude, number and time period depending on
stimuli. Short impulse (15 min TNF stimulation) will result in a single oscillation that will be
short enough for the transcriptional activation of early genes, such as gene encoding chemokine
IP-10 (Sarris et al., 1996). In contrast, chemokine RANTES is encoded by a late gene and
requires at least 2 hours of stimulation for detectable expression of this protein (Saccani et al.,
2001). Hoffmann et al. (2002) suggested that IκBα is necessary for this differential control
because it helps rapidly attenuate NF-κB activity in response to a short pulse of TNF. To test
this hypothesis, cells lacking IκBα (IκBα-/-) were pulsed with TNF for 15 min or stimulated
continuously. Because IκBα molecule is not present to inhibit NF-κB binding activity after its
resynthesis, both types of stimulation result in sustained NF-κB activation (no oscillations) and
expression of both early (IP-10) and late (RANTES) genes. This demonstrated that the presence
of IκBα and its inhibitory effect on NF-κB binding activity, influences the transcription of early
and late genes through the differences in timing of stimuli (Hoffmann et al., 2002).
Nelson et al. (2004) studied the effects of IκBα on the transcription of NF-κB target
genes. They concluded that increased transcription of IκBα, resulted in decreased frequency of
oscillations, confirming the Hoffmann et al.(2002) findings.

They also demonstrated that

phosphorylation and dephosphorylation of p65 subunit of NF-κB is responsible for persistency
of oscillations. Their studies also concluded that the oscillations are often asynchronous and
may vary in number, period and amplitude (Nelson et al., 2004).
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Effects of Propanil on signal transduction
Propanil interferes with signal transduction cascades in activated macrophages. To study
the effects of this herbicide, cell signaling cascades that result in macrophage activation were
investigated. TNF-α synthesis is dependent on the transcription factor, nuclear factor κB (NFκB) (Collart et al., 1990). Upon LPS stimulation, NF-κB translocates into the nucleus where it
binds the promoter regions of genes responsible for cytokine production. A series of studies
were performed using mouse peritoneal cell line, IC-21 to determine if the reduction in cytokine
production after exposure to propanil was due to effects on NF-κB activation. Propanil was
demonstrated to reduce TNF-α promoter activity in regions that contain NF-κB binding sites
(Frost et al., 2001). Nuclear levels of the p65 subunit of NF-κB were reduced in IC-21 cells
treated with 66 µM or 167 µM propanil and stimulated with LPS.

In addition, it was

demonstrated that there was decreased DNA binding of both the p65/p50 heterodimer and
p50/p50 homodimers of NF-κB after exposure to propanil (Frost et al., 2001). Overall, these
results suggest that propanil may reduce cytokine production through effects on NF-κB
activation.
Another aspect of macrophage activation is the release of intracellular Ca2+-stores that
initiate signal transduction cascades and the activation of transcription factors, including NF-κB
and nuclear factor of activated T cells (NFAT). A concentration of 66 µM propanil completely
abrogated intracellular Ca2+ release in PEC and IC-21 cells within 2 min of LPS stimulation (Xie
et al., 1997b). However, binding of LPS to macrophages (Xie et al., 1997b) as well as mobility
of plasma membrane lipid hydrocarbon chains were not affected by propanil (Brundage et al.,
2003).
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The hydrolysis of the membrane-associated phosphatidyl-inositol-4, 5-bisphophate
(PIP2) and formation of two breakdown products, inositol 1,4,5-triphosphate (IP3) and
diacylglycerol (DAG) are required to release Ca2+ from the internal store. IP3 is known to
directly induce intracellular Ca2+ release (Berridge and Irvine, 1984; Streb et al., 1983).
Measurement of IP3 levels in propanil-treated cells demonstrated an increase in the production
of this breakdown product. It did not, however, generate an increase in intracellular Ca2+ levels
(Xie et al., 1997b). Overall, these data suggest that propanil inhibits Ca2+ release after IP3
generation. Thus a potential mechanism for how propanil causes a reduction in inflammatory
cytokine production in macrophages is through an effect on NF-κB and Ca2+.

Summary
Immunotoxic effects of propanil have been studied for many years; however, the majority
of reports have investigated its toxicity at the organ and cellular level. The molecular level and
signal transduction mechanisms of toxicity are still unknown and require further investigation.
The present study examined effect of propanil on one of the cells of the innate immune
system, macrophages. The first report tested the hypothesis that propanil inhibits the ability of
activated macrophages to perform phagocytosis and kill bacteria through inhibition of the
inflammatory cytokine production, TNF-α, and through supressed generation of ROS and RNS.
The second study investigated the mechanism by which propanil dramatically decreases PGE2
production in activated macrophages. It was hypothesized that propanil affects the enzymes
participating in PGE2 production and their enzymatic activity. The third study described the
novel behavior of NF-κB transcription factor, oscillations.

The hypothesis of propanil’s

inhibition of oscillatory behavior was tested via characterization of the NF-κB binding activity
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using a mathematical model.

Overall, this research examines the functional and signaling

changes activated macrophages undergo upon treatment with propanil. The anti-inflammatory
potential of propanil suggests its possible use as an antioxidant/inhibitor for therapeutic
purposes.
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Abstract
The pesticide 3,4-dichloropropionanilide (propanil or alternatively, DCPA) is a member
of the acetanilide chemical family and is predominantly used for the control of weeds on
commercial rice crops worldwide. The present report was written to provide a brief review of
the general toxicity of propanil followed by a detailed summary of the immunotoxicity studies
that were performed to date in mammalian in vivo and in vitro models. Propanil affects the
immune system at organ, cellular, and molecular levels. Studies have demonstrated that it causes
thymic atrophy and splenomegaly and decreases developing T and B cell populations in the
thymus and bone marrow. Natural killer (NK) cells and macrophages are critical components of
the innate immune system. NK cell cytotoxicity and the ability of macrophages to phagocytose,
kill pathogenic bacteria, and produce inflammatory cytokines are suppressed by propanil.
Propanil also affects the respiratory burst of macrophages, inhibiting reactive oxygen and
nitrogen species production. Molecular mechanisms responsible for propanil’s effects have
begun to be elucidated and include alterations in NF-κB transcription factor activity and
intracellular Ca2+ signaling.

Propanil exposure alters a number of functions of mature T

lymphocytes and B lymphocytes that impacts the adaptive immune response. T cell cytotoxic
activity and cytokine production are major T cell functions inhibited by propanil. The humoral
antibody response to model antigens and intact bacteria is differentially affected after propanil
exposure. How these changes in innate and adaptive immune responses impact the host response
to bacterial challenge or vaccination has begun to be examined.
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Introduction
The pesticide 3,4-dichloropropionanilide (propanil or alternatively, DCPA, Figure 1) is
an herbicide that is predominantly used for the control of weeds on commercial rice crops.
Several studies investigated the adverse effects of propanil. Propanil was demonstrated to exert
significant effects on the nervous and immune systems. This report provides a brief background
of the general toxic effects attributed to propanil exposure and primarily focuses on the
immunotoxicity studies performed in mammalian in vivo and in vitro models. In addition,
epidemiological reports examining the immunotoxic effects of propanil on professional
applicators and people living in areas of propanil use are summarized. The majority of the
studies reviewed here were performed in animal models.

There is a continuing need for

additional epidemiology studies in humans to determine if the experimental data that
demonstrates immunotoxicity after exposure to herbicides has clinical relevance to humans. Vial
et al. (1996) reviewed the available human data for several pesticides that demonstrated the
potential for pesticides to cause immune modulation but also the divergent results reported for a
number of chemicals illustrating the need for additional human studies.

Background and General Toxicity
Propanil is in the acetanilide chemical family (U.S.EPA, 2003). Approximately 99% of
the propanil used in the United States is for the control of weeds on rice crops (U.S.EPA, 2003).
Roughly 50-70% of all rice grown in the U.S. is treated with propanil (U.S.EPA, 2003). In the
United States alone, a 2001 estimate by the Environmental Protection Agency ranked propanil as
the 17th most used pesticide in the U.S. (U.S.EPA, 2004). Although there have been numerous
studies published on the effects of propanil on the immune system, the EPA recommended in
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2002 that additional studies need to be performed on the immunotoxicity of propanil. The range
of propanil application extends throughout the lower southern states along the Mississippi River
and in some areas of California. Propanil is restricted exclusively to commercial use and rapidly
degrades in the soil and water. The half-life in the soil is 1-3 days and 2-3 days in the water
(Wauchope et al., 1992). Given the lack of residential use of propanil and the short half-life,
exposure to the chemical is primarily restricted to applicators and residents who live near treated
farms. The preferred method of application is via ground boom sprayers and aerial methods
(U.S.EPA, 2003).
The most common routes of propanil exposure include inhalation, dermal, orbital, and to
a lesser extent, oral. Upon entry into the organism, propanil is rapidly metabolized in the liver
by the enzyme acylamidase into the major metabolite 3,4-dichloroaniline (DCA) (Williams and
Jacobson, 1966).

Other metabolites of propanil include 2’-hydroxypropanil and 6’-

hydroxypropanil (McMillan et al., 1990a). DCA is subsequently metabolized to 6-hydroxy-3, 4dichloroaniline and N-hydroxy-3, 4-dichloroaniline. DCA can also undergo rapid redox cycling
within the erythrocytes, resulting in the oxidation of Fe2+ in hemoglobin to Fe3+, forming
methemoglobin. Due to the rapid metabolism of the parent compound, propanil remains at
detectable concentrations in the blood of rats for approximately 48 hr following exposure
(Izmerov, 1984).

A number of adverse side effects are induced after exposure to propanil

including hemolytic anemia, methemoglobinemia, and myelotoxicity. In vivo studies using
Sprague-Dawley rats showed that inhibition of the acylamidase activity with triorthotolyl
phosphate decreased the amount of methemoglobinemia formed following a 400 mg propanil/kg
body weight (mg/kg) intraperitoneal (i.p.) exposure to propanil (Singleton and Murphy, 1973).
In addition, i.p. injections of the metabolite N-hydroxy-3, 4-dichloroaniline into rats were found
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to induce the same amount of hemolytic anemia as the parent compound (McMillan et al., 1991).
In vitro studies analyzing the ability of propanil metabolites to oxidize hemoglobin in
erythrocyte suspensions confirmed that N-hydroxy-3, 4-dichloroaniline was the most potent
oxidizing metabolite (McMillan et al., 1990a). Together, these studies indicate that metabolism
of the parent compound is necessary for induction of anemia.
The duration of the anemic effects differ according to the exposure concentration of
propanil (McMillan et al., 1990b). Analysis of blood samples from acutely exposed SpragueDawley rats treated with a 300 mg/kg dose demonstrated that methemoglobinemia peaks at 4.5
hr post-exposure (24%) and is detectable for up to 24 hr (McMillan et al., 1990b). However, a
lower dose of 100 mg/kg induced a peak in methemoglobin levels at 1.5 hr (5%) that returned to
normal levels 12 hr following exposure (McMillan et al., 1990b). These data indicate that the
anemic effect induced by propanil is brief and does not persist following the clearance of
propanil from blood.
There have been animal studies to determine the overt toxicity of propanil. The reported
LD50 value for oral propanil exposure is 367 mg/kg up to 2500 mg/kg in rats (US National
Library of Medicine. Hazardous Substances Databank, 1995). In mice, acute toxicity occurs
between 400 and 800 mg/kg (Singleton and Murphy, 1973). Propanil is practically nontoxic via
the dermal route with a reported LD50 of greater than 5000 mg/kg in rabbits and is moderately
toxic via the inhalation route with a reported 4 hour LC50 or 1.12 mg/l in rats (Stevens and
Summer, 1991).
Other studies using common toxic endpoints such as mutagenicity, reproductive toxicity,
and carcinogenicity have yielded negative results. Propanil was not found to be mutagenic as
determined in Salmonella reversion assays (McMillan et al., 1988). The EPA determined that
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propanil is not a carcinogen in humans (U.S.EPA, 2003). Reproductive studies in rats showed
that chronic oral propanil exposure does not produce any abnormalities in the fertility of the
parents nor does it affect the health of the offspring (Ambrose et al., 1972). Thus, propanil is
classified in the “slightly toxic” toxicity class III for oral exposures and toxicity class IV for
inhalation and dermal exposures (U.S.EPA, 2003).
There is little literature available on the effects of human exposure to propanil. Propanil
is applied to rice crops by aerial spraying (Barnes et al., 1987). This technique allows for the
exposure of people in the area immediately surrounding the rice field to airborne particles of
propanil called drift.

Two studies measured the potential for dermal and mucosal exposure to

propanil drift as a function of distance from the rice field (Barnes et al., 1987; Richards et al.,
2001). Non-applicator personnel working in fields adjacent to propanil-treated fields were
exposed to low concentrations of propanil resulting from drift after aerial application (Barnes et
al., 1987). These personnel were calculated to be exposed to concentrations that were 106 fold
lower than the LC50 established in respiratory rat models (Barnes et al., 1987). Richards et al.
(2001) determined the levels of propanil in and around homes adjacent to rice fields by the
collection of drift on polyethylene patches and by active sampling of propanil vapor by air
pumps. Air pump samples taken near the fields had no detectable propanil vapor and passive
collection on polyethylene patches was highly variable. From this study it was determined that
the factors most important in the drift of aerially applied propanil were wind speed, direction and
distance from the field. Wind direction was correlated with deposition levels inside the homes.
In conjunction with the drift study, a two-year study of immune parameters in families living
adjacent to rice fields as compared to regional cohorts not exposed to aerial application of
propanil was performed (McClure et al., 2001). Blood samples from both children and adults
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were taken before spraying, 5-7 days after spraying, and after harvest, and analyzed for changes
in % of blood leukocytes, leukocyte cell numbers, mitogen-induced proliferation, mitogenstimulated cytokine production and natural killer cell (NK) activity. No significant differences
were found between control and group exposed to propanil in any of the immune parameters
measured (Richards et al., 2001). This might be due to the low atmospheric concentration of
propanil in family homes lying adjacent to the spray fields (Richards et al., 2001). Homes
located approximately 125 m from the spray fields were found to have no more than 6.65 μg of
propanil per sampling section (Richards et al., 2001). These studies highlight the difficulties that
arise in the determination of human exposure levels in field situations. From these studies, it
may concluded that direct exposure to propanil in rice growing areas is most likely highly
variable. Some exposures may occur by inhalation, although the more likely exposure route is
through skin and mouth. Although the population in the vicinity of spraying appears to be
unaffected, there may be a high degree of variability in the exposure of this population.
Assessment of the effects of propanil on humans demonstrates that the greatest risk of
high exposure is to applicators and manufacturing workers. Propanil was demonstrated to be
toxic to factory workers exposed during the production and packaging of the herbicide (Morse et
al., 1979).

Symptoms associated with propanil exposure included chloracne, small pupils,

nausea/vomiting, blurred vision, muscle weakness, fatigue and increased salvation (Morse et al.,
1979). Acne occurred in 61% of the workers in contact with propanil and was the only symptom
definitively connected to propanil exposure in in vivo tests on rabbit ears. Further research
demonstrated that the contaminants 3,4,3’, 4’-tetrachloroazobenzene and 3,4,3’, 4’tetrachloroazoxybenzene, which are found in propanil and the major metabolite DCA, are
responsible for the chloracne (Kimbrough 1980).
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Pastorelli, et al., (1998) developed a gas chromatography-mass spectrometry (GC-MS)
method to take advantage of the formation of adducts between DCA and hemoglobin (Hb) to
measure DCA levels in agricultural workers exposed to propanil. Blood and urine was collected
prior to, 2 days after, and 4 months after propanil exposure from two agricultural workers.
Detectable levels of DCA-Hb adducts were detectable at both 2 days (621 and 31 fmol/mg Hb)
and 4 months 65 and 57 fmol/mg Hb) post-exposure . Urine levels were only detectable at 2
days post-exposure (1.07 and 3.5 nmol/ml urine) (Pastorelli, et al., 1998). Although the study
was limited to only 2 subjects it suggests that for biomonitoring over time, the measurement of
DCA-hemoglobin adducts may be more sensitive. Two additional studies have used sensitive
GC-MS to measure the levels of DCA in human urine (Wittke et al, 2001; Turci et al., 2006).
Both studies reported levels of DCA in the urine of the general population. Since DCA is a
marker for exposure to number of pesticides the exposure could not solely be attributed to
propanil but the development of these more sensitive assays may now allow for closer
monitoring of pesticide exposure and levels of pesticides found in humans.

Immunotoxicity
The effects of exposure to propanil on primary and secondary immune organs have been
determined. Myelotoxic effects were demonstrated following propanil exposure (Blyler et al.,
1994; Malerba et al., 2002;). Ex vivo colony-forming assays from the bone marrow of acutely
exposed C57Bl/6 mice demonstrated that the early stem cell progenitors, myeloid stem cells
(CFU-S) and erythroid burst-forming units (BFU-E), are decreased in number following 200
mg/kg i.p. propanil exposure (Blyler et al., 1994). However, the more differentiated cell types
such as erythroid colony-forming units (CFU-E), granulocyte/macrophage progenitor cells
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(CFU-GM), macrophages (CFU-M), and neutrophils (CFU-G) are not reduced in number
following propanil treatment (Blyler et al., 1994). Similar effects on the early erythroid stem
cells are seen with human cord progenitor cells following propanil treatment (Malerba et al.,
2002). In vitro exposure of human cord blood to propanil demonstrated that the CFU-E and
BFU-E progenitors had 50% of their growth inhibited (IC50) by 234 μM and 441 μM of propanil,
respectively (Malerba et al., 2002). The more differentiated CFU-GM progenitors had an IC50 of
greater than 500 μM, indicating similar susceptibility to the effects of propanil on the more
immature progenitors in both humans and mice (Malerba et al., 2002). However, in humans, the
metabolite DCA is far less toxic to CFU/BFU-E progenitors than its parent compound (Malerba
et al., 2002).
Initial chronic and acute exposure studies found that secondary immune organs are also
affected after exposure to propanil (Ambrose et al., 1972; Barnett and Gandy, 1989). Female
rats exposed for 2 years to 400 ppm of propanil mixed in their feed had increased spleen weights,
but the heart, kidneys, liver and testes weights were not affected (Ambrose et al., 1972). In a
subchronic study, female and male rats treated for 3 months with 1000 or 3300 ppm of propanil,
respectively, did not have altered organ weights except increased spleen sizes (Ambrose et al.,
1972). Additionally, acutely exposed C57Bl/6 mice treated i.p. with 200 mg/kg of propanil had
decreased thymus weights and increased spleen weights (Barnett and Gandy, 1989). The
mechanism for thymic atrophy after propanil exposure is discussed in greater detail in the
following sections. The exact cause and nature of the splenomegaly is currently unknown,
however, the mature T cell and B cell populations are unchanged (Zhao et al, 1995; Salazar et
al., 2005). These studies suggest that propanil may be more toxic to secondary immune organs
than non-immune organs.
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Innate immunity
The innate immune system provides the first line of defense against invading pathogens
through physical barriers such as skin and mucous membranes, chemical barriers such as
enzymes and pH, and a range of cell types including monocytes, macrophages,
polymorphonuclear monocytes (PMN), and natural killer cells (NK). The innate immune system
is responsible for not only rapidly eliminating pathogens, but also initiating adaptive immune
responses through cell adhesion molecules and cytokines. Immunotoxic effects on cells of the
innate immune system may therefore compromise both the ability of an organism to control
initial infections and to generate an appropriate protective adaptive immune response. There are
limited studies that examined the effect of propanil on NK cell function. More extensive studies
were conducted to characterize the immunotoxic effects of propanil on macrophages and on
macrophage function. (Table 1)
NK cells are large granular lymphocytes that contribute to innate immunity through
cytokine production and as cytotoxic cells in anti-microbial and tumor immunity. Mice treated
with propanil, and the major metabolite DCA, have reduced NK cell cytotoxicity (Barnett et al.,
1992). Splenic NK cells from mice treated i.p. with propanil (50, 100 or 200 mg/kg) or molar
equivalents of DCA (75 or 150 mg/kg) had a concentration-dependent significant reduction in
NK cell activity 7 days post-exposure (Barnett et al., 1992). A more recent study demonstrated
that i.p. exposure to propanil (50, 75, or 100 mg/kg) suppressed NK cell activity as early as 12 hr
post-exposure in a dose-dependent manner (Pruett et al., 2000). The effect of propanil exposure
on NK cell cytokine production was not reported.
Macrophages play essential roles in both innate and adaptive immune responses. Their
major functions in the innate immune response are phagocytosis and killing of invading
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pathogens. Subsequently, macrophages function as antigen presenting cells in the initiation of an
adaptive immune response. The production of a number of chemokines and cytokines by
macrophages are important immune mediators in both innate and adaptive immune responses.
Two of the important cytokines produced by macrophages are interleukin (IL)-6 and
tumor necrosis factor-α (TNF-α). A series of studies were performed to determine the effect of
in vivo exposure to propanil on cytokine production by murine macrophages. Thioglycolateelicited peritoneal exudate cells (PEC) were obtained 3 and 7 days after i.p. propanil exposure
(200 mg/kg), re-stimulated ex vivo with lipopolysaccharide (LPS), and the culture supernatants
assayed for IL-6 and TNF-α (Xie et al., 1997a 1 ). Both IL-6 and TNF-α production were
inhibited at both 3 and 7 days post-exposure compared to cells from the vehicle-treated controls.
Oral administration of a high dose of propanil (400 mg/kg) resulted in the inhibition of IL-6
production by PEC at 3 and 7 days post-exposure; however, a lower dose (40 mg/kg) had no
effect (Xie et al., 1997a). TNF-α production was reduced significantly 3 and 7 days postexposure to both the 40 mg/kg and 400 mg/kg doses, demonstrating a more dramatic reduction of
TNF-α after oral administration of propanil.
Studies of thioglycollate-elicted PEC exposed in vitro to propanil and simultaneously
stimulated with LPS demonstrated a concentration-dependent suppression of IL-6 and TNF-α
production after 24 hr in culture. Concentrations of 33 µM and 66 µM propanil inhibited IL-6
production by 25% and 58%, respectively (Xie et al., 1997a). TNF-α production was also
reduced by 30% and 60% of control with the same propanil concentrations (Xie et al., 1997a).
Furthermore, mRNA levels of both cytokines were reduced in a concentration-dependent manner

1

Xie et al., 1997a and Xie et al., 1997b were originally published with incorrect doses for the in vitro
studies. The doses cited here are the correct doses.
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without affecting mRNA stability suggesting that propanil effects cytokine production at the
level of transcription (Xie et al., 1997a). It was also demonstrated that in vitro exposure to
propanil significantly inhibits the production of TNF-α by the murine macrophage cell line, IC21, and the human monocytic cell line, THP-1 (Ustyugova et al., 2007).
TNF-α synthesis is dependent on the transcription factor, nuclear factor κB (NF-κB)
(Collart et al., 1990).

Signals induced by many stimuli including LPS and other bacterial cell

wall components, growth factors and cytokines converge in the activation of NF-κB. NF-κB
translocates into the nucleus where it binds the promoter regions of genes responsible for
cytokine production. A series of studies were performed using IC-21 cells to determine if the
reduction in cytokine production after exposure to propanil was due to effects on NF-κB
activation. Propanil was demonstrated to reduce TNF-α promoter activity in regions that contain
NF-κB binding sites (Frost et al., 2001). Nuclear levels of the p65 subunit of NF-κB were
reduced in IC-21 cells treated with 66 µM or 167 µM propanil and stimulated with LPS. In
addition, it was demonstrated that there was decreased DNA binding of both the p65/p50
heterodimer and p50/p50 homodimers of NF-κB after exposure to propanil (Frost et al., 2001).
Overall, these results suggest that propanil may reduce cytokine production through effects on
NF-κB activation.
Another aspect of macrophage activation is the release of intracellular Ca2+-stores that
initiate signal transduction cascades and the activation of transcription factors, including NF-κB
and nuclear factor of activated T cells (NFAT). A concentration of 66 M propanil completely
abrogated intracellular Ca2+ release in thioglycollate-elicted PEC and IC-21 cells within 2 min of
LPS stimulation (Xie et al., 1997b1). However, binding of LPS to macrophages (Xie et al.,
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1997b) as well as mobility of plasma membrane lipid hydrocarbon chains were not affected by
propanil (Brundage et al., 2003).
The hydrolysis of the membrane-associated phosphatidyl-inositol-4, 5-bisphophate (PIP2)
and formation of two breakdown products, inositol 1,4,5-triphosphate (IP3) and diacylglycerol
(DAG) are required to release Ca2+ from the internal store. IP3 is known to directly induce
intracellular Ca2+ release (Berridge and Irvine, 1984; Streb et al., 1983). Measurement of IP3
levels in propanil-treated cells demonstrated an increase in the production of this breakdown
product. It did not, however, generate a rise in intracellular Ca2+ levels (Xie et al., 1997b).
Overall, these data suggest that propanil inhibits Ca2+ release after IP3 generation. Thus a
potential mechanism for how propanil produces a reduction in inflammatory cytokine production
in macrophages is through an effect on NF-κB and Ca2+.
As previously mentioned, a critical function of macrophages is phagocytosis and
destruction of pathogens.

The production of reactive oxygen species (ROS) and reactive

nitrogen species (RNS) is crucial for bactericidal activity. The effect of propanil exposure on
phagocytosis and bactericidal function was determined in murine thioglycollate-elicted PEC and
THP-1 cells. The ability of murine PEC and THP-1 cells to phagocytose fluorescent beads was
measured after exposure to 50 or 100 µM propanil (Ustyugova et al., 2007). Phagocytosis by
propanil-treated PEC was reduced by 34 and 51% in the 50 and 100 µM treatment groups,
respectively, compared to control cells. THP-1 cell phagocytic activity was reduced by 57 and
64% in the 50 and 100 µM treatment groups (Ustyugova et al., 2007). Together these data
demonstrate that propanil inhibited phagocytosis by both murine and human macrophages.
After phagocytosis, an ingested pathogen is destroyed by ROS and RNS that are
produced during the respiratory burst (Gwinn and Vallyathan, 2006). ROS production induced
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by LPS in vitro results in the recruitment of several of the cytosolic components to the membrane
where they join with membrane-bound flavocytochrome subunits to form an active nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase (Bonizzi et al., 2000).

Active NADPH

oxidase produces hydrogen peroxide and hydroxyl radicals (·OH-) that are detected
intracellularly by confocal microscopy.

The generation of oxygen intermediates in

thioglycollate-elicted PEC and THP-1 cells treated with 25 or 100 µM propanil and stimulated
with LPS was determined. PEC displayed a statistically significant decrease (45%) in ROS
production in the 100 µM treated group compared to controls (Ustyugova et al., 2007). THP-1
cells demonstrated a quantitative decrease in ROS generation at all concentrations of propanil,
which was not statistically significant. These results suggest the production of ROS by primary
macrophages was more sensitive to the effects of propanil then the THP-1 cell line.
RNS have potent anti-microbial activity and are a vital component in the elimination of
invading organisms by the innate immune system.

RNS are produced after ingestion of

microorganisms in vivo and after in vitro stimulation with LPS, due to the induction of inducible
nitric oxide synthase (iNOS) and results in the production of nitric oxide (NO). Short-lived NO
reacts with ROS giving rise to a number of toxic nitrogen compounds, such as peroxynitrite
(ONOO-) which in turn decompose into additional nitrates and nitrites (Hibbs et al., 1988; Miwa
et al., 1987; Rao, 2000; Stuehr and Marletta, 1987). An accumulation of nitrite in the media of
thioglycollate-elicited PEC treated with 25 or 100 µM propanil and stimulated with LPS was
determined (Ustyugova et al., 2007). Nitrite production was significantly decreased by 40% at
12hr after propanil-treatment (100 μM) compared to ethanol-treated control cells. Cells treated
with 25 or 100 μM propanil for 24 hr showed a 15 and 22% decrease in nitrate production,
respectively.

Propanil also decreased iNOS protein expression in PEC following LPS
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stimulation. Twenty-five and 100 µM propanil inhibited iNOS levels by 10 and 14% 6 hr postexposure, respectively. The largest inhibition of 29% was observed 12 hr following 100 µM
propanil exposure. The longest exposure to 100 µM propanil, 24 hr, decreased iNOS 12%
(Ustyugova et al., 2007). The inhibition of RNS, which are important in the initial clearance of a
bacterial infection, could potentially increase the susceptibility of an exposed individual to
infection.
The effect of propanil on the ability of THP-1 cells and thioglycollate-elicited PEC to kill
L. monocytogenes was measured as an indicator of the biological consequences of propanil
exposure. Cells treated with vehicle and stimulated with interferon-gamma (IFN-γ) and LPS,
showed a significant reduction in bacterial burden after 5 hr (Ustyugova et al., 2007). In
contrast, treatment of stimulated THP-1 cells with 100 μM propanil reduced the number of
bacteria initially phagocytosed followed by replication of the bacteria as demonstrated by an
increase in the number of colony-forming units (CFU). Stimulated PEC treated with 100 μM
propanil phagocytosed few bacteria and there was a quantitative increase in the number of CFU
over time (Ustyugova et al., 2007). These results demonstrate that propanil produced inhibition
of listeriacidal activity of macrophages and additional evidence that propanil inhibits
phagocytosis.

Adaptive Immunity
Adaptive immunity is a highly specific response that results in the generation of antigenspecific lymphocytes and a memory response. The main cellular components of the adaptive
response are B lymphocytes and T lymphocytes. B lymphocytes primarily function to produce
and secrete antibodies, which is the basis of the humoral immune response. T lymphocytes
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perform a number of essential functions in the generation and regulation of a potent adaptive
immune response. Very simplistically, CD4+ T cells are responsible for the activation and
regulation of the humoral immune response and cell-mediated immune responses. CD8+ T cells
function primarily as cytotoxic T lymphocytes (CTL) to destroy infected or transformed host
cells. T-regulatory/suppressor cells function in a variety of ways to control the adaptive immune
response. The following sections summarize the studies examining the effect of propanil on cellmediated and humoral immune responses (Table 2).

Thymic atrophy and T cell function
The thymus is the organ responsible for T cell development and maturation. As
mentioned above, propanil induces thymic atrophy.

Thymic atrophy is present in acutely

exposed mice approximately 2-4 days post-exposure (Cuff et al., 1996). Thymic weight is
reduced for up to 7 days following an i.p. dose of 200 mg/kg (Barnett and Gandy, 1989). By day
7 there is an increase in thymus size and cellularity in the propanil-treated mice, however,
atrophy is still significant (Cuff et al., 1996). After 14 days post-exposure, thymus size and
cellularity have returned to normal (Cuff et al., 1996). Analysis of the T cell populations in the
mesenteric lymph nodes and spleen 7 days post-exposure shows that T cell numbers in the
periphery are unaffected as a result of the thymic atrophy (Zhao et al., 1995). Failure to detect
decreases in the peripheral T cell populations of immune organs suggests that the transient
thymic atrophy is indicative of chemical stress and that acute propanil exposure does not lead to
long-term changes in immune cell populations.
The decrease in thymic weight is accompanied by a loss in the total number of
thymocytes, as well as an overall decline in the number of T cells in the various developmental
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stages of maturation (Zhao et al., 1995). Exposure to propanil at doses as low as 100 mg/kg
decrease the number of all the CD3+ and CD3- subpopulations (Zhao et al., 1995). Mice treated
intraperitoneally with 200 mg/kg have the largest decrease in % CD4+CD8+ double positive (DP)
thymocytes 4 days post-exposure (Cuff et al., 1996). Data indicate that DP cells are the most
sensitive of the thymocyte populations (Cuff et al., 1996).

The observed decrease in the

immature population results in a downstream effect of decreasing the number of the more mature
CD4+ single positive (SP) and CD8+ SP cells (de la Rosa et al., 2005; Cuff et al., 1996). In
response to the sudden loss in the thymocyte populations, the recovery of the thymocyte
population is generated by an increase in % cycling DP and CD8+ SP cells 4 days post-exposure
(Cuff et al., 1996). The % cycling thymocyte subpopulations returns to normal by day 7,
indicating that recovery is initiated rapidly after exposure (Cuff et al., 1996). The rapid recovery
of the thymus may explain why there are no significant changes in peripheral T cell populations.
The primary mechanism by which propanil induces thymic atrophy is by increasing the
level of glucocorticoids (Cuff et al., 1996; de la Rosa et al., 2005). Acute i.p. propanil exposure
(50 mg/kg) in C57Bl/6 mice elevated the levels of corticosterone in the serum to approximately
1000 ng/ml compared to approximately 60 ng/ml for control mice (de la Rosa et al., 2005). The
rise in corticosterone serum levels peaks within one hr following propanil exposure and returns
to baseline levels within 24 hr (de la Rosa et al., 2005). Inhibition of the glucocorticoid receptors
(GR) with the GR antagonist RU486 or removal of the adrenal glands, the primary site for
glucocorticoid production, substantially abrogates thymic atrophy induced by propanil (Cuff et
al., 1996; de la Rosa et al., 2005). The potent induction of glucocorticoids after propanil
exposure also led to its recent use in modeling and predicting the immunotoxicity of compounds
using the area under the corticosterone concentration versus time curve model (Pruett et al.,
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2000; Schwab et al., 2005). This mathematical model was developed to predict the potential
immunotoxic effects of a compound using the induction of corticosterone over time after
exposure to a chemical stressor.
The extent of thymic atrophy induced by propanil was also increased when combined
with other herbicides (de la Rosa et al., 2005). The herbicide 2,4-dichlorophenoxyacetic acid
(2,4-D) did not affect the number of DP or CD4+ SP cells following a 150 mg/kg i.p. exposure
(de la Rosa et al., 2005). However, the addition of 150 mg/kg of 2,4-D combined with a 150
mg/kg dose of propanil induced a greater-than-additive decrease in the number of both the DP
and CD4+ SP cell populations (de la Rosa et al., 2005). Data demonstrate the potential for other
chemicals to enhance the toxicity of propanil (de la Rosa et al., 2005).
Analysis of T cell function after in vivo exposure to propanil indicated that T cells are
relatively resistant to the adverse effects of propanil.

As mentioned previously, propanil

exposure produced splenomegaly (Ambrose et al., 1972; Barnett and Gandy, 1989). The spleen
is also an important secondary lymphoid organ. Therefore, the spleen was chosen for early
immunotoxic characterization studies. Mixed lymphocyte reactions (MLR) are typically used to
characterize CD4+ T cell function. MLR of spleen cells from mice treated with an acute i.p. dose
of propanil one week prior to harvest demonstrated that only at the highest dose tested (400
mg/kg) was there a significant decrease in the MLR (Barnett and Gandy, 1989). In vivo cell
mediated immune responses were assessed using the contact hypersensitivity reaction (CHR)
(Barnett and Gandy, 1989). The CHR was also decreased in animals treated with only the
highest tested dose (400 mg/kg) (Barnett and Gandy, 1989). Finally, proliferation of splenocytes
from mice treated in vivo with propanil was determined following ex vivo stimulation with the T
cell mitogen, Concanavalin A (ConA). Again, only animals treated with the highest tested dose
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had significant reductions in proliferation (Barnett and Gandy, 1989).

However, ConA

stimulated splenocytes from animals treated i.p. with 200 mg/kg showed a significant reduction
in IL-2 production (27% of control) and IL-6 production (45% of control) (Zhao et al., 19982).
Together, the studies characterizing the T cell toxicity of in vivo propanil exposure indicate that
several endpoints are required to establish an accurate inference of propanil’s toxicity.
A number of studies have been performed using in vitro exposure of primary spleen cells or T
cell lines to further characterize the effect of propanil on T lymphocyte function. Murine
splenocytes exposed in vitro to propanil and stimulated with the T cell mitogen ConA have
reduced IL-2 cytokine levels. Maximal reduction (59% of control) of IL-2 was observed 24 hr
post-exposure at the peak of cytokine production in control splenocytes (Zhao et al., 1998). The
lowest tested concentration of propanil that reduced IL-2 cytokine levels was 66 μM (Zhao et al.,
1998). Propanil was also found to suppress IL-2 production in the murine T cell lymphoma line,
EL-4, and the human T cell lymphoma line, Jurkat (Zhao et al., 1999 2 ; Brundage et al., 2004).
Similar to primary T cells, propanil reduced IL-2 production by EL-4 cells maximally at 24 hr
post-exposure (Zhao et al., 1999). Sixty-six μM of propanil was the lowest concentration that
significantly reduced IL-2 production 2-fold (Zhao et al., 1999). In addition, 66 μM of propanil
inhibited transcription of IL-2 mRNA by 50% and reduced the half-life of IL-2 mRNA from 140
to 90 min in EL-4 cells (Zhao et al., 1999). These studies suggest propanil acts at both the
transcriptional and post-transcriptional level to affect IL-2 production by murine cells.
Interestingly, the human T cell line Jurkat is more sensitive to the effects of propanil than
murine T cells. Forty-eight hr after in vitro exposure to 5 μM of propanil IL-2 mRNA levels

2

Zhao et al., 1998 and Zhao et al., 1999 were originally published with incorrect doses for the in vitro
studies. The doses cited here are the correct doses.
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were reduced by 77% (Brundage et al., 2004). Propanil was also found to reduce the binding of
the IL-2 transcription factor, activating-protein 1 (AP-1), to DNA suggesting a possible
mechanism for propanil-induced suppression (Brundage et al., 2004). Fifty μM of propanil
reduced AP-1 binding maximally (20% of control) 1 hr post-exposure (Brundage et al., 2004).
AP-1 may have reduced binding activity due to the effects of propanil on one of the proteins of
the heterodimer of AP-1. Propanil decreased both the phosphorylation of c-jun as well as the
protein levels of c-jun 1 hr post-exposure (Brundage et al., 2004). It was demonstrated that the
level of c-jun mRNA was decreased early after exposure compared to control and subsequently a
delayed degradation (Brundage et al., 2004). Electron-spin resonance analysis suggests that
propanil increased a small population of lipid molecules that exhibited reduced hydrocarbon
chain mobility near the bilayer hydrocarbon core following cell stimulation (Brundage et al.,
2003). The affect of this alteration in the distribution of lipids in the membrane on IL-2
production is currently unknown (Brundage et al., 2003).
In addition to cytokine production by T cells, recent in vitro studies have been reported
that assessed the effect of propanil exposure on Cytotoxic T Lymphocyte (CTL) function. CTL
exposed to propanil in vitro during a primary MLR had proliferative capacity and CTL activity
that was comparable to vehicle-treated cells (Sheil et al., 2006). Interestingly, however, when
the CTL that had been exposed to propanil in the primary culture were re-stimulated in the
absence of additional propanil in the culture, proliferation and CTL activity was significantly
reduced (Sheil et al., 2006). Data suggest that early exposure to propanil may exert a greater
ability to reduce T cell function during a secondary response; however, these results have not
been confirmed in vivo.
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The collective studies examining the effects of propanil on T lymphocytes suggest that
although the thymus is affected by the early induction of glucocorticoids, which results in thymic
atrophy, mature T cell populations and their functions are relatively intact. Cytokine production
was the most effected by propanil exposure and, while the exact mechanism has not been
defined, transcriptional, post-transcriptional, and transcription factor activity all were altered
after exposure.

B cell toxicity and the humoral immune response
As mentioned previously, propanil was found to be myelotoxic and induced
splenomegaly. The bone marrow microenvironment is the site of B cell maturation prior to
release into circulation. The spleen is an important site for antibody production to bacterial
pathogens (Martin et al., 2001; Manz et al., 2002; Zandvoort and Timens, 2002). Approximately
40% of the lymphocytes in the spleen are B lymphocytes (Salazar et al., 2005). Together, these
organs represent two important sites for evaluating the immunotoxic effects of propanil on the
development and function of B cells.
B cell maturation proceeds in the bone marrow from the pro-B cell to pre-B cell and
finally to the immature IgM+ B cell (Rosenberg and Kincade, 1994). As discussed above,
propanil had adverse effects on developing T cell populations in the thymus. To determine if
exposure to propanil also affected developing B cell populations, pro-B, pre-B, and immature
IgM+ B cell populations were enumerated in the bone marrow after propanil treatment.

Similar

to the effect observed in the thymus propanil exposure decreased the number of developing B
cells in the bone marrow available for maturation. In vivo i.p. propanil exposure at the lowest
studied dose of 50 mg/kg decreased the number of murine pre-B cells in the bone marrow (50%
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of control) 7 days post-exposure (de la Rosa et al., 2003). Immature IgM+ B cells were also
decreased in number (50% of control) at a dose of 150 mg/kg 7 days post-exposure (de la Rosa et
al., 2003).

Fourteen days after propanil exposure the pre-B and immature IgM+ B cell

populations had returned to control levels. In addition, the transient decrease in immature B cells
in the bone marrow did not result in a loss of circulating B cells as determined by an analysis of
splenocyte populations (Salazar et al., 2005). Total splenic B cell numbers, as well as the
circulating follicular B cell population, remained unchanged following propanil exposure
(Salazar et al., 2005). Therefore, in both the thymus and the bone marrow propanil had a
transient effect on the developing immature T and B cell populations that did not result in
changes in the number of mature T cells and B cells in the periphery.
Although propanil exposure did not affect the number of B cells in the periphery, it was
demonstrated to suppress some B cell functions. Exposure in vivo to 400 mg/kg of propanil
suppressed splenic B cell proliferation after ex vivo stimulation with the B cell mitogen LPS
(Barnett and Gandy, 1989). Analysis of the IgM antibody response to both T-independent type 2
(TI-2) and T-dependent (TD) model antigens found that these responses were more sensitive to
propanil’s adverse effects than B cell proliferation (Barnett and Gandy, 1989; Barnett et al.,
1992). Exposure to propanil followed by immunization with sheep red blood cells (SRBC) on
day 3 (post-propanil treatment) decreased the number of SRBC plaque forming cells (PFC) in a
dose-dependent fashion when assayed on day 7 (Barnett and Gandy, 1989). Fifty mg/kg of
propanil was the lowest dose to significantly reduce the number of SRBC PFC (67% of control)
(Barnett and Gandy, 1989). Higher doses of propanil, 200 mg/kg, and a molar equivalent of the
major metabolite, DCA, 150 mg/kg, respectively, were found to decrease the number of PFC in
animals immunized with DNP-Ficoll 4 days following propanil exposure (75% of control)
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(Barnett at al., 1992). These reports suggest that propanil exerts immunotoxic effects either
directly on B cells or the supporting microenvironment critical for normal B cell function.

Adaptive immune response to bacteria
In general, the collective studies on immune function demonstrated that propanil exerted
suppressive effects on the immune system. Challenging the immune system with live and killed
whole bacteria provides important information toward understanding the relevance of the altered
immune functions described in the previous sections. Live bacterial challenge studies may be
utilized to determine the significance of the effect of decreased immune cell function on clearing
infections produced by common pathogens. These studies are important for assessing the risk of
infection that is associated with a specific level of immunotoxicity.
The toxic effects of propanil on the cell-mediated immune response were studied using a
Listeria monocytogenes infection model in C57BL/6 mice (Watson et al., 2000). Animals were
exposed to propanil and at various days after exposure were challenged with live L.
monocytogenes. Spleen cells and liver cells from the propanil-treated and L. monocytogenes
challenged animals had a 50% reduction in IFN-γ production compared to cells from control
animals after ex vivo stimulation with Con A or heat-killed L. monocytogenes (Watson et al.,
2000). However, analysis of spleen and liver homogenates taken directly from propanil-treated
and L. monocytogenes-infected animals showed no significant difference in the levels of IL-6,
IFN-γ, TNF-α, and IL-1β compared to control animals only infected with L. monocytogenes
(Watson et al., 2000). Additionally, animals treated with 200 mg/kg propanil and challenged
with a LD50 of L. monocytogenes did not demonstrate any greater susceptibility to infection than
control animals (Watson et al., 2000).

This indicates that a 200 mg/kg dose produces
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immunotoxic effects on cell-mediated responses measured in vitro, but does not significantly
affect the host’s ability to mount an effective immune response in vivo. A limitation of this
study is that L. monocytogenes infections are initially controlled in mice lacking an adequate
cytotoxic T cell response (Bancroft et al., 1991). However, there have been no studies reported
to date characterizing the effect of an acute propanil exposure on the immune response to a
pathogen that predominantly requires a competent cytotoxic T cell response to clear the
infection.
The effect of propanil exposure on the antibody response to a bacterial challenge was also
characterized.

The antibody response to the bacterial vaccine heat-killed Streptococcus

pneumoniae (HKSP) elicits both a TI-2 and a TD antibody response. The immunodominant TI-2
antigen is the cell wall polysaccharide phosphorylcholine (PC). S. pneumoniae also has a
number of TD antigens capable of stimulating an antibody response. Pneumococcal surface
protein A (PspA) is a TD antigen that was well characterized in antibody response studies.
C57Bl/6 mice treated i.p. with 150 mg/kg of propanil at the time of i.p. vaccination with 2x108
colony forming units (CFU) of HKSP have increased numbers of PC-specific IgM, and the
predominant PC isotypes IgG2b and IgG3, splenic antibody secreting cells (ASC) compared to
vehicle treated vaccinated animals (Salazar et al., 2005). Propanil increased the PC-specific
antibody response 4-fold 5 days post-exposure. Propanil maximally elevated the PC-specific
ASC response 4-6-fold 7 days post-exposure (Salazar et al., 2005). However, when mice were
treated i.p. with 150 mg/kg of propanil on the day of HKSP vaccination, the number of PspAspecific IgM and IgG splenic ASC was unchanged from control animals 14 days post-exposure
and vaccination (Salazar et al., 2005). Interestingly, if treatment with propanil was delayed until
day 9 after HKSP vaccination, the number of IgM and IgG PspA-specific ASC increased 2-fold
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over vehicle-treated mice on day 14, the time of the peak PspA-specific serum antibody response
(Schafer, unpublished observations).

The increase in PC-specific and PspA-specific ASC

following propanil exposure and HKSP vaccination affected IgM and IgG in a similar manner
and did not alter either the kinetics or the predominant isotypes produced to either antigen.
The mechanism regulating the increased antibody response due to propanil exposure has
not been established. However, it is clear that the ovaries play a role in mediating the antibody
increase (Salazar et al., 2006). Mice that were surgically ovariectomized and treated i.p. with
propanil and HKSP did not produce the 4-6-fold rise in PC-specific ASC (Salazar et al., 2006).
Although the ovaries are required for the propanil-induced antibody stimulation, several lines of
evidence demonstrated that the enhanced response was independent of an estrogenic mechanism
(Salazar et al., 2006). In male mice, propanil exposure also induced a similar increase in PCspecific ASC but the rise was independent of the testes as demonstrated using castrated mice
(Salazar et al., 2006).
The studies discussed above suggest that propanil is able to increase or decrease the
antibody response to a diverse set of antigens depending on the time of propanil exposure. The
initial studies characterizing the effect of propanil on the antibody response to model antigens
suppressed the response when animals were exposed to propanil prior to immunization (Barnett
and Gandy, 1989; Barnett et al., 1992). More recently, the S. pneumoniae studies demonstrated a
several fold amplification of the antibody response when animals were exposed to propanil
simultaneously or following vaccination (Salazar et al, 2005).

The data illustrate that the

consequences of propanil exposure vary depending on both the timing of the humoral immune
response and the type of antigen presented.
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The studies examining the effect of propanil on in vivo humoral and cellular immune
responses to bacteria (Watson, et al., 2000; Salazar et al., 2005) suggest that in vitro analysis of
cell function is not always indicative of the effects observed on in vivo immune responses.
Although the studies characterizing the toxicity of propanil on immune cell populations
suggested that propanil might inhibit the response to a virulent pathogen or a bacterial vaccine,
data demonstrated either no discernable change in immune effectiveness or a stimulated immune
response. The requirement for the ovaries in amplifying the humoral immune response also
underscores the importance of potential interactions with the endocrine system in influencing the
immune system.

Future Studies and Conclusions
This review should provide the basis for future studies on understanding the mechanisms
of how this commonly used pesticide affects the immune system. There are additional areas that
remain to be studied to complete the profile of the immunotoxicity of propanil in mammalian
systems. The first major gap that was discussed previously is the paucity of human studies to
definitively quantitate both the levels of exposure in humans and the outcomes of exposure.
Areas that could begin to be addressed in animal models include the effects of developmental
exposure and long-term immune deficits that may result from in utero and/or neonatal exposure
to propanil. There are several questions that remain as to propanil’s effects on additional
components of the innate immune system including complement activation and function, the
expression of Toll-like receptors or potential interaction with toll-like receptors. As CTL activity
and NK activity are inhibited after propanil exposure, the potential consequences of the
inhibition of lytic function on anti-viral and anti-tumor immunity remain to be determined. The
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differential effect propanil has on antibody production to different antigens is also not
understood. Propanil may have a direct effect on B cells, in the processing and presentation of
antigens, or on signaling pathways necessary for antibody production.

The demonstration that

propanil can enhance the humoral response after a bacterial vaccination could potentially have
implications for propanil acting as an environmental trigger for autoimmune disease, a poorly
understood area in immunology. Potential routes of environmental exposure to propanil include
aerosol or ingestion. There is very limited information on if propanil alters mucosal immune
response in the gut or the respiratory tract.
The overall literature on propanil illustrates the diverse effects a chemical exerts on the
immune system and the role that in vivo and in vitro exposure regimens play in defining the
immunotoxicity of a chemical and its mechanisms of toxicity. Propanil exerts diverse effects on
several components of the immune system including effector cells of both innate and adaptive
immune responses. A review of the literature demonstrates that the immunotoxic effects of a
chemical are quite complex and involve a number of different mechanisms underlying toxicity.
To add to the complexity, exposure to propanil may result in either suppression of immune
responses or enhancement depending on the exposure regimen and the particular response being
evaluated. The results of the studies reviewed here serve to illustrate the usefulness of in vivo
and in vitro assays in defining mechanisms underlying toxicity but also as a reminder that the
results obtained in one system may not always reflect the response that will be observed in the
other. Overall, for accurate risk assessment, a thorough analysis of the effects of chemical
exposure on the immune system must be performed using a variety of experimental systems.
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Table 1. Summary of the in vivo and in vitro effects of propanil on natural killer cells and macrophages
Cell Origin
Spleen
Peritoneal
cavity
Peritoneal
cavity
Peritoneal
exudate
cells

Route of exposure/
Length of exposure
Intraperitoneal/
7 days
Intraperitoneal/
7 days
Oral/
7 days
In vitro/24 hours

In vitro/24 hours

In vitro/2 hours

Assessment

Result

LOAEL1

Reference

NK lytic activity

Decreased (20%)2

50 mg/kg

Barnett et al., 1992

Cytokine production
(LPS stimulation)
IL-6
TNF-α
Cytokine production
(LPS stimulation)
IL-6
TNF-α
Cytokine production
(LPS stimulation)
IL-6
TNF-α
mRNA levels
(LPS stimulation)
IL-6
TNF-α
Phagocytosis

Xie et al., 1997a
Decreased (32%)
Decreased (55%)

200 mg/kg
200 mg/kg
Xie et al., 1997a

Decreased (35%)
Decreased (46%)

400 mg/kg
40 mg/kg

Decreased (25%)
Decreased (30%)

33 μM
33 μM

Xie et al., 1997a, b3

Xie et al., 1997a, b
Decreased (50%)
Decreased (50%)
Decreased (33%)

33 μM
33 μM
50 μM

Ustyugova et al., 2007

In vitro/24 minutes

ROS production
(LPS stimulation)

Decreased (45%)

100 μM

Ustyugova et al., 2007

In vitro/12 hours

RNS production
(LPS stimulation)

Decreased (40%)

100 μM

Ustyugova et al., 2007
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In vitro/12 hours

iNOS protein levels
(LPS stimulation)

THP-1
(Human
Monocytic
Cell line)

In vitro/6 hours

Cytokine production
(LPS stimulation)
TNF-α
Phagocytosis

IC-21
(Murine
macrophage
cell line)

In vitro/24 hours

In vitro/2 hours

Cytokine production
(LPS stimulation)
TNF-α

Decreased (29%)

100 μM

Ustyugova et al., 2007

Ustyugova et al., 2007
Decreased (30%)

50 μM

Decreased (57%)

50 μM

Ustyugova et al., 2007
Frost et al., 2001

Decreased (30%)

33 μM

In vitro/18 hours

NF-κB-dependent
promoter activity
(LPS stimulation)

Decreased (40%)

42.5 μM

Frost et al., 2001

In vitro/4 hours

NF-κB (p65) nuclear
levels
(LPS stimulation)
Intracellular Ca2+
release

Decreased (59%)

167 μM

Frost et al., 2001

Decreased (100%)

20 μM

Xie et al., 1997b

In vitro/2 minutes

1

LOAEL – lowest observed adverse effect level tested, mg/kg = mg propanil/kg body weight, m = in vitro dose
Result (% change) – represents the % decreased compared to the control group response
3
Xie et al., 1997a and Xie et al., 1997b were originally published with incorrect doses for the in vitro studies. A correction was
submitted to the journal. The doses listed in the table are the correct doses.
2
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Table 2. Summary of the in vivo immunotoxicity of propanil on T cell functions of the adaptive immune system
Tissue/Cell Route of exposure/ Assessment
Day post-exposure
Result
LOAEL1
line
Reference
Thymus

Intraperitoneal/
2-4 days

Spleen

Intraperitoneal/
7 days

Cell population
CD4-CD8CD4+CD8+
CD4+CD8CD4-CD8+
Mixed lymphocyte
response

Spleen

Intraperitoneal/
7 days

Contact hypersensitivity
response

Spleen

Intraperitoneal/
7 days

Cytokine production
(ConA stimulation)
IL-2
IL-6
Cytokine production
(ConA stimulation) IL-2

Splenocytes

In vitro/
24 hours

EL-4

In vitro/
24 hours

Jurkat

Cytokine production
(PMA stimulation)
IL-2
IL-2 mRNA levels
IL-2 mRNA half-life
IL-2 mRNA

Cuff et al., 1996
de la Rosa et al., 2005

No change
Decreased
Decreased
Decreased
Decreased (47%)

100 mg/kg
100 mg/kg
200 mg/kg
400 mg/kg

Barnett and Gandy, 1989

Decreased (55%)

400 mg/kg

Barnett and Gandy, 1989

200 mg/kg

Zhao et al., 1998

Decreased (27%)
Decreased (45%)
Decreased (59%)

66 μM

Zhao et al., 1998

Decreased (22%)

66 μM

Zhao et al., 1998

Decreased (2 fold)
Decreased
Decreased (77%)

66 μM
66 μM
5 μM

In vitro/
Brundage et al., 2004
48 hours
1 hour
AP-1 binding
Decreased (20%)
50 μM
1 hour
c-jun protein
Decreased
50 μM
1 hour
c-jun phosphorylation
Decreased
50 μM
1
LOAEL – lowest observed adverse effect level tested, mg/kg = mg propanil/kg body weight
2
Result (% change) – where indicated the (%) represents the % decreased compared to the control group response
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Table 3. Summary of the in vivo immunotoxicity of propanil on B cell functions of the adaptive immune system
Tissue
Route of exposure/
Assessment
Result
LOAEL1
Reference
Day post-exposure
Bone
marrow

Intraperitoneal/
7 days

Cell population
pro-B
pre-B
IgM+ B

de la Rosa et al., 2003
No change
Decreased (50%)2
Decreased (50%)

50 mg/kg
50 mg/kg

Spleen

Intraperitoneal/
7 days

Proliferation
(LPS stimulation)

Decreased (33%)

400 mg/kg

Barnett and Gandy, 1989

Spleen

Intraperitoneal/
7 days

SRBC Plaque forming
units

Decreased (33%)

50 mg/kg

Barnett and Gandy, 1989

Spleen

Intraperitoneal/
7 days

DNP-Ficoll Plaque
forming units

Decreased (75%)

200 mg/kg

Barnett et al., 1992

Spleen

Intraperitoneal/
7 days

PC-specific antibody
secreting cells

Increased (4 fold)

150 mg/kg

Salazar et al., 2005

1
2

LOAEL – lowest observed adverse effect level tested, mg/kg = mg propanil/kg body weight
Result (% change) – where indicated the (%) represents the % decreased compared to the control group response
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Abstract
Macrophages are a critical part of the innate immune response and natural surveillance
mechanisms. As such, proper macrophage function is crucial for engulfing bacterial pathogens
through phagocytosis and destroying them by generation of reactive oxygen (ROS) and reactive
nitrogen (RNS) species. The production of a number of cytokines by macrophages such as
tumor necrosis factor-α (TNF-α), interleukin-1β and interleukin-6, plays an important role in the
initiation of the acquired immune response creating an inflammatory environment favorable for
fighting a bacterial infection.

3,4-Dichloropropionaniline (DCPA) suppresses several

inflammatory parameters, including TNF-α production through a mechanism where nuclear
factor-κB (NF-κB) DNA binding is inhibited but not entirely abrogated. The goal of the present
study was to evaluate the effects of DCPA on the inflammatory mediators of macrophages,
including ROS and RNS in both murine peritoneal exudate cells (PEC) and the human
monocytic cell line, THP-1. The ability to perform phagocytosis and directly kill Listeria
monocytogenes was also assessed. The results indicate that DCPA decreases the ability of both
types of macrophages to phagocytize beads and generate both types of reactive species, which
was correlated with a decrement in listericidal activity. These results demonstrate that DCPA
has profound effects on macrophage function, and provide insight into the potential mechanisms
of immunosuppression by DCPA.

Key words
bactericidal, phagocytosis, Listeria monocytogenes, Dichloropropionaniline, macrophage, THP-1 cell line
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Introduction
Macrophages are critical for normal maintenance of homeostasis as well as immune
regulation and tumor surveillance.

Whereas phagocytosis of apoptotic cells is a normal

homeostatic function of macrophages, phagocytosis and clearance of bacteria and viruses is a
crucial function of innate immunity.

Through cytokine and chemokine production, direct

cellular contacts and antigen presentation, macrophages orchestrate the initiation of adaptive
immune responses (Adams and Hamilton, 1984; Celada and Nathan, 1994; Ganz 1993). Clearly,
alterations in any of the normal functions of these cells can lead to serious, even fatal
consequences.
Defects in normal macrophage function contribute to chronic granulomatous disease
(CGD) and result in altered immunity to bacterial and fungal pathogens. Patients with CGD
develop granulomas consisting of fused monocytes and macrophages, which have engulfed
bacteria but are unable to destroy them as a result of a defect in the nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase. Activation of NADPH oxidase is normally induced
by microbial products such as bacterial lipopolysaccharide (LPS), or by cytokines such as
interferon-γ, interleukin (IL)-1β, or IL-8 (Bonizzi et al., 2000).

Superoxide produced by

NADPH oxidase diffuses into the bacterium and kills it by inactivating essential enzymes (Miller
and Britigan, 1997; Roos et al., 1984). Superoxide can be converted to hydrogen peroxide
(H2O2), which can be a more reactive oxidant. H2O2 oxidizes cellular membranes and enzymes
and causes DNA damage by interacting with Fe2+ to form the toxic ferryl radical which inhibits
membrane transport processes (Forman and Torres, 2002; Imlay et al., 1988; Weiss and Peppin,
1986). Hydroxyl radicals (•OH) are also very potent oxidants implicated in the oxidation of
bacterial proteins, DNA and lipids (Ohya et al., 1998a). All these reactive oxygen intermediates

88

are critical for macrophage bactericidal mechanisms against the facultative intracellular
pathogen, Listeria monocytogenes (Alvarez-Dominguez et al., 2000; Ohya et al., 1998a).
Production of reactive nitrogen species (RNS) is also important for control of microbial
proliferation. Nitric oxide (NO) is produced by the inducible nitric oxide synthase (iNOS or
NOS2) in the presence of O2, which catalyzes enzymatic oxidation of L-arginine to L-citrulline,
using NADPH-derived electrons (Marletta, 1994).

Increased iNOS expression and NO

production are observed at sites of infection in animal models, such as toxoplasmosis and
leishmaniasis, or in human infections such as tuberculosis (Nicholson et al., 1996). NO readily
reacts with O2 resulting in production of transient and unstable N2O3 and, ultimately, unreactive
NO2- ion product. Activated macrophages will also produce superoxide, which reacts with NO to
form the reactive and toxic peroxynitrite (ONOO-) which in turn decomposes into additional
nitrates and nitrites (Hibbs, Jr. et al., 1988; Miwa et al., 1987; Stuehr and Marletta, 1987).
Expression of the iNOS gene in macrophages is regulated mainly at the transcriptional level,
particularly by NF-κB, which binds to multiple sites on the iNOS gene promoter (Xie et al.,
1993). iNOS, similar to NADPH oxidase, in that it is stimulated by proinflammatory cytokines
such as IFN-γ, TNF-α and IL-1β, as well as by LPS (Fang, 1997).
Major listericidal mechanisms include the production of ROS and RNS by activated
macrophages (Alvarez-Dominguez et al., 2000; Muller et al., 1999; Ohya et al., 1998b;
Ouadrhiri et al., 1999). Although ROS and RNS have been identified as major anti-bacterial
defense mechanisms, the details of how these agents work in activated macrophages are not
completely understood. Both interferon-γ (IFN-γ) activation of macrophages and production of
tumor necrosis factor-α (TNF-α) are necessary for clearance of L. monocytogenes (Buchmeier
and Schreiber, 1985; Kiderlen et al., 1984; Nakane et al., 1988; Nakane et al., 1989). Therefore,
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reductions in macrophage cytokine production, reactive oxygen and/or nitrogen species
generation result in increased susceptibility to L. monocytogenes infection.
The most common routes of exposure to DCPA are thought to be inhalational and dermal
during manufacturing and application and to a lesser extent oral through drinking water and
food. Upon entry into the individual, propanil is rapidly metabolized in the liver by the enzyme
acylamidase into the major metabolite 3,4-dichloroaniline (3,4-DCA). Both DCPA and 3,4DCA are often detected in the urine of the general population living in the agricultural areas as
well as occupationally exposed people (Turci et al., 2006;Wittke et al., 2001).

In

nonoccupationally exposed people, the urine levels of 3,4-DCA were reported to reach a
maximum level of 6.19 lg/l (Turci et al., 2006). Thus, it is apparent that the general population in
areas that use DCPA carry a measurable body burden of 3,4-DCA.
The experiments reported herein were conducted in vitro, and the relationship of the in
vitro concentrations used with expected body burdens found in humans is a relevant question.
However, given that blood levels of a pesticide, which would be more relevant for study, may
exceed the urine levels (McMullin et al., 2003), and that data on in vivo organ concentrations are
unavailable, extrapolating from measured human urine levels to in vitro exposure concentrations
is imprecise.
DCPA reduces several macrophage functions, including TNF-α and IL-6 production, IP3mediated calcium release and nuclear NF-κB translocation (Frost et al., 2001; Xie et al., 1997a;
Xie et al. 1997b). The present report was designed to determine the direct effects of DCPA on
different macrophage functions. The results demonstrate that DCPA reduced phagocytic ability,
ROS and RNS generation, and listericidal activity of both human and mouse macrophages.
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Materials and Methods
Cell line culture and maintenance
The human monocytic cell line THP-1 was obtained from the American Type Culture
Collection (Rockville, MD). The cells were maintained in RPMI 1640 media (BioWhittaker,
Walkersville, MD) supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan UT),
10mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine and 5×10-5 M
2-mercaptoethanol (all obtained from Sigma, St. Louis, MO) (complete media), and incubated at
37°C in an atmosphere of 5% CO2.
Animals
C57Bl/6 female and male mice were purchased from Charles River Farms (Wilmington,
DE). Animals were allowed to acclimate for 7 days before experimental procedures were
initiated. Food and water were provided ad libitum. Experimental procedures were conducted
between the ages of 7 and 12 weeks. All animal experiments were reviewed and approved by the
WVU Animal Care and Use Committee.
Primary macrophage harvest and preparation
Resident and inflammatory primary macrophages (PEC, peritoneal exudate cells) were
utilized.

Inflammatory macrophages were elicited by injecting 1.5 ml of aged 4% sterile

thioglycollate broth intraperitoneally (i.p.) four days before macrophage harvest. To harvest the
PEC, 10 ml sterile Dulbecco's PBS (DPBS, BioWhittaker) containing 10 U/ml heparin or 100μM
EDTA (Sigma) was injected into the mouse’s exposed peritoneum and syringe aspirated.
Resulting cell suspensions were washed twice in complete media, plated at the appropriate
density in tissue culture dishes, and allowed to adhere for 3 hours at 37°C in 5% CO2.
Nonadherent cells were removed by the addition of two bursts of warm PBS and vacuum
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aspiration. Macrophage enrichment was monitored by nonspecific esterase staining and was ≥
95%. Viability was monitored by trypan blue exclusion and was routinely ≥ 95%.
Cell stimulation and exposure to DCPA
PEC or THP-1 cells were simultaneously stimulated with LPS from Escherichia coli
Serotype 055:B5 (Sigma) and treated with DCPA (3,4-dichloropropionanilide, 99% purity,
ChemServices, West Chester, PA) diluted in absolute ethanol (Mallinckrodt, Paris, KY) at
concentrations indicated in the Results section. Control cultures received an equivalent amount
of absolute ethanol only and are referred to as vehicle or 0 μM DCPA. The final concentration
of ethanol for all cultures was 0.10%. LPS was dissolved in RPMI 1640 at 1 mg/ml and added to
cultures at 1 µl per ml of culture media. The possible cytotoxic effects of DCPA alone during
the culture period were determined and no significant difference in viability was measure at any
DCPA concentration used for this study.
TNF-α specific enzyme-linked immunosorbent assay (ELISA)
THP-1 cells were plated at 1.5×106 cells/3ml in 6 well plates then differentiated by
addition of 100 ng/ml of phorbol 12-myristate 13-acetate (PMA, Sigma) for 24 hours.
Differentiation of the cells led to their adherence to tissue culture dishes. Monolayers were
washed vigorously with PBS and cultured in complete media for 72 hours. Differentiated cell
were stimulated with 1μg/ml LPS (Sigma) in the presence of DCPA or vehicle and incubated for
6, 12 and 24 hr at 37°C in 5% CO2. Supernatants were collected and assayed by human TNF
ELISA set with detection limit of 7.8 pg/ml (cat. 555212, BD Biosciences PharMingen, San
Diego, CA) according to manufacturer’s instructions. The plates were then read at an optical
density of 450 nm on a μQuant plate reader (BioTek Instruments, Inc. Winooski, VT).
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Bacteria
Listeria monocytogenes, strain EGD, were grown overnight in 10 ml of brain-heart
infusion (BHI) broth (Difco Laboratories, Detroit, MI) with aeration at 37°C. One ml of this
culture was inoculated into 50 ml of sterile BHI broth and incubated at 37°C with aeration until
culture reached an OD600 of approximately 0.4 (2 to 4 hours). An OD600 absorbance value of
1.000 is equivalent to 1 × 109 bacteria/ml. The culture was diluted to the appropriate number of
viable L. monocytogenes.
Phagocytosis
THP-1 cells were differentiated by addition of 100 ng/ml PMA (Sigma) as described
above. On the day of the phagocytosis assay, differentiated THP-1 cells or PEC (previously
prepared and allowed to adhere overnight) were trypsinized, washed in PBS, seeded in 5 ml
snap-cap tubes at 1 × 106 cells/ml in PBS +1% FBS. Phagocytosis assays were conducted as
described with minor modifications (Antonini et al., 2000). Briefly, carboxylate-modified, 2.0
μm yellow-green FluoroSpheres (Molecular Probes, Eugene, OR) were added at a concentration
of approximately 30 beads/cell. LPS, DCPA and vehicle treatments were added as indicated.
Cells were incubated on a rocker in constant motion at 37°C in 5% CO2 for 2 hours. Cells were
pelleted by centrifugation at 500 g, washed twice to remove any free beads and allowed to
adhere to sterile cover slips placed in 6 well plates for two hours. Adherent cells were washed
twice with warm PBS, fixed with 2% paraformaldehyde for 30 minutes, stained with the
fluorochrome nile red (0.1 μg/ml; Molecular Probes) for 5 minutes and washed with PBS.
Coverslips were then mounted to glass slides and stored in the dark (a maximum of 48 hours
before analysis). Confocal microscopy using a Zeiss LSM 510 microscope equipped with an
argon laser (Zeiss, Thornwood, NY) was performed to evaluate the cells which were scored as
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having 0, 1-2, 3-4, ≥5 beads/cell. A weighted phagocytic index was calculated by multiplying
the number of cells with 0 beads by 0; the number of cells with 1-2 beads/cell by 1; the number
of cells with 3-4 beads/cell by 2; and the number of cells with 5 or more beads/cell by 4,
summing these products, and dividing by 200 (the total number of cells counted).
Determination of Listericidal activity
THP-1 or PEC (5 × 105 cells/ml) were activated with 100 U/ml rhIFN-γ (BD
PharMingen) or rmIFN-γ (BD PharMingen), respectively, for 24 hours in RPMI 1640 media
containing 10% FBS (no antibiotics). This activation did not cause adhesion of THP-1 cells,
which continued to grow in loose suspension as described (Ouadrhiri et al. 1999). THP-1 cells
were washed with PBS, resuspended in 1 ml PBS containing 1% FBS and infected with 2.5 × 106
Listeria monocytogenes, strain EGD/ml. Activated PEC were trypsinized, washed in PBS,
resuspended in PBS containing 1% FBS, and also infected with 2.5 × 106 L. monocytogenes,
strain EGD/ml. LPS stimulation and vehicle and DCPA treatments were initiated at the same
time as initial infection. Cells were transferred to 5 ml snap-cap tubes and incubated at 37°C in
5% CO2 on a rocker for 1 hour to allow for infection. Cells were then centrifuged at 500 g and
washed twice with PBS.

The final pellet was resuspended in PBS containing 25 μg/ml

gentamicin. Initial infection levels (1 hour) were obtained by lysing cells in 500 μl of ice-cold,
sterile, distilled water and plating 50 μl of the lysate. Remaining treatment groups were returned
to incubation conditions in the gentamicin solution. Cell lysates were prepared at 3 and 5 hours
post infection. Lysates were plated on TSA plates (Trypticase Soy Agar; Difco Laboratories,
Detroit, MI) using an Autoplate 4000 (Spiral Biotech, Bethesda, MD) in triplicate. Plates were
incubated at 37°C for 24 hours, and colonies were counted using a CASBA 4 plate scanner and
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CIA-BEN colony imaging and analysis software (Spiral Biotech). Resulting L. monocytogenes
colony forming units (CFU) per 1ml were calculated and compared across treatments.
Respiratory burst
Luminol, 5-amino-2-3dihydro-1,4 phthalazinedione (Sigma) was used to amplify
chemiluminescence (CL) signals generated by activation of the NADPH-oxidase (Allen and
Loose, 1976; Dahlgren and Karlsson, 1999). The CL signal generated by luminol occurs as the
compound accepts an electron from free radical species as they return to ground state. To
measure respiratory burst, we differentiated THP-1 cells, or harvested PEC as previously
described. All cells were plated at 5 × 105 cells/ml in 35 mm tissue culture dishes. Cells were
washed with PBS before elicitation of the respiratory burst. In a total reaction volume of 2 ml,
respiratory burst activity was elicited by addition of 100 μM PMA simultaneously with PBS, 5
μM luminol, and indicated concentrations of LPS, and either ethanol or propanil. Dishes were
placed in a pre-warmed luminometer (Berthold, Co., Wilbad, Germany) and CL readings were
taken every minute for 20 minutes. Data shown represent CL curves generated from these
readings over time to peak values. Control experiments to determine if DCPA alone quenched
the CL signal showed no interference of the assay by DCPA.
Intracellular ROS measurement
THP-1 cells were plated at 2.25 × 105 cells per ml in Lab-Tek® chambered cover glass
system (4 chamber; Nalge Nunc International Corp, Naperville, IL) in phenol red-free complete
RPMI and differentiated by addition of PMA as described above. Cells were washed with PBS
three times and incubated for 40 min at 37oC in 5% CO2 in the dark with 5μM 5-(and 6)chloromethyl-2',7'-dichlorodihydrofluorescein

diacetate,

acetyl

ester

(CM-H2DCFDA,

Invitrogen, Carlsbad, CA). CM-H2DCFDA is a non-fluorescent dye which enters the cells by
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passive diffusion; it becomes fluorescent only when it is oxidized by ROS, particularly by
hydrogen peroxide (H2O2), hydroxyl radicals (•OH), or their down stream free radical products.
After incubation with the dye, cells were washed three times with PBS and Hanks’ Balanced Salt
Solution (HBSS, BioWhittaker) was added to the wells. Cells were treated with different doses
of DCPA or vehicle control and simultaneously stimulated with 1μg/ml LPS and 100μM PMA.
Cultures were examined with a Zeiss Axiovert 100M microscope equipped with a laser scanning
confocal attachment (model LSM 510; Zeiss) to locate the cells and analyze their images
overtime at 512 × 512 pixel resolution. CM-H2DCFDA was excited with the 488-nm line of an
argon/krypton mixed-gas laser; emission was collected with a 505 nm long-pass filter. Images
were collected every 2 min for up to 26 min; 14 images total were taken for the course of each
experiment; cells were treated and stimulated after the first scan. Pixel time was 1.76 μs with the
scan time of 983.04 msec for each image taken. Plan-Neofluar 40×/0.75 objective was used to
obtain the images. Fluorescence emission from 25-30 cells per experiment was analyzed by LPS
510 software, and at least 3 experiments were performed per treatment group.
NO release from mouse peritoneal macrophages
Resident PEC were harvested as previously described and cultured in 5 ml of complete
RPMI in 60 mm plates. The cells were stimulated with 1µg/ml LPS and simultaneously treated
with 0, 5, 25 or 100 µM DCPA and incubated for 12, 24 and 48 hours for NO induction. Each
treatment was plated in duplicate and analyzed in triplicate. The supernatant of each culture was
transferred to a plastic tube, centrifuged at 2000 rpm, and the supernatant was stored at -80oC
assayed for NO. Greiss reagent was used to measure nitrite (NO2-) as a stable form of NO.
Briefly,

100µl

test

sample

was

mixed

with

150μl

of

Greiss

reagent

(0.1%

naphthylethylenediamine chloride (Sigma) in 60% acetic acid and 1% sulfanilamide (Sigma) in
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30% acetic acid) for 10 min, and color development was assessed at 540 nm with a μQuant plate
reader (BioTek Instruments, Inc. Winooski, VT). A standard curve was generated with a serial
dilution of sodium nitrite dissolved in culture medium.
Immunoblotting
PEC were harvested as described above and plated at 6.5 × 106 cells/5ml in 60 mm dishes
(Becton Dickinson Labware, Franklin Lakes, NJ) in complete RPMI and allowed to adhere for 3
hr at 37Co 5% CO2. Nonadherent cells were removed by addition of three bursts of warm DPBS
and aspirated by pipette; 5 ml of complete RPMI was added to the wells and cells were incubated
for 1 hr before treatments were administrated. The cells were stimulated with 1µg/ml LPS and
simultaneously treated with 5, 25 or 100 µM DCPA or ethanol, and incubated for 6, 12 and 24
hours for iNOS protein detection. Whole-cell extracts were prepared using lysis buffer (Cell
Signalling Technology, Beverly, MA) according to manufacturer instructions, and protein levels
were quantitated using BCA protein assay kit (Pierce, Rockford, IL). 15μg of whole-cell lysates
were separated by 8% polyacrylamide gels using SDS-PAGE, transferred to polyvinylidene
fluoride membranes (Pall Corporation, Pensacola, Fl) overnight at 0.1A. The membranes were
then blocked by incubation for 45 min with 5% nonfat dry Carnation milk (Nestle) in Trisbuffered saline (TBS: 20 mM Tris-HCl, ph 7.6, 137 mM NaCl) containing 0.1% Tween 20
(TBS-Tween), and then rinsed three times with TBS-Tween. The protein blots were cut across
to incubate the upper half overnight with rabbit polyclonal IgG anti-NOS2 (Santa Cruz
Biotechnology, Santa Cruz, CA; sc-650; 1:2000 dilution) and the lower half with goat polyclonal
IgG anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA; sc-1616; 1:1000 dilution) in TBSTween plus 5% BSA. After incubation with the appropriate secondary antibodies (Sigma,
A0545 and A5420), blots were developed using Phototope-HRP detection kit for western blots
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(Cell Signaling) and visualized by exposing to X-Ray film (Kodak BioMax Light Film, Eastman
Kodak Company, Rochester, NY) for 15 sec to 3 minutes. Densitometric analysis was completed
with Optimas software (Media Cybernetics, Silver, MD).
Statistical Analysis
Data were analyzed using JMP (SAS, Inc, Belmont, CA) and SigmaStat (SPSS, Inc.
Chicago, IL) statistical analysis software. Significance of interactions between treatment groups
was assessed using an analysis of variance.

For all analyses, the minimum criterion of

significance was set at p < 0.05. Each experiment was repeated at least twice with similar
results. Data shown represent means of at least three experiments or representative experiments,
as indicated. Error bars represent standard deviation unless otherwise noted to represent standard
error, where appropriate.

Results
DCPA suppresses TNF-α production by THP-1 cells
The production of TNF-α, a key inflammatory mediator produced by activated
macrophages, is reduced when murine macrophages are exposed to DCPA (Xie et al., 1997b;
Xie et al., 1997a). To provide a closer link to possible effects on humans, a human cell line was
used throughout this study. To determine if DCPA caused a similar reduction in TNF-α in
human cells, we measured TNF-α production from the human monocytic cell line, THP-1
(Figure 1). DCPA reduced TNF-α production from THP-1 cells at all time points tested. In a
representative experiment, DCPA caused a reduction in TNF-α production from 2465 ± 107,
2279 ± 196, and 1998 ± 18.68 pg/ml in the vehicle control cells to 1637 ± 125, 1321 ± 142, and
1202 ± 168 pg/ml at 6, 12, and 24 h, respectively, in the 100μM DCPA-treated cells. The
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difference in TNF-α levels between the 0 and both 50 and 100μM DCPA was statistically
significant at all time points (p < 0.001). A statistically significant reduction in TNF-α
production was also observed in the 25μM DCPA–treated cells at 12 h (p < 0.001). Differences
in TNF-α production between the 0 and 5 or 25μM concentrations were not significantly reduced
at 6 and 24 h.
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Figure 1. TNF-α production by differentiated THP-1 cells.
THP-1 cells were differentiated by PMA, treated with DCPA or vehicle control, stimulated with
LPS, and incubated for 6, 12, and 24 h. Supernatants were removed and assayed for TNF-α
production by ELISA. The experiment was performed three times, and each treatment was
performed and analyzed in triplicate. The mean TNF-α production of a representative
experiment ± SD is shown; * indicates significant difference from vehicle control (p<0.001).
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In vitro exposure to DCPA reduces phagocytic capabilities
A major function of macrophages in vivo is phagocytosis of bacteria and cellular debris.
To determine if DCPA affected the ability of PMA-differentiated THP-1 cells and PEC to
phagocytize fluorescent 2.0 μm beads a weighted phagocytic index was measured. The weighted
phagocytic index allows a quantification of the amount of phagocytosis (number of beads per
cell) in addition to the number of macrophages that are capable of phagocytosis. DCPA caused
significant reductions (p< 0.05) in the ability of THP-1 and PEC cells to phagocytize beads. The
weighted phagocytic index for THP-1 cells was reduced from 0.730 ± 0.303 in the vehicle
control to 0.320 ± 0.07 and 0.267 ± 0.068 in the 50 and 100 μM DCPA groups, respectively
(Figure 2A). Significant differences (p< 0.05) were also evident with the DCPA-treated PEC,
from an average of 1.084 ± 0.108 in the vehicle control group to 0.724 ± 0.071 and 0.534 ± 0.072
in the 50 μM and 100 μM treatments, respectively (Figure 2B).
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Figure 2. Phagocytic abilities are reduced by DCPA.
PMA-differentiated THP-1 (A) or PEC (B) were activated by IFN-γ for 24 hours before addition
of LPS with either vehicle or indicated concentrations of DCPA.

Phagocytosis of 2 μm

fluorescent beads was determined by confocal microscopy. A weighted phagocytic index was
calculated as described in the Materials. Experiments were performed 3 times with similar
results. The mean phagocytic index ± SD is shown. The asterisk indicates significant difference
from vehicle control (p<0.05).
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In vitro exposure to DCPA reduces anti-bacterial capabilities
The effect of DCPA on the ability of THP-1 and PEC macrophages to kill L.
monocytogenes was measured as an indicator of the biological consequences of DCPA exposure.
IFN-γ plus LPS stimulated macrophages that were treated with vehicle had significant bacterial
reductions by 5 hours (p<0.05) (Figure 3A and 3B). Treatment of both THP-1 cells and PEC
cells with 100 μM DCPA abrogated or reduced their listericidal activity (Figure 3A and 3B).
Fewer bacteria were initially phagocytosed by THP-1 cells and PEC treated with 50 or 100 μM
DCPA than by cells treated with vehicle (p<0.05) (Figure 3A and 3B; 1 hour). THP-1 cells
treated with 100 μM DCPA actually showed that the bacteria continued to multiply in these cells
at least until the 3 h time point, while vehicle treated cells showed a consistent decline in the
number of intracellular bacteria. PEC cells treated with 50 μM DCPA showed a steady decline
in the number of intracellular bacteria. Those treated with 100 μM phagocytosed a much smaller
number of bacteria (1 h value) and there appeared to be a slight increase in their CFU over time.
These results demonstrate that DCPA causes inhibition of listericidal activity of macrophages,
and further support the effects of DCPA on phagocytosis described above.
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Figure 3. DCPA reduces listericidal activity of macrophages.
Mean Listeria CFU ± SEM from IFN-γ activated THP-1 (A) or PEC (B) following Listeria
infection. The mean CFU ± SEM of each time point is shown. The asterisk represents a
significant differences at the noted time point between the vehicle control and DCPA-treated
macrophages (vertical comparison) (p<0.05) and, contrary to convention, a dagger represents no
significant difference between the 1h time point and the indicated time point of the same
experimental group (horizontal comparison).
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DCPA exposure inhibits the generation of a respiratory burst
Functional aspects of macrophage biology include destruction of phagocytosed
organisms via generation of reactive oxidants and nitrogen species. Exposure to 100 μM DCPA
virtually shuts down the respiratory burst activity of both cell types, whereas 50 μM DCPA had
an intermediate effect on the respiratory burst (Figure 4A and 4B). The response of THP-1 cells
treated with 25 μM DCPA was similar to vehicle control cells (data not shown). The respiratory
burst of PEC was more sensitive to the effects of DCPA, resulting in significantly different
concentration-dependent decreases in integrated relative light units upon exposure to 50 and 100
μM DCPA (Figure 4B).
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Figure 4. DCPA reduces respiratory burst activity.
Generation of respiratory burst was measured from PMA-differentiated THP-1 cells (A) and
PEC (B). PMA was used to elicit the respiratory burst from cells simultaneously treated

with

LPS, and either vehicle or the indicated concentrations of DCPA, in the presence of luminol.
Chemiluminescence was detected by a luminometer and expressed as

relative

light

units.

Experiments were performed twice in THP-1 cells and 3 times in PEC with similar results. A
representative THP-1 experiment (A) is shown due to variability in the level of luminescence
detected from the THP-1 cells in experiments conducted on different days. Mean relative light
units ± SD are shown for PEC (B). ANOVA results confirm differences between each treatment
of PEC from the 3-minute time until the experiment was terminated (*p<0.05).
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Intracellular ROS production is inhibited by DCPA.
The respiratory burst due to ROS production in phagocytic cells produced by hydrogen
peroxide and hydroxyl radicals is an important function of macrophages. Figure 5A shows
representative confocal image fields of PEC cells at 0, 10 and 20 min after LPS stimulation with
or without DCPA. Amount of fluorescence produced by the cells during oxidation of CMH2DCFDA dye directly corresponded to the amount of ROS generated. Figure 4B shows the
increase in measured fluorescent intensity with respect to time of PEC cells treated with the
vehicle. PEC cells exposed for 20 min to vehicle and LPS demonstrated a 2-fold increase in
fluorescent intensity from 53.73 ± 2.76 to 103.47 ± 15.63, indicating an induction of ROS
production (Figure 5B). PEC treated with 25 or 100μM DCPA showed a significant decrease in
ROS generation over the 26 m assayed (P<0.05). Further, 5 μM DCPA treated cells also
demonstrated a decrease in ROS generation for the 26 min (data not shown). Altogether, these
data confirm the luminol CL data, providing more specific characterization of the respiratory
burst in the presence of DCPA. THP-1 cells show a decrease in ROS generation (fluorescent
intensity) at all concentrations of DCPA; however, none of these decreases were significantly
different (data not shown). The lack of significance for the 100 µM treated THP-1 cells may be
due to a high variance in the data as there is a constant decrease in fluorescence intensity during
the initial 14 min of the experiment, however, the lack of an apparent concentration-dependent
decrease at 5 and 25 µM would imply that THP-1 cells are fairly resistant to DCPA with regard
to ROS generation.
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Figure 5. DCPA reduces ROS production by macrophages.
A) Generation of ROS species was measured in PEC (A-L). PMA was used to elicit a reactive
oxygen species production from cells simultaneously treated with LPS, and either vehicle or the
indicated concentrations of DCPA, in the presence of CM-H2DCFDA dye. ROS production was
observed for 26 min and images were collected every 2 min with 0.983 sec scan time. Images
taken at 0, 10 and 20 min of each treatment are shown. Images are representative of typical
fields, 230.3 x 230.3 μm, seen in three experiments. The magnification is 40X. Scale bar is
generated and inserted by LSM software and represents 100μm. B) Time course of ROS
production observed in PEC. An average of three experiments shown, fluorescent intensity ±
SD. * indicates significant difference from vehicle control (p<0.05).
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DCPA inhibits nitrite production
RNS are important anti-microbial factors and their production over time can be
monitored by measuring nitrite accumulation in culture supernatants of activated macrophages.
The production of nitrite by PEC was significantly decreased in 100 μm DCPA-treated cells
compared to vehicle treated control cells by 40% at 12 hr (P<0.05) (Figure 6). Cells treated with
25μM and 100μM DCPA for 24 h resulted in 15% and 22% decreases, respectively (P<0.01) in
nitrate production (Figure 5). Treatment with 5μM DCPA did not decrease nitrate production at
any time point (data not shown). Nitrite production by THP-1 cells was not measured because
human macrophages do not produce NO when stimulated in vitro (Stuehr and Marletta, 1987).
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Figure 6. DCPA inhibits nitrite production.
PEC were treated with DCPA or vehicle control, stimulated with LPS and incubated for 12, 24
and 48 hours. Supernatants were removed and assayed for nitrite (NO2-) accumulation in the
media by Griess reagent. Experiments were performed three times, each treatment was run and
analyzed in triplicates. The mean nitrite production of a representative experiment ± SD is
shown, * indicates significant difference from vehicle control (p<0.05 at 12 hr; p<0.01 at 24 hr).

110

DCPA inhibits iNOS protein expression
In activated macrophages, nitric oxide is produced by iNOS, an enzyme converting Larginine to L-citrulline. To determine whether the reduced NO production by PEC exposed to
DCPA was due to the inhibition of iNOS protein expression, cellular lysates were analyzed by
Western Blotting. In these experiments PEC were treated with 5, 25 or 100 µM DCPA or
vehicle and simultaneously stimulated with LPS for 6, 12 and 24 h. iNOS protein expression
was undetected in unstimulated PEC, however gradual induction of expression was observed
over period of time as a result of LPS stimulation (Figures 6A and 6B). A 6 h treatment resulted
in detectable levels of iNOS, demonstrating 10% and 14% inhibition at 25 and 100 μM DCPA,
respectively. A 12 h treatment resulted in a dose-dependent decrease in iNOS protein levels
demonstrating the largest decrease of 29% in 100 μM DCPA treated cells and 9% in 25 μM
DCPA treated cells compared to vehicle-treated controls. The longest exposure to DCPA, 24 h,
demonstrated a 12% decrease at 100 μM DCPA. The lowest concentration of DCPA, 5 μM, did
not decrease expression in comparison to control-treated cells.
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Figure 7. DCPA inhibits iNOS protein expression.
PEC were treated with DCPA or vehicle control, stimulated with LPS and incubated for 6, 12
and 24 hours. A) The protein levels of iNOS and β-actin in whole-cell lysates were analyzed by
Western Blotting. B) Ratio of relative band density between iNOS and β-actin was calculated.
Values are means ± SD of three independent experiments.
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Discussion
Appropriate macrophage function is critical for normal immune functions and
homeostasis, as macrophages participate in various aspects of innate and adaptive immunity as
well as tumor surveillance. The present report demonstrates that DCPA decreased TNF-α
production from the human THP-1 cell line, similar to results shown previously in murine cells
(Frost et al. 2001; Xie et al. 1997a). DCPA also caused reductions in phagocytic ability, ROS
and RNS production, and listericidal activity in both the THP-1 cell line and primary murine
PEC. The nuclear factor primarily responsible for activating TNF-α transcription is NF-κB.
Previous work has demonstrated that DCPA causes reductions in nuclear levels of NF-κB in
THP-1 cells (Frost et al., unpublished data). Since DCPA inhibits NF-κB activation it likely
plays a role in the reduction of TNF-α and investigations are underway to further elucidate the
mechanism of suppression of TNF-α production by DCPA.
The THP-1 cell line is a human monocytic cell line that has been extensively
characterized (Tsuchiya et al., 1980, Tsuchiya et al., 1982). These cells have been shown to
mobilize NF-κB into the nucleus upon stimulation with LPS and produce cytokines typical of
activated human macrophages (Steer et al., 2000; Gatanaga et al., 1991). Further differentiation
of the cells with PMA leads to a mature, differentiated macrophage phenotype (Tsuchiya et al.,
1982). We wanted to demonstrate the effects of propanil in both murine and human models.
Primary PEC were used for murine studies because we had previously established the effects of
propanil on cytokine production, and other immune parameters with these cells (Xie et al.,
1997a, Xie et al., 1997b, Frost et al., 2001). THP-1 cells were chosen for a human model due to
the existing body of literature regarding their monocytic phenotype, and characterizing their
cytokine response, respiratory burst activity, and phagocytic abilities (Condino-Neto et al, 1998;
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Delbosc et al., 2002; Gatanaga et al., 1991; Steer et al., 2000; Tsuchiya et al., 1980). The use of
THP-1 cells also did not impose the restrictions of utilizing primary human monocytes.
DCPA has also been shown to ablate the IP3-mediated calcium release in macrophages
despite the generation of IP3 equivalent to control cells (Xie et al. 1997b). An extensive body of
literature has established a critical role for calcium (Ca2+) in various aspects of the generation of
a respiratory burst in macrophages and neutrophils (Dahlgren et al., 1992; Dusi et al., 1993;
Foyouzi-Youssefi et al., 1997; Geiszt et al., 1999; Movitz et al., 1997). Calcium has specifically
been implicated to play a role in the translocation of the p47phox cytosolic component of the
NADPH oxidase to the membrane-bound cytochrome b portion (Zhou et al., 1997). Recently,
Granfeldt et al. (2002) further evaluated the differential activation of plasma membrane- and
granule-localized NADPH oxidase, showing that intracellular NADPH oxidase activity could be
activated by an increase in intracellular Ca2+ via the capacitative Ca2+ entry, whereas plasma
membrane-localized NADPH oxidase activity required the capacitative Ca2+ influx in addition to
other signaling events. The results demonstrating reductions in respiratory burst activity have
been generated using luminol, which can cross the plasma membrane (Dahlgren and Karlsson,
1999), as the chemiluminescent detector, therefore the measurements may reflect a decrease in
activity of either intracellular or plasma membrane-localized NADPH oxidase activity, or both.
This decrease in NADPH oxidase activity is potentially a result of the altered calcium dynamics
induced by DCPA.
The effects of DCPA on respiratory burst activity may also affect the listericidal
capability of macrophages. Contributions of the various phagocyte oxidase (phox) proteins to
the listericidal capacity of macrophages have been investigated using mice with targeted gene
deletions (Dinauer et al., 1997; Endres et al., 1997; Shiloh et al., 1999).
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These studies

demonstrated that macrophages harvested from gp91phox-/- mice were substantially defective in
their ability to kill L. monocytogenes (Shiloh et al., 1999). Dinauer et al. (1997), also using
gp91phox-/- mice, suggested that neutrophils and ROS controlled early in vivo Listeria infection.
Macrophages and RNS production were suggested to be important in later stages of infection.
The CM-H2DCFDA fluorescent method demonstrated that within 2-3 min of LPS and
PMA stimulation hydrogen peroxide and hydroxyl radical were produced. DCPA treatment
inhibited their production and that can potentially decrease the ability of macrophages to fight L.
monocytogenes and other bacterial infections. Previous studies by Watson et al. (Watson et al.,
2000) demonstrated that exposure to DCPA 2 or 7 days prior to L. monocytogenes infection did
not affect bacterial colonization of the spleens and livers at 3 days post-infection when compared
to control mice. However, it is not known if exposure to DCPA at the time of infection would
have an immediate effect on the ability of macrophages to control early bacterial replication and
thus increase susceptibility of the host. Myers et al (Myers et al., 2003) demonstrated that
reactive oxygen species were absolutely required for L. monocytogenes clearance by activated
macrophages. In their model, gp91phox-/- mice defective in NADPH oxidase were unable to
generate superoxide, resulting in bacterial escape from the phagolysosome and proliferation in
the cytoplasm (Myers et al., 2003). A critical factor implicated in the escape of Listeria from the
phagolysosome is lysteriolysin O (LLO), a sulfhydryl-activated pore-forming hemolysin secreted
by L. monocytogenes. It has been reported that mutants lacking LLO remained in vacuoles
without proliferating (Gaillard et al., 1987; Portnoy et al., 1988). Myers et al (Myers et al.,
2003) suggest that ROS could inactivate LLO, thereby preventing the escape of Listeria into the
cytosol. The present report studies the initial events in the course bacterial infection, which does
not contradict with previously published report by Watson et al (2000).
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THP-1 cells generally were less sensitive that primary mouse cells. There are known
changes in this cell line from normal blood monocytes that may explain this difference includes
the lack of functional p53 resulting in impaired signal transduction (Traore et al., 2005). THP-1
cells also failed to respond to chemokine stimulation to polymerize actin and demonstrate cell
polarization (Vaddi and Newton, 1994). NADPH oxidase activity and superoxide production in
THP-1 cells were also diminished compared to primary blood monocytes (Almeida et al., 2005).
Examination of NO2 accumulation in the media allowed for direct RNS detection upon
LPS stimulation of primary mouse cells. A decrease in nitrite production can be explained by
down regulation of iNOS enzyme, resulting in low levels of nitric oxide production. Studies on
LPS-activated macrophages demonstrated that the iNOS gene has two consensus sequences for
binding of NF-κB. Upon LPS activation, the heterodimer p65/p50 has been reported to be
responsible for NF-κB binding to the iNOS promoter (Na et al., 1999; Spink et al., 1995; Xie et
al., 1994; Kim et al., 1997). DCPA exposure caused a decrease in NF-κB binding and its
transcriptional activity (Frost et al., 2001) and could explain a decrease in NO production
through inhibition of iNOS gene expression. A study by Ohya et al. (1998a) observed an
induction of iNOS mRNA transcription and gene expression followed by accumulation of nitrite
in culture media as a result of L. monocytogenes infection.
DCPA also decreases phagocytosis.

Interestingly, phagocytosis in macrophages is

regulated, to some extent by activation of the signaling proteins syk and PI-3K (Aderem and
Underhill, 1999). Activation of PI-3K leads to the downstream activation of PKC, Akt and NFκB. The Internalin B (Inl B) protein of L. monocytogenes, which mediates internalization of the
bacterium, also requires activation of PI-3K (Ireton et al., 1996). InlB ultimately leads to NF-κB
activation via PI-3K and Akt (Mansell et al., 2001). DCPA alters NF-κB activation (Frost et al.,
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2001) and further studies have demonstrated that DCPA also affects Akt activity (Barnett et al.,
unpublished data). Studies examining the effects of DCPA on the upstream mediator PI-3K are
ongoing. It is possible that the signaling alterations induced by DCPA exposure affect several
pathways that culminate in the observed reductions in phagocytosis.
The data herein demonstrate the profound effects of DCPA on macrophage function.
DCPA exposure results in decreased TNF-α production, phagocytosis, ROS and RNS production
and listericidal activity. Additionally, the effect of DCPA on the respiratory burst suggests the
potential use of DCPA as an inhibitor/antioxidant. Future laboratory experiments are aimed at
furthering our understanding of respiratory burst regulation and redox signaling in cells using
DCPA.
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Abstract
Activated macrophages produce a number of inflammatory mediators, such as tumor
necrosis factor-α (TNF-α), interleukin-1β and interleukin-6. These mediators play an important
role in the initiation of the acquired immune response creating an inflammatory environment
favorable for fighting bacterial infections and attracting other cell types to the inflamed site.
Prostaglandins (PGs) are another type of inflammatory mediator produced by two enzymes in
response to bacterial stimuli and secreted by activated macrophages. The first enzyme, known as
cytosolic phospholipase A2 (CPLA2), converts membrane phospholipids into free arachidonic
acid.

The second enzyme, cyclooxygenase (COX), utilizes arachidonic acid to produce

endoperoxide intermediate (PGH2), which is in turn metabolized to various prostaglandins.
PGE2 is the major type of prostaglandins produced by activated macrophages.

3,4-

dichloropropionaniline (DCPA) is a chemical known to suppress several inflammatory
cytokines, including TNF-α, IL-6 and IL-1β. It also suppresses the ability of macrophages to
perform phagocytosis and generate reactive oxygen and nitrogen species. The goal of the
present study was to evaluate the effects of DCPA on the production of PGE2 by murine
peritoneal exudate cells (PEC).

A dramatic decrease of PGs secretion was observed after

exposure to DCPA. An induction of CPLA2 and COX-2 enzymes was studied to investigate the
mechanisms behind this inhibition. A known selective COX-2 inhibitor, CAY10404, was used
to compare its effect on PGE2 secretion with DCPA. The mouse ear inflammation model also
confirmed the anti-inflammatory properties of DCPA. However, examination of CPLA2 protein
phosphorylation, COX-2 protein induction and COX-2 enzymatic activity were not affected by
DCPA suggesting a different mechanism of PGs inhibition.

129

Introduction
Prostaglandins (PGs) are ubiquitous compounds involved in a variety of homeostatic and
pathological processes. They mediate a wide range of physiological functions, such as control of
blood pressure, contraction of smooth muscle, and modulation of inflammation. During acute
and chronic inflammation PGs are produced by activated macrophages among other
inflammatory mediators, such as cytokines, reactive oxygen and reactive nitrogen species. The
first step in PGs formation is a conversion of membrane-bound phospholipids into free
arachidonic acid (AA) by Ca2+-dependent cytosolic phospholipase A2 (cPLA2). This enzyme is
known to play a major role in the overproduction of lipid mediators during inflammation
(Bonventre et al, 1997; Uozumi et al, 1997). Arachidonic acid is in turn converted into the
endoperoxide intermediate (PGH2) by two isozymes, cyclooxygenase (COX)-1 and COX-2.
PGH2 diffuses from the COX proteins and is converted by the action of cell-specific synthases in
to the various prostaglandins, such as PGE2, PGF2α, PGD, PGI (Smith et al, 2000). PGE2 is one
of the major PGs produced. COX-1 and -2 share 60% homology at the amino acid levels;
however, they have different physiological functions (reviewed in Wu T., 2005). COX-1 is
expressed constitutively and is responsible for regulating normal physiological functions such as
gastric acid secretion and platelet aggregation (Roth et al, 2001). COX-2 is not constitutively
expressed, but is transiently induced by growth factors, cytokines and bacterial toxins.
Overexpressed COX-2 is a characteristic of chronic inflammatory conditions, such as rheumatoid
arthritis (Sano et al, 1992; Anderson et al, 1996) and experimental peritonitis (Hinson et al,
1996). It is induced by several transcription factors, such as AP-1, NF-IL-6, NF-κB and NF-AT
(Smith et al, 2000).
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There are several strategies for inhibiting PGs synthesis. Inhibitors of PLA2 will limit the
amount of AA available for PGs production. Non-steroidal anti-inflammatory drugs (NSAIDs)
will reduce levels of PGs by inhibiting the activity of COX isozymes.

Due to the small

differences in the amino acid sequences near catalytic site, COX-1 and COX-2 can be inhibited
by different NSAIDs (Gierse et al, 1996; Kurumbail et al, 1996; Meade et al, 1996). Aspirin
inhibits both enzymes non-specifically, where as CAY10404 affects only COX-2 activity and is
proven to be the most specific inhibitor with a Selectivity Index (SI) of (COX-1 IC50/COX-2
IC50) > 500,000 (Parashar et al, 2005). In comparison, the SI of celecoxib, the second selective
COX-2 inhibitor, is about 400 (Habeeb et al, 2000).
3,4-Dichloropropionaline (DCPA) is the aniline compound known to suppress several
inflammatory mediators produced by activated macrophages.

Overproduction of the

inflammatory mediators is involved in many diseases, such as rheumatoid arthritis, chronic
hepatitis and pulmonary fibrosis (Tilg et al, 1992; Isomaki et al, 1998; Coker et al, 1998).
DCPA inhibits the production of cytokines such as tumor necrosis factor-alpha (TNF-α),
interleukin (IL)-1β and IL-6 which is accompanied by a reduction in NF-κB DNA binding
activity (Frost et al, 2001). The reactive oxygen and reactive nitrogen species (ROS and RNS)
generation is also reduced by DCPA, affecting not only nitrite production but decreasing the
protein levels of inducible nitric oxide synthase (iNOS), an enzyme responsible for NO
production. The ability of DCPA to suppress a number of inflammatory mediators suggests its
use as an inhibitor/antioxidant (Ustyugova et al, 2007).
In this report, we demonstrate that DCPA dramatically inhibits PGE2 production by LPSstimulated macrophages without affecting COX-2 protein expression and its enzymatic activity.
The degree of PGE2 inhibition by DCPA was similar to the inhibition by CAY10404, the most
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specific COX-2 inhibitor. An in vivo animal model of ear inflammation confirmed the antiinflammatory properties of the studied compound.
Materials and Methods
Cell culture and maintenance
Resident and inflammatory primary macrophages (PEC, peritoneal exudate cells) were
maintained in RPMI 1640 media (BioWhittaker, Walkersville, MD) supplemented with 10%
fetal bovine serum (FBS, Hyclone, Logan UT), 10mM HEPES, 100 U/ml penicillin-100 μg/ml
streptomycin, 2 mM L-glutamine and 5×10-5 M 2-mercaptoethanol (all obtained from Sigma, St.
Louis, MO) (complete media), and incubated at 37°C in an atmosphere of 5% CO2.
Animals
C57Bl/6 female and male mice were purchased from Charles River Farms (Wilmington,
DE). Animals were allowed to acclimate for 7 days before experimental procedures were
initiated. Food and water were provided ad libitum. Experimental procedures were conducted
between the ages of 7 and 12 weeks. All animal experiments were reviewed and approved by the
WVU Animal Care and Use Committee.
Primary macrophage harvest and preparation
Resident and inflammatory primary macrophages (PEC, peritoneal exudate cells) were
utilized.

Inflammatory macrophages were elicited by injecting 1.5 ml of aged 4% sterile

thioglycollate broth intraperitoneally (i.p.) four days before macrophage harvest. To harvest the
PEC, 10 ml sterile Dulbecco's PBS (DPBS, BioWhittaker) containing 100μM EDTA (Sigma)
was injected into the mouse’s exposed peritoneum and syringe-aspirated.

Resulting cell

suspensions were washed twice in complete media, plated at the appropriate density in tissue
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culture dishes, and allowed to adhere for 3 hours at 37°C in 5% CO2. Nonadherent cells were
removed by the addition of two bursts of warm PBS and vacuum aspiration.
Cell stimulation and exposure to DCPA
PEC were harvested as described above and plated at concentration of 6.5×106 cells/5ml
in 60 mm dish (Corning, Acton, MA) in complete RPMI and allowed to adhere for 3 hr at 37Co
5% CO2. Nonadherent cells were removed by addition of three bursts of warm DPBS and
aspirated by pipette; 5 ml of complete RPMI was added to the wells and cells were incubated for
1 hr before treatments were administrated. The cells were stimulated with 1µg/ml LPS from
Escherichia coli Serotype 055:B5 (Sigma) and simultaneously treated with DCPA (3,4dichloropropionanilide, 99% purity, ChemServices, West Chester, PA) diluted in absolute
ethanol (Mallinckrodt, Paris, KY) at concentrations indicated in the Results section. Control
cultures received an equivalent amount of absolute ethanol only and are referred to as vehicle or
0 μM DCPA. The final concentration of ethanol for all cultures was 0.10%. LPS was dissolved
in RPMI 1640 at 1 mg/ml and added to cultures at 1 µl per ml of culture media. The possible
cytotoxic effects of DCPA alone during the culture period were determined and no significant
difference in viability was measure at any DCPA concentration used for this study.
PGE2 release from mouse peritoneal macrophages
PGE2 secretion was measured in supernatants using Correlate-EIA Prostaglandin E2 kit
(Assay Designs, Ann Harbor, MI) according to the manufacturer’s protocol. Time course study
has not been conducted beyond 24 h because no further increase in PGE2 production was
observed between 24 and 48 h. CAY10404 (Cayman Chemical, Ann Arbor, MI) and Aspirin
(Sigma) were diluted in absolute ethanol (100%) (Mallinckrodt) and added directly to the cell
cultures before LPS stimulation.

133

COX enzyme activity assay
After removal of supernatants cells were layered with 5 ml RPMI complete containing 30 μM
arachidonic acid (Cayman Chemical) and incubated for 10 min at 37oC. Next, the reaction was
stopped by an addition of aspirin (Sigma, 2.1mM ), then supernatants were immediately removed
and stored at -80oC. Cells were then incubated with 300 μl of 1M sodium hydroxide (NaOH,
Sigma) for 5 min, and supernatants were removed and stored at -20oC for protein analysis by
BCA Protein Assay (Pierce, Rockford, IL).
Mouse ear inflammation model
Phorbol 12-myristate 13-acetate (PMA, 2.5μg, Sigma) dissolved in 20μl DMSO (Sigma) was
applied in 10μl volume to both inner and outer surfaces of the left ear of C57Bl/6 mice. The
right ear was treated with 25, 100 or 1000 μM DCPA dissolved in DMSO and PMA. Four mice
per treatment group were used. Mice in the control group received DMSO as a vehicle control
on the left ear, and right ear was left untreated to monitor the effects of the vehicle. After 4 h,
the animals were sacrificed by cervical dislocation and circular sections (8 mm diameter) of both
ears were punched out and weighed.
Immunoblotting
PEC were harvested and plated as described above, stimulated with 1µg/ml LPS and
simultaneously treated with 5, 25, 100 µM DCPA or ethanol, and incubated for 6, 12 and 24
hours for COX-2 protein detection. Whole-cell extracts were prepared using lysis buffer (Cell
Signaling Technology, Beverly, MA) according to manufacturer instructions, and protein levels
were quantified using BCA protein assay kit (Pierce, Rockford, IL). 15 μg of whole-cell lysates
were separated by 8% polyacrylamide gels using SDS-PAGE, transferred to polyvinylidene
fluoride membranes (Pall Corporation, Pensacola, Fl) overnight at 0.1A. The membranes were
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then blocked by incubation for 45 min with 5% nonfat dry Carnation milk (Nestlé, Glendale CA)
in Tris-buffered saline (TBS: 20 mM Tris-HCl, ph 7.6, 137 mM NaCl) containing 0.1% Tween
20 (TBS-Tween), and then rinsed three times with TBS-Tween. The protein blots were cut
across to incubate the upper part overnight with rabbit polyclonal IgG anti-COX-2 (sc-1745) or
rabbit polyclonal IgG anti-phospho cPLA2 (sc-34391-R) from Santa Cruz Biotechnology, Santa
Cruz, CA at 1:2000 dilution and the lower part with goat polyclonal IgG anti-actin (Santa Cruz
Biotechnology, sc-1616; 1:1000 dilution) in TBS-Tween plus 5% bovine serum albumin (BSA).
After incubation with the appropriate secondary antibodies (Sigma, A0545 and A5420), blots
were developed using Phototope-HRP detection kit for western blots (Cell Signaling
Technology) and visualized by exposing to X-Ray film (Kodak BioMax Light Film, Eastman
Kodak Company, Rochester, NY) for 15 sec to 3 minutes. Densitometric analysis was completed
with Optimas software (Media Cybernetics, Silver Springs, MD).
Statistical Analysis
Significance of interactions between treatment groups was assessed using an analysis of
variance. For all analyses, the minimum criterion of significance was set at p < 0.05. Each
experiment was repeated at least twice with similar results.

Error bars represent standard

deviation unless otherwise noted to represent standard error, where appropriate.

Ear

inflammation model was analyzed using one-way ANOVA comparing two ears of the same
animal.
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Results
DCPA inhibits PGE2 production from mouse peritoneal macrophages
To assess effects of DCPA on LPS-induced PGE2 production in PEC, cell culture media
was harvested and the amount of secreted PGE2 was measured for over 24 h period (Figure 1).
PGE2 levels in unstimulated cultures were 891 ± 144 at12 hr. This low amount of PGE2 was
attributed to the functional activity of constitutively expressed COX-1 enzyme.

In LPS-

stimulated macrophages, PGE2 production was significantly higher and continually increased
over time from 3592 ± 490.73 pg/ml at 6 h to 11470 ± 275.32 pg/ml at12 h and reaching 13214.5
± 590 pg/ml by 24h post-stimulation. This large increase in PGE2 production by LPS-stimulated
macrophages can be explained by a rapid induction of COX-2 enzyme. DCPA treatment had a
dramatic effect on PGE2 production by LPS-stimulated macrophages reducing it in
concentration-dependent manner (Figure 1). The highest concentration of DCPA used, 5 μM,
reduced PGE2 production by 89% (1913.5 ± 71.4 pg/ml) and 83.9% (23203 ± 123 pg/ml) at 12
and 24 h, respectively, compared to ethanol-treated control cultures produced 17713 ± 574.1
pg/ml and 14323 ± 1315 pg/ml. Lower concentrations of 1, 0.5 and 0.05 μM DCPA resulted in
73, 60 and 22% inhibition at 12 h after stimulation, and 64, 52, 25% decrease at 24 h compared
to ethanol-treated controls. Even 0.01 μM DCPA reduced PGE2 production by 30% at 24 h time
point (Figure 1).
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Figure 1. DCPA inhibitis PGE2 production in a dose dependent manner.
Secreted PGE2 (pg/ml) production by LPS-stimulated PECs treated with 0.01, 0.05, 0.1, 1, 5 μM
DCPA for 12 and 24 h. Experiments were performed three times, each treatment was run and
analyzed in triplicates. The mean PGE2 production of a representative experiment ± SD is
shown, * indicates significant difference from vehicle control (p<0.01).
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CAY10404 inhibits PGE2 production and COX enzymes activity
To compare the ability of DCPA to inhibit PGE2 production by activated macrophages, a
specific inhibitor of COX-2 was used. As shown in Figure 2a, the lowest concentration of 1 nM
CAY10404 had no effect on cell cultures which released 13428 ± 996 pg/ml and 15047 ± 1653
pg/ml PGE2 at 12 and 24 h post-treatment, respectively.

Treatment with 0.5 and 5 μM

CAY10404 resulted in 80% and 90% reduction in PGE2 at 12 h compared to ethanol-treated
controls, respectively. At 24 h, PGE2 levels were decreased by 67% and 84% for 0.5 and 5 μM
CAY10404 compared to ethanol-treated cultures, respectively. These results demonstrate that
similar micromolar concentrations of DCPA and CAY10404 were able to inhibit PGE2
production by 70-90%.
The ability of CAY10404 to inhibit COX-2 activity as a measure of PGE2 secreted over a
10-min period was tested (Figure 2b). Cells treated with CAY10404 and stimulated with LPS
for 6, 12 and 24 hrs were washed, and then an exogenous source of prostaglandins, arachidonic
acid, was added to the cell cultures and PGE2 secretion was measured after 10 min incubation by
EIA. The largest concentration of CAY10404, 1 μM, inhibited COX-2 activity by 80-90% at all
time-points measured (Figure 2b).
CAY10404 inhibits COX-2 through binding into an active site pocket of enzyme,
preventing it from converting arachidonic acid into PGs. The next set of experiments was
designed to test whether DCPA affects PGE2 production through the same mechanism.
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Figure 2. CAY10404 inhibits PGE2 production and COX enzyme activity.

a). Secreted PGE2 (pg/ml) production by LPS-stimulated PEC at 12 and 24 h. b). Secreted PGE2
(pg/ml / 10 min / 2 mg/ml) produced over 10-min period from exogenously added arachidonic
acid by LPS-stimulated PEC at 6, 12 and 24 h. Experiments were performed twice, each
treatment was run and analyzed in duplicates. The mean PGE2 production of a representative
experiment ± SD is shown, * indicates significant difference from vehicle control (p<0.01).
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DCPA does not affect in vitro COX isozymes activity in PEC
To examine in vitro COX enzyme activity, DCPA-treated and stimulated cell cultures
were supplemented with arachidonic acid, and PGE2 secreted during 10-min period was
measured as described for CAY10404 experimets (Figure 3).
difference among treatments and time points were found.
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Figure 3. DCPA does not affect in vitro COX isozymes activity.

Secreted PGE2 (pg/ml / 10 min / 2 mg protein) produced from exogenously added arachidonic
acid by PEC. The mean PGE2 production of a representative experiment ± SD is shown.
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DCPA does not affect COX-2 protein expression
A dramatic decrease in PGE2 production might be explained by an impaired induction of
COX-2 protein. To test this hypothesis, protein extracts from unstimulated and stimulated cells
were resolved by SDS-Page and probed for COX-2 protein expression (Figure 4). As expected,
unstimulated macrophages did not express any detectable levels of COX-2, while LPSstimulated macrophages expressed protein at all time points measured, reaching maximum at 12
h and declining by 24 h post-treatment. No changes among the treatment groups have been
observed demonstrating that induction of COX-2 enzyme was not affected by DCPA treatment.
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Figure 4. DCPA does not affect COX-2 protein expression.
PECs were treated with DCPA or vehicle control, stimulated with LPS and incubated for 6, 12
and 24 hours. The protein levels of COX-2 and β-actin in whole-cell lysates were analyzed by
Western Blotting.
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DCPA does not affect cPLA2 phosphorylation
cPLA2 activation is triggered by two events: an increase in intracellular Ca2+ levels and
phosphorylation on Ser505 within the first 5 min after stimulation. To investigate whether
phosphorylation of protein was affected by DCPA, whole cell lysates were subjected to SDSPage and probed for phospho-cPLA2 expression (Figure5). To capture the initial steps of protein
activation and subsequent phosphorylation, 5, 15, 30 and 45 min time-points were observed. As
expected, 5 min after LPS stimulation macrophages expressed low levels of phosphorylated
cPLA2 similar to unstimulated cells.

Later time-points (15, 30 and 45 min) demonstrated

upregulated levels of phosphorylated protein. However, no changes between treatment groups
were observed.
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Figure 5. DCPA does not affect cPLA2 protein phosphorylation.
PECs were treated with DCPA or vehicle control, stimulated with LPS and incubated for 5, 15,
30 and 45 min. The protein levels of cPLA2and β-actin in whole-cell lysates were analyzed by
Western Blotting.
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Ear inflammation model
To determine the ability of DCPA to inhibit the synthesis of inflammatory mediators in
vivo, the mouse ear inflammation model has been used. In this model, inflammation was
induced by PMA dissolved in DMSO (control) and applied topically to the both surfaces of the
mouse ear (Figure 6). The other ear of the same animal was treated with mixture of PMA and
DCPA also dissolved in DMSO.

Induction of an inflammation was demonstrated by an

increased weight of the 8 mm ear section from 17.7 ± 0.35 mg in DMSO treated controls to 27.3
± 1.31 mg in PMA-treated samples. In animals treated with 25 μM DCPA + PMA, the ear
section weight was 25.06 ± 1.5 mg, which was not statistically significantly different from PMAtreated samples with a weight of 25.26 ± 1.2 mg. However, treatment with 100 μM DCPA
reduced the ear section weights from 32.05 ± 1.9 mg in PMA treated controls to 27.35 ± 2.47 mg
in DCPA-treated (15% decrease) (p<0.005). The highest concentration of DCPA tested, 1000
μM resulted in even larger reduction of the section weights from 30.05 ± 3.9 mg to 24.62 ± 4.6
mg (19% decrease).
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Table 1. Ear inflammation model.

Mice per

Left Ear

Right Ear

treatment group

Ear section weight (± SD), mg

Ear section weight (± SD), mg

n=2

16.2±0.98 (untreated)

17.75±0.35 (DMSO)

n=4

25.26±1.16 (PMA+DMSO)

25.06±1.53 (25μM DCPA in DMSO)

n=4

32.05±1.93 (PMS+DMSO)

27.35±2.47*(100μM DCPA in DMSO)

n=4

30.07±3.91 (PMA+DMSO)

24.62±4.607 (1mM DCPA in DMSO)

PMA-induced ear inflammation presented as ear section weights (mg) from different treatment
groups (n=4 per group) measured 4 h after stimulation. The mean ear section weight of a
treatment group ± SD is shown, * indicates significant difference from vehicle control (p<0.05)
(one-way ANOVA).
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Discussion
The ability of DCPA to suppress the production of inflammatory mediators, such as TNFα and IL-6, and the generation of ROS and RNS, has been previously described (Xie, et al,
1997a, Xie, et al, 1997b, Ustyugova et al, 2007). The present study demonstrates that DCPA
dramatically inhibits PGE2 production by LPS-stimulated macrophages, without affecting COX2 protein induction or interfering with its enzymatic activity. In vivo studies of the inflammatory
potential of DCPA confirms its ability to reduce the local inflammatory response in the PMAinduced mouse ear inflammation model.
Prostaglandins are considered to promote inflammation by inducing vasolidation,
increasing vascular permeability and cellular migration to the site of inflammation (Dubois et al,
1998; Williams and Shacter, 1997; Williams and Morley, 1973). The present study demonstrates
that DCPA dramatically inhibits PGE2 production by LPS-activated macrophages.

A

concentration as low as 0.01 μM DCPA inhibited secreted PGE2 release by 30% at 24 h posttreatment. The highest dose of 5 μM DCPA suppressed PGE2 production to the baseline levels
of unstimulated cells, totally abrogating induced PGE2 generation. The ability of DCPA to
inhibit PGE2 was compared to a highly selective COX-2 inhibitor, CAY10404. A concentration
of 5 μM CAY10404 completely abrogated the LPS-induced PGE2 production, through
suppression of COX-2 enzyme activity. Surprisingly, the micromolar concentrations of DCPA
and CAY10404 used were strikingly similar and resulted in a comparable degree of PGE2
inhibition. 0.1 mM Aspirin, a prototypic non-specific COX-1 and COX-2 inhibitor also inhibited
PGE2 production to the baseline levels.
The ability of DCPA to inhibit COX enzymatic activity was tested by supplementing cell
cultures with exogenous arachidonic acid and evaluated the amount of PGE2 secreted during 10-
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min period. No significant difference among the treatment groups was observed, suggesting that
the enzymatic ability of COX isozymes was not affected by DCPA. Next, the protein expression
of COX-2 was examined to test whether the enzyme is properly induced by LPS stimulation. It
was possible that DCPA was inhibiting COX-2 expression through a decrease in NF-κB binding
activity, previously reported by Frost et al. (2001). Previous studies also demonstrated that
DCPA treatment caused a reduction in inducible levels of iNOS protein, whose transcription is
NF-κB-dependant (Ustyugova et al, 2007). COX-2 protein expression is also regulated by NFκB, including a number of other transcription factors, such as AP-1, NF-AT and NF-IL6 (Smith
et al, 2000). However, the relative importance NF-κB and its contribution to COX-2 induction
in macrophages is controversial. Some studies report a correlation between an inhibition of NFκB activation and a decrease in the induction of COX-2 followed by treatment with antiinflammatory compounds (Won et al, 2005; Park et al, 2006). A study of cardamonin applied to
LPS-stimulated macrophages demonstrated reduced iNOS protein induction through a
mechanism of interfering with NF-κB DNA binding. However, the induction of COX-2 enzyme
has not been affected by this compound, which parallels with the present study (Hatziierema et
al, 2006).
Another enzyme known to be crucial for prostaglandin production is cytosolic
phospholipase A2 (cPLA2) located upstream from COX isoezymes in the PGs signaling cascade.
In order to become activated, cPLA2 is directly phosphorylated by members of the mitogenactivated protein kinases (MAPK) (Lin et al, 1993), and then, upon an increase in intracellular
Ca2+ levels, it is translocated to the membrane (Clark et al, 1995). These two events allow for
translocation of cPLA2 from the cytosol to the membrane site to where its substrate resides
(Kramer et al, 1997; Leslie 1997).

No change in phosphorylation pattern of cPLA2 was
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observed. However, an increase in intracellur Ca2+ release might be affected. It has been
previously demonstrated, that 20 µM DCPA completely abrogated intracellular Ca2+ release in
LPS-stimulated PEC (Xie et al, 1997b), which might potentially suppress cPLA2 activation and
inhibit downstream signaling events resulting in a decrease in arachidonic acid release and
subsequent reduction of prostaglandins production.
A study by Burke et al. (1999) characterized a choline derivative known to inhibit cPLA2
reversibly. The studied compound acts by inhibiting cPLA2 enzyme at the lipid-water interface
through partitioning into the bilayer and competing with membrane phospholipids for the active
site of the enzyme. It is possible that DCPA interferes with the macrophage membrane by
inserting into the lipid bilayer or changing its architecture. Brundage et al. (2003) studied the
mobility of hydrocarbon chains in T-lymphocytes and demonstrated that DCPA alters the
distribution of lipids in the membrane by increasing a small population of lipid molecules that
exhibited reduced hydrocarbon chain mobility. The study of macrophage cell line, IC-21, did
not produce similar data, but it is possible that the membrane of activated macrophages is
affected differently, and these changes can not be captured by the methods used in the study.
The in vivo ear inflammation model tested whether DCPA was able to reduce local
inflammation induced by PMA. The inflammatory response is coordinated by many cell types
including macrophages, lymphocytes, leukocytes and mast cells.

DCPA is known to

suppress/alter T and B lymphocyte functions, which may reduce an inflammatory response or
suppress inflammation.

The weight reduction of the sections indicates the lower rate in

infiltration of polymorphonuclear leukocytes and a decrease in vascular permeability in the
treated ear, through suppression of ROS and RNS generation, cytokines, histamine and
prostaglandins production (Dugas et al., 1995; Wilkinson 1994).
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The data herein demonstrate the profound ability of DCPA to suppress PGE2 production
by activated peritoneal macrophages. The degree of inhibition was comparable with the newest
selective inhibitors of COX-2. However, COX-2 protein expression and its enzymatic activity
were not affected suggesting a different mechanism of PGs inhibition. The in vivo model of
PMA-induced mouse ear inflammation provided additional evidence for the anti-inflammatory
abilities of DCPA.
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Abstract

The transcription factor NF-κB (nuclear factor·κB) plays a central role in the inducible
expression of a wide range of immune and inflammatory response genes. This cellular response
is a dynamic process characterized by either oscillations or stable induction of NF-κB nuclear
binding. Changes in dynamics of binding result in the expression of distinct subsets of genes
leading to different physiological outcomes. Chemical manipulation of NF-κB binding activity
can be used to study differential gene expression and used in treatment of pathological
conditions. We examined NF-κB DNA binding activity in LPS stimulated IC-21 cells by EMSA
and NTFA assay.

Both methods detected damped oscillatory behavior of NF-κB with

differences in a degree of sensitivity and reproducibility. Based on experimental data, a kinetic
model simulating NF-κB activation process was developed to capture the dynamic of its
regulation.

The oscillatory behavior of activated NF-κB was manipulated using 3,4-

dichloropropionaniline (DCPA) in conjunction with LPS stimulation. DCPA is known to inhibit
production of two of NF-κB inducible cytokines, IL-6 and TNF-α, by reducing but not
completely abrogating NF-κB-induced transcription. In this paper we demonstrated that DCPA
treatment resulted in a potentiation of early NF-κB activation by LPS. Results from the NTFA
with lower signal-to-noise ratio than EMSA combined with in silico modeling revealed changes
in NF-κB dynamics which have never been previously reported. Our results highlight the
importance of cell type and stimuli specificity in transcription factor activity assessment, which
makes assay selection important for determining network inference and drug discovery.
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Introduction
NF-κB is a family of structurally related and evolutionarily conserved proteins related to
the proto-oncogene c-rel. In mammals, the family of NF-κB proteins includes Rel (cRel), RelA
(p65), RelB, NF-κB1 (p50), and NF-κB2 (p52) (Ghosh et al., 1998). Homo- and heterodimers of
these NF-κB proteins combine to form active and repressive complexes of gene transcription.
The p50/p65 heterodimer of NF-κB is the most frequently studied and most abundant complex in
cells (Baldwin, 1996).

In resting cells, NF-κB is maintained inactive in the cytoplasm

complexed with its inhibitors (IκBs), which exist in three isoforms, IκBα, β and ε (Baldwin,
1996). Upon activation through a variety of receptor signaling pathways, including the Toll-like
receptor (TLR 3 ) 4 and Tumor Necrosis Factor (TNF) receptor family members, IκBs undergo
phosphorylation, ubiquitination and proteolytic degradation (Ghosh et al., 19981; Wallach et al.,
1999). Phosphorylation of the IκBs is regulated by a multi-subunit kinase, termed IκB kinase
(IKK), which contains two catalytic subunits, IKKα and IKKβ, and a regulatory subunit IKKγ
(NEMO) (Hayden et al,. 2004). Proteolytic degradation of IκBs allows for rapid translocation of
free NF-κB from the cytoplasm to the nucleus. While in the nucleus, active NF-κB binds to
DNA and promotes the transcription of multiple genes, including the auto-inhibitor IκBα. Newly
synthesized IκBα enters the nucleus where it binds to NF-κB, thereby enhancing NF-κB’s
dissociation from the DNA and causing it’s re-exportation to the cytoplasm where it joins the
pool of inactive NF-κB complexes (Ghosh et al., 1998).

Continuous cycling of IκBα

degradation and resynthesis results in oscillations in nuclear NF-κB activity (Hoffmann et al.,
2002). Moreover, due to the importance of aberrant activation of NF-κB in a variety of diseases,
over 780 compounds have been identified that modulate NF-κB activation (Gilmore et al., 2006).
3

Abbreviations: TLR, Toll-like receptors; DCPA, 3,4-dichloropropionaniline; EMSA, electromobility shift assay;
NTFA, non-radioactive transcription factor assay
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As illustrated by efforts to recapitulate temporal regulation of the NF-κB pathway using
mathematical models, e.g. Hoffmann et al. (2002), the dynamics of this process has been the
subject of intense scientific scrutiny (Hoffmann and Baltimore, 2006).

However, how

therapeutics modulate the dynamics of the activation of NF-κB is still unknown.
Present in all body compartments, macrophages initiate an innate immune response to
bacterial pathogens through phagocytosis, thereby eliminating them by the generation of reactive
oxygen (ROS) and reactive nitrogen (RNS) species (Nathan and Hibbs, 1991; Miller and
Britigan, 1997). Macrophages also activate T lymphocytes by acting as a professional antigen
presenting cell (APC) and secreting cytokines, such as IL-6 and TNF-α (Unanue, 1981). These
cytokines are important early mediators of acute inflammatory responses contributing to
downstream lymphocyte activation (Unanue, 1984, Adams and Hamilton, 1984). Due to their
importance in immune surveillance, macrophages provide a highly relevant context for the study
of NF-κB.
DCPA effects on the immune response have been studied extensively and its ability to
suppress various macrophage functions has been characterized. DCPA was demonstrated to
decrease phagocytic activity of macrophages along with their ability to generate both reactive
oxygen and nitrogen species (Ustyugova et al., 2007).

The production of inflammatory

cytokines, such as TNF-α, IL-1β and IL-6 was also decreased (Xie et al., 1997a; Xie et al.,
1997b). Effects of DCPA on the steady-state levels of NF-κB activation have been studied and
demonstrated a decreased nuclear localization of NF-κB accompanied by a reduced, but not
entirely abrogated binding to DNA (Frost et al., 2001).
DNA binding of activity of transcription factor can be determined by different methods.
An electromobility shift assay (EMSA) detects complexes of protein (e.g. NF-κB) and
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32

P-

labeled DNA containing transcription factor consensus sequences migrating through a nondenaturing polyacrylamide gel (Hendrickson, 1985; Revzin, 1989). DNA-protein complexes
will migrate more slowly than unbound radioactive probe and thus they are visualised by discrete
bands of radioactivity in the upper part of an acrylamide gel image (Fried and Crothers, 1981;
Garner and Revzin, 1981). This technique is labor intensive and requires radioactivity.
A non-radioactive transcription factor assay (NTFA) combines the principle of EMSA
where protein:DNA interaction is observed in enzyme-linked immunosorbent assay format
(Benotmane et al., 1997; McKay et al., 1998; Renard et al., 2001). Active NF-κB is captured as
it binds to its non-radioactive DNA consensus sequence that has been immobilized on a
streptavidin-coated plate. The transcription factor that formed complexes with DNA is then
probed with specific primary antibody (anti-p65) followed by HRP-conjugated secondary
antibody and substrate detection. This method allows sampling a larger number of tests in a
shorter period of time and does not require radioactive labeling.
The present study explores the initial phase of nuclear NF-κB oscillatory behavior
induced in LPS-stimulated macrophages by the means of two independent methods commonly
used for quantifying the binding activity of transcription factors. Immunosuppressant DCPA is
used to modulate NF-κB activity and incorporated in the dynamic model to demonstrate the
changes in transcription factor activation.

Materials and Methods
Cell culture, stimulation and DCPA treatment. The murine peritoneal macrophage
cell line, IC-21, was cultured in 5% CO2 at 37°C to 80% confluency in complete RPMI (cRPMI)
(BioWhittaker, Walkerville, MD). cRPMI consists of RPMI 1640 supplemented with 10% fetal
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bovine serum (Hyclone, Logan, UT), L-glutamine (2 mM), penicillin (100 U/ml), streptomycin
(100 μg/ml), 2-mercaptoethanol (5 x 10-5 M), and Hepes buffer (10 mM) (all obtained from
Sigma-Aldrich, St. Louis, MO). Cells were treated with 99% pure DCPA (ChemService, Inc.,
West Chester, PA) and simultaneously stimulated with 1 μg/ml LPS phenol extracted (SigmaAldrich) for various times.

Appropriate concentrations of DCPA were dissolved in 100%

ethanol (Mallinckrodt Baker, Inc., Paris, KY) and added to cells at concentrations ranging from 0
to 150 μM. The final ethanol concentration added to all cultures was 0.1%; control cultures
received equal concentrations of ethanol.
Nuclear Extracts. Cells were plated at a concentration of 8 x 105 cells in 5 ml of cRPMI
in 60 mm dish and incubated overnight at 37°C 5% CO2. Cells were then treated with either
0.1% ethanol or DCPA at concentrations of 25 μM, 100 μM, 150 μM, then simultaneously
stimulated with 1 μg/ml LPS. Cells were washed with 2.5 ml of ice-cold Dulbecco’s phosphate
buffered saline (DPBS) (BioWhittaker) and lysed by adding 200 μl of a buffer consisting of 10
mM HEPES pH 7.9, 10 mM KCl, 0.1 mM ethylenediamineteraacetic acid (EDTA), 0.1 mM
ethylene glycol-bis(2-aminoethyl ether) N, N, N’, N’-tetraacetic acid (EGTA), 1 mM phenyl
methyl sulfonyl fluoride (PMSF), 1 mM dithiothreitol (DTT), and 1 μg/ml of the protease
inhibitors leupeptin, antipain, chymostatin and pepstatin A (Sigma-Aldrich). Cells were scraped
off the dishes and lysates were transferred to a microcentrifuge tubes and incubated on ice for 15
min. Next, 50 μl of 10% NP-40 was added, samples were vortexed for 30 sec and the lysates
were pelleted by centrifugation for 30 sec at 14000 rpm at 4°C. The supernatants (cytoplasmic
extracts) were collected and saved at -20°C. Pellets were resuspended in 30 μl of 20 mM
HEPES buffer containing 400 mM NaCl, 1mM EDTA, 1 mM EGTA, 1mM PMSF, 1 mM DTT
and 1 μg/ml of the protease inhibitors (see above), vortexed and incubated for 15 min on ice.
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The lysates were pelleted by centrifugation at 14000 rpm for 5 min at the same conditions and
the supernatants containing the nuclear fraction stored at -70°C. A total protein concentration for
nuclear extracts was determined with Coomassie Plus Protein Assay Reagent, as described by
manufacturer (Pierce, Rockford, IL).
Electrophoretic mobility shift assay (EMSA). NF-κB consensus oligonucleotides (sc2505; Santa Cruz Biotechnology, Santa Cruz, CA) were labeled with γ-32P-ATP (PerkinElmer,
Boston, MA) using Ready-To-GoTM T4 polynucleotide kinase kit (Amersham Pharmacia Biotech
Inc., Piscataway, NJ). Nuclear extracts, 5μg per sample, were incubated with 50,000 cpm of
labeled probe and 1 μg/ml dI:dC for 30 min at room temperature in 1x binding buffer (5x stock:
250 mM NaCl, 50 mM Tris-Cl, 50% (v/v) glycerol, 5 mM DTT, 2.5 mM EDTA, adjusted to pH
7.6, stored at-20°C) to allow formation of band shift complexes. Next, complexes were resolved
from free probe in 5% polyacrylamide gels (1× TGE, 5% glycerol, 0.075% ammonium
persulfate, 0.1% TEMED). Samples were electrophoresed at 125 V for 4 h, dried on Whatman
3MM paper, and placed on PhosphoImage Screens for analysis with ImageQuant TL Software
(Amersham Pharmacia Biotech Inc.). The EMSA experimental results are reported as the ratio
of the intensity measured for a particular condition (i.e. time > 0) relative to the intensity of
nuclear NF-κB prior to treatment (i.e. time = 0).
Transcription factor assay (NTFA). Nuclear extracts, 5 μg per sample, were analyzed
by a Chemicon Non-Radioactive Transcription Factor Assay to determine NF-κB p65 DNA
binding activity, as described by manufacturer (Chemicon Int., Temecula, CA). Briefly, nuclear
extracts were incubated for 2 h with biotinylated NF-κB consensus DNA sequences in a
transcription assay buffer containing sonicated salmon sperm DNA to allow the formation of
protein/DNA complexes. Next, NF-κB protein in the nuclear extracts bound to biotinylated
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consensus sequences was immobilized to the streptavidin-coated plate, and any unbound material
was washed away. NF-κB protein was detected with a specific rabbit anti-p65 antibody, followed
by incubation with anti-rabbit HRP-conjugated antibody detected by TMB/E substrate.
Absorbance

of

the

samples

was

measured

with

a

μQuant

Universal

Microplate

Spectrophotometer (Bio-Tek Instruments, Winooski, VT). The NTFA experimental results are
reported as the ratio of the absorbance measured for a particular condition (i.e. time > 0) relative
to the absorbance prior to treatment (i.e. time = 0).
NF-κB Model Development. The stimulation of macrophages by LPS results in the
activation of the TLR4 pathway (Poltorak et al., 1998). The transduction of signals via TLR4
results in the activation of a series of intermediate signaling proteins and ultimately in the
activation of IKK.

The activation of IKK leads to the liberation of NF-κB from protein

complexes with IκB inhibitor proteins. Active NF-κB translocates to the nucleus where it
initiates the transcription of various genes, including the IκB proteins. Newly transcribed and
translated IκB proteins reenter the nucleus and deactivate NF-κB.
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Figure 1. Schematic diagram of mathematical model developed to represent the initial
activation of NF-κB.
Shown schematically in Figure 1, the initial dynamics of NF-κB activation following LPS
stimulation is represented by the following three chemical kinetic equations:
⎛
d [cN ]
α ⋅ [DCPA] ⎞
⎟ ⋅ [cN ]
= − k1 ⋅ ⎜⎜1 +
[
] + K DCPA ⎟⎠
dt
DCPA
⎝

(1)

⎛
α ⋅ [DCPA] ⎞
d [aN ]
⎟ ⋅ [cN ] − k 2 ⋅ [aN ]⋅ [iN ]
= k1 ⋅ ⎜⎜1 +
[
] + K DCPA ⎟⎠
dt
DCPA
⎝

(2)

d [iN ]
= k 3 ⋅ [aN ]
dt

(3)

where cN, aN, iN, and DCPA represent the concentrations of inactive NF-κB in the cytosol,
active NF-κB in the nucleus, IκBα, and DCPA, respectively. The dynamic change in NF-κB in
the cytosol is represented by equation 1, where the impact of IKK on liberating NF-κB and
transport to the nucleus is represented by a single parameter k1. DCPA modulates the activation
of NF-κB with the strength parameter α. A negative value for α signifies that DCPA inhibits the
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activation of NF-κB while a positive value potentiates. The change in active NF-κB in the
nucleus is represented by equation 2, where the second term represents the inactivation of
nuclear NF-κB by IκBα. The dynamic transcription, translation, and re-import to the nuclear of
the NF-κB inhibitor protein, IκBα, in response to active NF-κB is represented by equation 3.
The initial normalized concentrations of aN and iN were set equal to 1 and 0, respectively. The
estimates for the initial concentration of cN and parameters k1, α, and k3 were determined using
these three ordinary differential equations and experimental measurement of active NF-κB in the
nucleus. The half-maximal inhibition constant, KDCPA, was assumed to be 5 μM based on the
study by Xie et al. (1997a). The rate constant for the deactivation of active NF-κB in the
nucleus, k2, was assumed to be equal to 0.015 conc-1min-1. These three ordinary differential
equations were evaluated within MatLab V7.1 (MathWorks, Natwick, MA). Summed squared
error between experimentally measured and simulated values for active NF-κB in the nucleus
were used to determine goodness-of-fit.

Optimal values and confidence intervals for the

parameters are detailed in the Table 1.
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Table 1. List of variables and parameters for NF-κB activation model. Optimal value for
initial conditions and parameters were determined using a genetic algorithm. Separate values
were determined from dose-escalation measurements obtained using EMSA or NTFA assays.
Non-parametric bootstrapping using residual errors provided estimates of confidence intervals.
Name

Definition

Assay

Value

95% CI

Units

k1

NF-·κB activation rate

NTFA

0.0624

(0.0033 - 0.111)

min-1

constant

EMSA

0.102

(0.0005 - 0.164)

“

NF-κB inactivation rate

NTFA

0.015

assumed

Conc-1 × min-1

constant

EMSA

“

“

“

Synthesis of NF-κB inhibitor

NTFA

0.0043

(0.0030 - 0.0144)

min-1

rate constant

EMSA

0.0057

(0.0029 - 0.0288)

“

Effect of DCPA on NF-κB

NTFA

0.465

(0.0625 – 0.999)

unitless

activation

EMSA

0.0687

(-0.187 - 0.716)

Half-maximum DCPA

NTFA

5

Reference (14)

concentration

EMSA

“

“

Initial concentration of NF-

NTFA

56.1

(38.5 – 868)

Conc

κB in cytosol

EMSA

13.6

(10.8 – 1760)

“

Initial concentration of

NTFA

1

assumed

conc

active nuclear NF-κB

EMSA

“

“

“

Initial concentration of IκBα

NFTA

0

assumed

conc

EMSA

”

“

“

NTFA

0 – 150

experimental conditions

μM

EMSA

“

“

“

k2

k3

α

KDCPA

cN

aN

iN

DCPA

Concentration of DCPA
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μM

Bootstrap Re-sampling - Confidence Interval Estimation. The bootstrap re-sampling
is an effective method for the estimation of confidence intervals of model parameters (Efron and
Tibshirani, 1986). Let’s assume that the experimental measurement of a dynamic system can be
described by the following equation
yexp(ti) = ymod(ti; θ) + ε(ti)

(4)

where yexp(ti) is the measured value at time ti and θ is the vector of model parameters that are
constant with respect to time. A mechanistic model of the dynamic system provides an estimate
of the expected biological response, ymod(ti, θ), at time ti, given the parameter vector θ. The
measurement error, or residual, is represented by ε(ti) and can be obtained at each time point, ti.
The population of ε(ti) determined from the data set is a representative sample of the variability
in observing this phenomena experimentally. Analysis of the variance ensures that there are no
systematic errors in the residual population.
Experimentally, replication is used to establish significance of an observation. Bootstrap
resampling is a computational approach that creates synthetic replicates drawn from the
population of residuals. The residuals are first normalized based on the appropriate error model
of the experimental assay. Error models for each of the assays (NTFA and EMSA) were based
upon an analysis of the residuals. Synthetic sets of experimental replicates were created using
the following steps. First, optimal values for k1, k3, α, and the initial value for cN were
determined based upon the DCPA dose-escalation experiments using either NTFA or EMSA.
Second, expected values (ymod(ti)) were calculated using equations 1–3 (the NF-κB model) and
the set of optimal parameters for every measured experimental condition (yexp(ti)) to yield the
residuals, ε(ti). The residuals were normalized based upon the error model that corresponds to
the particular assay. Finally, a large number (N = 1000) of synthetic data sets (i.e. bootstrapped
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data sets) that replicate the original experimental protocol were created by sampling, with
replacement, from the population of residuals. These sampled residuals are then recombined
with the expected values (ymod(ti)) to give new synthetic data sets. A new optimal set of
parameter values were determined for the NF-κB model that capture the synthetic DCPA doseescalation experiments. Each one of the bootstrap data sets yields a novel set of values for k1,
k3, α, and the initial value of cN. This collection of optimal values provides an estimate of the
95% confidence intervals for k1, k3, α, and cN(t = 0), shown in the Table 1. The reported
significance corresponds to the probability that the strength parameter α is positive.

Results
We first wanted to characterize the dynamics of NF-κB activation in macrophage cell
line. As shown in Figure 2, sustained LPS stimulation of a mouse peritoneal macrophage cell
line, IC-21, resulted in damped oscillations in NF-κB DNA binding activity. Over a period of
six hours, the dynamic activation of NF-κB was quantified using an electromobility shift assay
(EMSA) at the indicated time points (Figure 2a). IC-21 macrophages were treated with either
ethanol (control) or 100 μM DCPA and stimulated with LPS to induce active NF-κB DNA
binding. Both treatments demonstrated similar damped oscillations graphically represented in
Figure 2b (EtOH – solid line, open circles, 100 μM DCPA – dashed line, plus sign).

169

a
unstim

minutes
5

10 15 30 45 60

75 90 105 120

E D E D ED ED ED E DE DE D E D E D

p65/p50
150 180 210 240 270 300 330 360
E D E D E DE D E D E DE D E D

p65/p50

Nuclear NF-κB (fold baseline)

b
14

100 μM DCPA
EtOH Control

12
10
8
6
4
2
0

0

100

200

300

400

Time (minutes)

Figure 2. Biochemical measurement of oscillations in LPS-stimulated IC-21 macrophages
persists following DCPA treatment.
(a) Nuclear NF-κB DNA binding activity was assayed by EMSA at the indicated times after
sustained stimulation with LPS (1 μg/ml). Macrophages were either treated with ethanol (E) or
100 μM DCPA (D). (b) The specific NF-κB mobility shift phosphoimage was quantified using
ImageQuant and normalized to basal levels.

Both control (○) and DCPA pretreated (+)

macrophages exhibit similar damped oscillatory behavior.
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These damped oscillations observed in macrophages are in variance with the findings of
Covert et al. (2005), who demonstrated sustained NF-κB activation following LPS stimulation in
mouse embryonic fibroblasts.

While the EMSA measurements shown in Figure 2 are

representative of the dynamic response in IC-21 macrophages to LPS, significant variability was
observed between replicates following the initial peak in NF-κB activation (data not shown).
Moreover, observed variability in amplitude of response and frequency of response inhibited the
ability to quantify the pharmacological effect of a particular mediator on the dynamics of NF-κB.
Based on these findings, we focused subsequent efforts on quantifying the dynamics of NF-κB
activation within the first 45 minutes following LPS stimulation.
Next, both EMSA and NTFA were used to replicate measurements of active NF-κB in
the nucleus at multiple time points during initial peak of DNA binding activity (0-45 min) in
response to LPS stimulation. Figure 3a demonstrates multiple replicates of this process using
EMSA, for comparison, Figure 3b represents the data obtain from NTFA.

Both methods

demonstrated that the initial peak of NF-κB activation reached maximum at 20 min, which is
caused by rapid degradation of IκBα inhibitor and results in maximum DNA binding.
Subsequent diminishing of NF-κB binding activity and triggered by a resynthesis of IκBα
graphically displayed as a decline of the curve. A mathematical model, shown schematically in
Figure 1, incorporating these biochemical steps was created to capture this dynamic behavior.
Parameter values that correspond to a particular assay are shown in Table 1. The EMSA
measurements obtained from LPS-induced macrophage cell line are compared against the
mathematically-simulated EMSA response in Figure 3a represented by solid (ethanol) and
dashed (150 μM DCPA) lines.

For comparison, data from NTFA is compared against

mathematically-simulated NF-κB activation dynamics in Figure 3b.
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Figure 3. Modeling the potentiation by DCPA of the early activation of NF-κB in IC-21
macrophages following LPS stimulation.
The dynamic response in nuclear NF-κB was measured using (a) EMSA and (b) NTFA. The
active NF-κB in the nucleus as measured following LPS stimulation and treatment with 0μM (□,
EMSA n=8, NTFA n=3), 25 μM (○, EMSA n=2, NTFA n=3), 100 μM (+, EMSA n=4, NTFA
n=3), and 150 μM (×, EMSA n=1, NTFA n=3) DCPA. The simulated time courses of active
NF-κB in the absence and pretreated with 150 μM DCPA are shown as the solid curves and
dashed curves, respectively.
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The overall kinetics of the underlying biological mechanism observed using the NTFA
and EMSA assays are in agreement. The results of comparison between the two assays revealed
that NTFA exhibits greater sensitivity and reproducibility in measuring active NF-κB relative to
the EMSA as shown by the differences in dynamic ranges observed during the control
experiments.
To

manipulate

the

dynamics

of

NF-κB

oscillatory

behavior,

a

known

immunosuppressant, DCPA, was introduced into the experimental system. IC-21 macrophages
were treated with three different concentrations of DCPA: 25, 100, and 150 μM DCPA and
simultaneously stimulated with LPS. In order to quantify the effect of DCPA on dynamics of
binding activity, we focused on the initial peak of NF-κB activation following LPS stimulation.
Both assays were used to characterize alterations in NF-κB binding activity by DCPA in
response to LPS stimulation, and experimental results from EMSA and NTFA are show in
Figures 3a and 3b, respectively. All concentrations of DCPA are graphically represented by a
separate sign (25 μM –“○”, 100 μM –“+”; 150 μM –“×”). The effect of DCPA on the dynamic
activation of NF-κB was represented in the mathematical model by modulating the activation
rate of NF-κB in the cytosol, k1. The pharmacologic effect of DCPA on the initial activation of
NF-κB was quantified by the strength parameter α. Using the EMSA parameter values shown in
Table 1, the simulated NF-κB response to LPS following treatment with 150 μM DCPA was
compared against the EMSA results in Figure 3a. Similarly, the simulated NTFA measurements
following DCPA treatment were compared against the NTFA results in Figure 3b. Overall, the
simulated responses for both NTFA and EMSA showed agreement with the experimentally
measured values. In comparison, the simulated NTFA results showed greater discrimination
between macrophages treated with DCPA and controls compared to the EMSA results. These
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differences were a reflection of the values of α estimated using NTFA versus EMSA. The results
from both assays suggest that DCPA potentiates the activation of NF-κB at the early time points
(0-45 min). Quantitatively, the NTFA results suggest that DCPA increases the activation rate of
NF-κB by 46.5% (α = 0.465). In contrast, the EMSA results suggest that DCPA increases the
activation rate by 6.9% (α = 0.069). These results seem counter-intuitive as we have previously
reported that 66 μM DCPA resulted in an 80% reduction in IL-6 mRNA and a 50% reduction in
TNF-α mRNA following stimulation with 10 μg/ml LPS (Xie et al., 1997a). This suppression in
mRNA resulted in an inhibition of IL-6 production by 60% and TNF-α production by 50%.
However, the stabilities of IL-6 and TNF-α mRNA were not affected by DCPA suggesting that
DCPA modulates cytokine production specifically at the pre-transcriptional level as inhibition of
the IκB proteins would change the dynamics of NF-κB.
One of the most important aspects of data analysis is the determination of confidence
intervals for model parameters that represent the data. A bootstrap resampling approach applied
to the residuals (ε(ti)) between the predicted (ymod(ti, θ)) and measured (yexp(ti)) values was used
to estimate the confidence intervals of the model parameters. Prior to applying the bootstrap
algorithm, we analyzed the population of residuals for underlying structure. The residuals are
assumed to have a Gaussian distribution with a zero mean (i.e. ε(ti) ∈ N(0, σ2(ti, θ, λ)).
Generally, the variance of residuals, σ2(ti, θ, λ), is a function of time, the model parameters, and
a parameter vector that is unique to the variance, λ. The underlying structure in the variance of
the residuals is sometimes referred to as the error model. Separate error models were created for
the EMSA and NTFA measurements. In this study, we assume that the error model is a linear
function of the predicted value:
σ2(ti,θ,λ) = λ1 ⋅ ymod(ti,θ) + λ2

(5)
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The parameter, λ1, quantifies the variance that is proportional to the underlying signal that is
being measured. The λ2 parameter quantifies the contribution of a random noise distribution to
the error model. Values for λ1 and λ2 can be estimated by combining the error model with the
equation for the residuals (ε(ti) = yexp(ti) – ymod(ti, θ)) and rearranging terms to yield:
yexp (ti ) − ymod (ti ,θ )
ymod (ti , θ )

= Λ1i + Λ 2i ⋅

1
ymod (ti , θ )

(6)

where Λ1i and Λ2i provide estimates of variance parameters λ1 and λ2. The left hand side of
equation 6 represents the normalized error values and is plotted against

−1

y in Figure 4. As
mod

identified in Figure 4, the normalized error values were grouped into two groups based on their
respective values of
4.

−1

y . The variances of the two groups for each assay are labeled in Figure
mod

The variance compared between the high and low NTFA groups was not statistically

significant while the difference between the EMSA groups was significant (p<0.05). These
results suggest that λ2 is equal to zero for the NTFA error model and that the residuals are
proportional only to the underlying signal (ymod).

In contrast, the variance in the EMSA

measurements is proportional to the underlying signal and contains contributions from random
noise.
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Figure 4. Analysis of the NTFA and EMSA residuals to construct appropriate error
models.
The difference between experimental measurement (yexp) and simulated response (ymod) of active
nuclear NF-κB (residual error) following LPS stimulation in IC-21 macrophages is shown as a
function of

−1

y . The EMSA measurements are shown as circles and the NTFA measurements
mod

are shown as squares. The residual errors are normalized by the simulated response. EMSA
residuals with

y

−1
mod

> 0.2 were assigned to EMSA Group 2 while remaining residuals were

assigned to EMSA Group 1. Similar grouping was applied to NTFA residuals. Variances for
each group are shown in the figure. The difference in variance between NTFA groups was not
significant while the EMSA groups exhibited significant differences in variance (p < 0.05).
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Given this analysis of the residuals for the NTFA and EMSA measurements, we
constructed a bootstrap sample population using the following error models:
yexp (ti ) − ymod (ti , θ NTFA )

(7)

ε EMSA (ti ) = yexp (ti ) − ymod (ti ,θ EMSA )

(8)

ε NTFA (ti ) =

ymod (ti , θ NTFA )

The bootstrapped sample populations were used to provide estimates of the confidence intervals
associated with the model parameters. The 95% confidence intervals for the model parameters
are shown in the Table 1. We are particularly interested in the confidence intervals associated
with the strength parameter α. Based upon bootstrapping of the EMSA residuals, the 95%
confidence interval for the strength parameter α spans the range -0.187 to 0.716 (p < 0.2). In
contrast, the 95% confidence interval for the strength parameter α based on the NTFA residuals
spans 0.0625 to 0.999 (p < 0.01). The distributions in estimates of the strength parameter α
provided by bootstrapped replicates of the EMSA and NTFA residuals are shown in the
Supporting Information (Figures S1 and S2). In summary, the higher signal-to-noise ratio
observed using the NTFA provides a superior platform for observing biologically significant
phenomena.

Discussion
NF-κB regulates the inducible expression of a wide range of immune and inflammatory
response genes (Kopp and Ghosh, 1995). As a result, NF-κB is one of the most studied
molecules in the area of signal transduction. Due to the complex nature of biological system, the
study of NF-κB is important for two reasons. First, the objective of biomedical research is to
infer biochemical mechanisms that underpin biological response to stimuli. Second, biomedical
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research aims to develop strategies that modulate aberrant biochemical mechanisms to revert a
pathogenic state.

In both cases, biological assays provide avenues for observing cellular

response following biochemical interrogation.
One of the most important aspects in the design of a biological assay is selecting a
physiologically relevant context. We first observed damped oscillations in active NF-κB in
macrophages following LPS stimulation. This observation is in contrast to other published
studies examining the dynamic activation of NF-κB following LPS stimulation. In particular,
Werner et al. (2005) observed in fibroblasts that the initial activation of NF-κB by 0.1 μg/ml LPS
was not rapid but dependent on autocrine feedback via the TNF-α pathway. Covert et al. (2005)
observed that 0.5 μg/ml LPS induced stable NF-κB activation through a combination of MyD88dependent and MyD88-independent pathways.

In Figure 5, the NF-κB activation in

macrophages obtained from IC-21 cells was compared to LPS-stimulated fibroblasts activation
profile obtained by Werner et al. (2005) and Covert et al. (2005). The data from all three studies
were combined and graphically presented in Figure 5.
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Figure 5.

Macrophages 1 μg/ml LPS
Fibroblasts 0.5 μg/ml LPS
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The dynamic activation of NF-κB in macrophages compared against prior

studies using fibroblasts.
Nuclear NF-κB was assayed by EMSA at the indicated times after persistent stimulation with 1
μg/ml LPS in macrophages (□, this study), 0.5 μg/ml LPS in fibroblasts demonstrated by Covert
et al. (2005) (○), and 0.1 μg/ml LPS in fibroblasts demonstrated by Werner et al. (2005) (×).
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The initial rates of NF-κB activation are similar in both previous studies using mouse
embryonic fibroblasts. We observed a much higher initial rate of activation using 1.0 μg/ml
LPS. This higher activation rate may be attributed to the increased expression of CD14 in
macrophages compared to fibroblasts and/or increased stimulant. Cellular response to LPS is
mediated by the TLR4 pathway (Poltorak et al., 1998). CD14, an accessory cell surface protein,
interacts with TLR4 to increase the sensitivity to LPS a thousand-fold (Wright et al., 1990) and
facilitates the robust response to LPS. Thus, the cellular context plays an important role in
determining the contribution of a particular signaling pathway on the dynamic behavior of NFκB activation.
Chemical manipulation of NF-κB binding activity with immunosuppressant DCPA
resulted in the earlier activation of the initial peak observed during first 45 minutes after LPS
stimulation. This earlier activation might result in altered frequency of the oscillations that, in
turn, will change the transcriptional regulation of some genes. Changes in number, period and
amplitude of oscillations were observed by Nelson at al. (2004) in HeLa cell line continuously
stimulated with TNF-α. Furthermore, the transcription of NF-κB target genes was dependent on
persistence of oscillations. Nelson et al. (2004) also suggest that changes in oscillations could
have functional consequences on NF-κB signaling in response to different stimuli. Therefore,
inhibition of NF-κB-inducible cytokines, TNF-α and IL-6, observed in DCPA treated cells at the
later time points (12 and 24 h after sustained LPS stimulation) may be a result of the early
potentiation of NF-κB activation caused by a shift in oscillatory behavior. Alternatively, treating
cells with DCPA may shift the dynamic equilibrium of active NF-κB among the corresponding
DNA binding sites within the nucleus, resulting in a change in the profile of NF-kB-inducible
genes.
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An additional consideration in the design of a biological assay is how to observe a
cellular response. Observed variability in measured data is due to technical variation (e.g. error
in measurement) or biological variation (e.g. cellular heterogeneity, asynchrony, or
stochasticity).

Implicitly, design of the experimental protocol is intended to limit the

contributions of biological variation by selecting cellular systems that exhibit favorable
characteristics. In contrast, the contribution of technical variation has received little attention.
Moreover, the experimental tools of molecular biology have been criticized due to their
qualitative nature (Maddox, 1992; Maddox, 1994). Over the years, biochemical assays have
been developed with improved sensitivity (Renard et al., 2001). Yet, as we have shown herein,
technical variation can be attributed to multiple sources.

Improved sensitivity alone is an

insufficient criteria to improve the information context of an assay. If the technical variation is
associated solely with the magnitude of the signal, there will be no difference in extracting
meaningful information regarding cellular response using either assay. However, when an assay,
such as the EMSA assay discussed here, exhibits a higher contribution of random noise,
pharmacologically significant modulation of cellular response and insight into underlying
biological mechanisms can be masked. Thus, assays, such as NTFA, that provide a greater
signal-to-noise ratio contribute to a clearer window into fundamental cellular behavior. The
importance of developing biological assays that exhibit improved signal-to-noise ratios is
highlighted by our study of the potentiation of NF-κB activation by DCPA.
While much effort has focused on identifying the dynamic phenomena associated with
the activation of NF-κB, we focused our efforts on understanding how this dynamic phenomena
can be modulated for therapeutic aims. Following our investigations into the impact of DCPA
on the dynamic modulation of NF-κB activation within a mouse peritoneal macrophage cell line,
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we come to the following three conclusions. First, the dynamic behavior of NF-κB in response
to stimuli is dependent on cell type and developmental stage. Second, DCPA potentiates early
activation of NF-κB yet suppresses inflammatory gene expression. Extraction of this counterintuitive behavior could only be achieved through the use of a mechanistic model that encoded
the relevant biochemical events. Finally, non-radioactive transcription factor assays provide
superior signal-to-noise ratios over electromobility shift assays for observing cellular response.
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Supporting Information
Parameter Identification.
An important aspect of sensitivity analysis is to identify model parameters that can be uniquely
determined from the available data. A priori identifiability is one approach to select identifiable
parameters given unlimited information about the modeled system (Jacquez and Perry, 1990;
Audoly et al., 2001). This assessment of parameter identifiability is intimately linked to the

sensitivity of the model results to changes in parameter values. Local sensitivity analysis is
defined as the relative change in model variables (yj) in response to a perturbation of the model
parameters (ki) around a local optimum (Turanyi et al., 2001). The resulting sensitivity function
is defined as,
Sij (t ) =

∂y j (t )
ki
⋅
MAX ( y j , (t )) ∂ki

(A-1)

where the partial derivative values are scaled by the parameter value and the maximum value of
the model variable during the simulation. In practice, the sensitivity function is approximated by
obtaining the sensitivity measure Sij at a set of discrete time points, tk, and experimental
conditions, [Cn]n. In addition, measurements of only a subset the model variables may be
obtained experimentally. A reduced sensitivity matrix (M) is then constructed using a subset of

(

)

the sensitivity measures S iˆj (t k , Cnn ) such that

[

]

M = S iˆj (t1 , Cn0 ),..., S iˆj (t k , Cn0 ), S iˆj (t1 , Cnn ),..., S iˆj (t k , Cnn )

T

(A-2)

A set of correlation coefficients between model parameters is calculated from M. Parameters
that are locally identifiable have correlations with all other parameters between -1 and +1.
Parameters that are not locally identifiable, termed a priori unidentifiable, have correlations of
exactly +1 or -1 with at least one other parameter.
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We are particularly interested in the

confidence intervals associated with the strength parameter α. The correlation coefficients listed
in the Supporting Information (Table S1) demonstrate that estimates of the strength parameter α
are unique if KDCPA is specified to be 5 μM, as determined previously (Xie et al., 1997a).
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Table S1: Correlation coefficients of model parameters and initial concentrationof NF-κB
in cytosol.
Significantly correlated parameters (p < 0.05) are highlighted in bold.
Correlation
Coefficient

k1

k2

k3

α

KDCPA

cN(t=0)

k1

1

0.422

0.422

0.671

-0.667

0.664

k2

0.422

1

1

0.352

-0.341

-0.283

k3

0.422

1

1

0.352

-0.341

-0.283

α

0.671

0.352

0.352

1

-0.999

0.492

KDCPA

-0.667

-0.341

-0.341

-0.999

1

-0.514

cN(t=0)

0.664

-0.283

-0.283

0.492

-0.514

1
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Parameter alpha (unitless)

Figure S1: Frequency of parameter values for the strength parameter α determined via
bootstrap resampling of the EMSA residuals.
The confidence interval corresponding to 95% of population of bootstrapped parameter values is
highlighted in the figure.
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Figure S2: Frequency of parameter values for the strength parameter α determined via
bootstrap resampling of the NTFA residuals.
The confidence interval corresponding to 95% of population of bootstrapped parameter values is
highlighted by the double arrow in the figure.

192

References
Jacquez, J. A., and Perry, T. (1990). Parameter estimation: local identifiability of parameters.
Am. J Physiol 258(4 Pt 1), E727-E736.
Audoly, S., Bellu, G., D'Angio, L., Saccomani, M. P., and Cobelli, C. (2001). Global
identifiability of nonlinear models of biological systems. IEEE Trans. Biomed. Eng
48(1), 55-65.
Turanyi, T., Rabitz, H., in Sensitivity Analysis, eds Saltelli A, Chan K, & Scott, E. M. (John
Wiley, New York), pp 81-100 (2000).
Xie, Y. C., Schafer, R., and Barnett, J. B. (1997a). Inhibitory effect of 3,4-dichloropropionaniline on cytokine production by macrophages is associated with LPS-mediated
signal transduction. J. Leukoc. Biol. 61(6), 745-752.

193

CHAPTER 5.
GENERAL DISCUSSION
The immunotoxic effects of propanil on different components of the immune system have
been demonstrated in numerous studies. The current dissertation focuses on one of the major
components of the innate immune system, macrophages. The first section discusses the ability of
macrophages to initiate the immune response by recognizing and phagocytosing bacteria in the
presence of propanil. It is followed by an examination of inflammatory mediators, such as
cytokines, prostaglandins, ROS and RNS, produced in response to bacterial challenge. The
second section focuses on alterations in NF-κB signaling, specifically, on oscillatory behavior of
the activated transcription factor and modulation of its binding activity by propanil.
I.

Propanil suppresses normal macrophage function.

The production of a number of chemokines and cytokines by macrophages are important
immune mediators in both innate and adaptive immune responses.

Two of the important

cytokines produced by macrophages are IL-6 and TNF-α. Ex vivo and in vitro studies have
previously demonstrated the inhibitory effects of propanil on the production of both cytokines by
mouse macrophages after 24 hr LPS stimulation (Xie et al., 1997a; Xie et al., 1997b; Frost et al.,
2002). The current study demonstrated similar inhibition of TNF-α production by the human
monocytic cell line, THP-1 (Ustyugova et al., 2007).
TNF-α is mainly produced by activated macrophages and T lymphocytes (Jadus et al.,
1986; Cuturi et al., 1987). It stimulates endothelial cells to produce IL-1, hematopoeitic growth
factor, arachidonic acid metabolites, thus promoting an inflammatory response (Libby et al.,
1986; Pober et al., 1986). It also induces the expression of adhesion molecules, such as ICAMs
and VCAMs, which makes endothelial cells adhesive and leads to accumulation of leukocytes at
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local sites of inflammation (Bevilacqua, 1993). TNF-α also directly affects neutrophils, causing
degranulation of their preformed granules, stimulating phagocytic activity and generating ROS
(Figari et al., 1987; Shalaby et al., 1987; Sayers et al., 1988). TNF-α is known to stimulate the
production of other inflammatory cytokines, such as IL-1, IL-6, GM-CSF and even activates its
own transcription by leukocytes at the site of immune reaction (Broudy et al., 1986; Libby et al.,
1986; Cicco et al., 1990). During the development of an adaptive immune response, TNF-α may
act as a co-stimulator for T cell activation. By stimulating other macrophages in the inflamed
area to produce IL-1 and IL-6 cytokines, TNF-α indirectly stimulates antibody production by B
cells, thus mediating humoral response (Ghiara et al., 1987).
TNF-α synthesis is dependent on the transcription factor NF-κB (Collart et al., 1990).
Upon LPS stimulation, NF-κB translocates into the nucleus where it binds the promoter regions
of genes responsible for cytokine production. A series of studies were performed using the
mouse peritoneal macrophage cell line, IC-21 to determine if the reduction in cytokine
production after exposure to propanil was due to effects on NF-κB activation. Propanil was
demonstrated to reduce TNF-α promoter activity in regions that contain NF-κB binding sites
(Frost et al., 2001). In addition, nuclear levels of the p65 subunit of NF-κB were reduced, as
well as DNA binding of both the p65/p50 heterodimer and p50/p50 homodimers of NF-κB was
inhibited after exposure to propanil (Frost et al., 2001). Overall, these results suggest that
propanil may reduce cytokine production through effects on NF-κB activation.
The ability of macrophages to phagocytose fluorescent beads and the pathogenic bacteria,
Listeria monocytogenes was decreased. This process can be interrupted at several levels, starting
with receptor recognition and binding, followed by bacterial engulfment and final destruction of
the microorganism. Two types of receptors are involved in recognition and binding: complement
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receptor 3 (CR3) and Fc gamma receptors (FcγRs). CR3 binds C3bi on complement-opsonized
targets, whereas FcγRs bind to immunoglobulin G (IgG)-coated targets. First, Fc R-mediated
uptake is accompanied by pseudopod extension and membrane ruffling, whereas complementopsonized targets sink into the cell, producing little protrusive activity (Kaplan, 1977). Second,
FcγR ligation is accompanied by the activation of the respiratory burst, and by the production of
arachidonic acid metabolites and cytokines, such as TNF-α. C3bi-dependent uptake occurs in
the absence of any of these proinflammatory signals (Aderem et al., 1985; Wright and
Silverstein, 1983; Yamamoto and Johnston, 1984; Scholl et al., 1992; Stein and Gordon, 1991).
The Rho family of small guanosine triphosphatases (GTPases) is involved in the
reorganization of filamentous actin structures in response to extracellular stimuli (Hall, 1998).
Rho induces the assembly of contractile actomyosin filaments, whereas Rac and Cdc42 control
actin polymerization into lamellipodial and filopodial membrane protrusions, respectively
(Ridley and Hall, 1992; Ridley et al., 1995; Nobes and Hall., 1995). In addition, these GTPases
can affect gene transcription through the activation of NF-κB (via IκBα phosphorylation), JNK
and p38 mitogen-activated protein kinase (MAPK) (Perona et al., 1997; Coso et al., 1995;
Minden et al., 1996; Teramoto et al., 1996). Rac regulates the reduced form of NADPH oxidase,
an enzyme responsible for the respiratory burst, specifically through assembly of the p47 and
p67 oxidase components on the cytosolic face of plasma membrane via cytoskeletal
reorganization (Gabig et al., 1995).
Propanil-treated cells were able to phagocytose a smaller number of fluorescent beads,
which indicates the disruption of receptor binding or inability of macrophages to reorganize their
actin filaments in response to stimuli.

Previous studies have demonstrated that propanil

abrogates the initial IP3-mediated calcium release (Xie et al., 1997b). However, binding of LPS
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to macrophages (Xie et al., 1997b) as well as mobility of plasma membrane lipid hydrocarbon
chains were not affected by propanil (Brundage et al, 2003).
The transient increase in intracellular calcium has been demonstrated in both
macrophages and neutophils (Geiszt et al., 2001; Larsen et al., 2000). Calcium is also important
in the activation of the NADPH oxidase (Dusi et al., 1993; Foyouzi-Youssefi et al., 1997; Geiszt
et al., 1999; Granfeldt et al., 2002; Zhou et al., 1997). Translocation of the phox proteins, p47
and p67 is triggered by an increase in intracellular calcium (Dusi et al., 1993; Zhou et al., 1997).
Supporting data on Ca2+-inlux inhibition was obtained from in vitro studies in human Jurkat T
cell line. Fluorescent measurement of intracellular Ca2+ in anti-CD3 stimulated Jurkat and
primary mouse cells revealed a concentration-dependent reduction in Ca2+ levels after propanil
exposure (Lewis et al, unpublished data).
Reduced bactericidal activity of propanil-treated macrophages was partially explained by
their decreased ability to produce a respiratory burst. Listeria monocytogenes clearance is a
result of NADPH oxidase activity (Dinauer et al., 1997; Shiloh et al., 1999), and is accompanied
by endogenous TNF-α production (Havell et al., 1989; Kato et al., 1989; Leenen et al., 1994).
Active NADPH oxidase produces hydrogen peroxide and hydroxyl radicals (·OH-) which are
detectable intracellulary by confocal microscopy. The decreased amount of ROS observed in
propanil-treated macrophages may partially explain their reduced listericidal activity.
Another component of the respiratory burst examined in Chapter 2 was RNS, produced
by inducible nitric oxide synthase (iNOS) as a result of LPS stimulation or a combination of
treatment with cytokines, such as, TNF-α and IL-1β (Lowenstein et al., 1993; Xie et al., 1993).
Short-lived NO reacts with ROS giving rise to a number of toxic nitrogen compounds, such as
peroxynitrite (ONOO-) which in turn decompose into additional nitrates and nitrites. Decreased
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levels of nitrites, which are partially generated from the reaction with ROS, demonstrated an
inhibition of RNS generation in propanil-treated macrophages. Another cause of low RNS
production is the level of iNOS gene expression. In macrophages, it is regulated mainly at the
transcriptional level, particularly by NF-κB, which binds to multiple sites on the iNOS gene
promoter (Xie et al., 1993). Decreased levels of iNOS protein were detected in propanil-treated
cells, which can be explained by a low NF-κB transcriptional activity in macrophages (Frost et
al., 2002). Interestingly, NF-κB activity can be also upregulated in response to ROS, suggesting
a novel positive feedback loop in which NO might activate transcription factors, which in turn
could increase NO synthesis by causing additional iNOS expression (Schreck et al., 1991).
The last inflammatory mediator discussed in Chapter 3 is PGE2. Its production is also
dependent on calcium influx which causes translocation of cytosolic PLA2 enzyme to the
membrane resulting in its activation. Another signal for cPLA2 activation is PKC-dependant
phosphorylation which triggers the production of free arachidonic acid (AA) (Kramer and Sharp,
1997). Phosphorylation of cPLA2 protein studied in activated macrophages was not affected by
propanil exposure. Next, the release of AA into the media was evaluated, but no effects of
propanil were observed. The last enzymatic step in prostaglandins production is the conversion
of AA to PGH2 by cyclooxygenase-1, -2 enzymes (William and Shakter, 1997). COX-2 is
rapidly induced by inflammatory and mitogenic stimuli, and its transcription is activated by
several transcription factors, such as AP-1, NF-IL6, NF-κB and NF-AT (reviewed in Williams et
al., 1999). However, neither the levels of COX-2 nor its enzymatic activity were affected by
propanil treatment. Phosphorylation of cPLA2 protein was not changed as well. So far, the
mechanism by which propanil dramatically decreases PGE2 production is still unknown.
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Among possible mechanisms is the decreased availability of membrane phospholipids for
cPLA2 and reduced secretion of prostaglandins into the extracellular space due to the impaired
function of prostaglandins transporter (PGT) (Schuster, 1998). PGs have low intrinsic plasma
membrane permeabilities, they cross it twice: first upon release from the cytosol into the blood,
and again upon cellular uptake prior to oxidation. PGT catalyzes the rapid, specific, and highaffinity uptake of PGE2, PGF2 alpha, PGD2, 8-iso-PGF2 alpha, and thromboxane B2 (Schuster,
1998). Therefore, the decreased levels of PGE2 secreted into the media are hypothesized to be
due an inhibition of this transporter.
II.

Propanil affects LPS-induced NF-κB activation in macrophages

Propanil has been previously shown to decrease TNF-α in murine macrophages and a
human monocytic cell line. The reduction of protein levels corresponded to reduced mRNA
levels of this cytokine (Xiet et al., 1997b). In activated macrophages, TNF-α is produced in
response to a variety of stimuli and is strongly dependent on NF-κB transcription factor (Trede et
al., 1995; Frost et al., 2002). However, other transcription factors, such as AP-1, EGR, Elk and
Ets have been implicated in cooperative binding to the TNF-α promoter (Tsai et al., 1996;
Sheppard et al., 1999; Zagariya et al., 1998). Mutation studies of κB binding sites within the
TNF-α promoter demonstrated drastic effects on its transcriptional activity (Collart et al., 1990;
Kuprash et al., 1999; Shakhov et al., 1990). Examination of nuclear levels of the p65 subunit of
NF-κB in LPS-stimulated macrophages revealed reduced levels of this transcription factor after
exposure to propanil. In addition, it was demonstrated that there was decreased DNA binding of
both the p65/p50 heterodimer and p50/p50 homodimers of NF-κB after exposure to propanil
(Frost et al., 2001).

Overall, these results suggested that propanil may reduce cytokine

production through effects on NF-κB binding activity.
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The ability of NF-κB to regulate gene expression is controlled by interactions with other
members of the IκB family. NF-κB-activating stimuli activate IKK that phosphorylates IκB
isoforms on Ser32 and Ser36 and NF-κB on Ser536 and Ser276 (DiDonato et al., 1997; Sakurai
et al., 1999). Phosphorylated IκBs are then ubiquitinated and degraded by the 26S proteosome,
freeing NF-κB dimers to translocate to the nucleus and bind to DNA.
NF-κB activates transcription of its own cytoplasmic inhibitor, IκBα, thereby creating a
negative feedback loop for its own activity. IκBα contains both nuclear localization and export
sequences, enabling nuclear-cytoplasmic shuttling (N-C). Newly synthesized free IκBκ binds to
nuclear NF-κB, causing exportation of the complex to the cytoplasm (Arenzana-Seisdedos et al.,
1995).

This complex, but not free IκBα is targeted by IKK again, resulting in IκBα

phosphorylation and degradation (Nelson et al., 2002; Zandi et al., 1998). This N-C shuttling
results in oscillatory behavior of activated NF-κB (Hoffmann et al., 2002). These oscillations
are asynchronous and decrease (damp) in frequency with increased IκBα transcription (Nelson et
al., 2004).
To characterize NF-κB binding activity, macrophages were stimulated with LPS and
exposed to propanil in study three (Chapter 4). Two independent assays were used to detect
damped oscillatory behavior of NF-κB with a different degree of sensitivity and reproducibility.
Based on experimental data, a kinetic model simulating NF-κB activation process was developed
to capture the dynamic of its regulation. Propanil treatment resulted in a potentiation of early
NF-κB activation by LPS. This earlier activation might result in altered frequency of the
oscillations that, in turn, will change the transcriptional regulation of some genes.
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Nelson et al. (2004) demonstrated that transcription of target genes was also dependent
on oscillation persistence, which was not only triggered by cycles of IκBα degradation and
resynthesis, but by cycles of p65 phosphorylation and dephosphorylation. Changes in number,
period and amplitude of oscillations were observed by Nelson at al. (2004) in HeLa cell line
continuously stimulated with TNF-α. Nelson and colleagues (2004) also suggested that changes
in oscillations could have functional consequences on NF-κB signaling in response to different
stimuli. Therefore, inhibition of NF-κB-inducible cytokines, TNF-α and IL-6, observed in
propanil-treated cells at the later time points (12 and 24 h after sustained LPS stimulation) may
be a result of the early potentiation of NF-κB activation caused by a shift in oscillatory behavior.
Therefore, treating cells with propanil may shift the dynamic equilibrium of active NF-κB
among the corresponding DNA binding sites within the nucleus, causing imbalance between
nuclear and cytoplasmic concentrations of NF-κB. Potentiation of NF-κB activation can also
result in asynchronized binding of other transcription factors which normally bind cooperatively
to the promoters of certain genes. All these alterations may result in a change in the profile of
NF-κB-inducible genes.
In summary, our work has demonstrated that propanil exposure significantly inhibits a
number of pro-inflammatory mediators, such as TNF-α and prostaglandins in activated
macrophages. Propanil also suppressed the ability of these cells to perform phagocytosis and
generate bactericidal ROS and RNS.

Evaluation of NF-κB binding activity demonstrated

damped oscillatory behavior following LPS stimulation which was altered by propanil
suggesting a molecular mechanism of its immunotoxic effects. The changes described in the
dissertation examine the effects of propanil at the molecular and cellular levels; however, these
changes can be translated into the organ and systemic effects. For instance, exposure to propanil
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could possibly inhibit a person’s ability to initiate an innate immune response by suppressing
normal macrophage functions, such as phagocytosis and respiratory burst. The development of
an adaptive immune response is also helped by macrophage’s Ag presentation to CD4+T helper
cells and cytokine production, which attracts other cell types to the area of inflammation and
creates a favorable environment for the bacterial clearance as well as proliferation of the immune
response. Thus, applicators and propanil’s manufacturers exposed to propanil are potentially
vulnerable to bacterial and viral infections, and their tumor-surveillance abilities could be
compromised.
The ability of macrophages to phagocytose apoptotic cells is another important function
for normal homeostasis as well as resolution of inflammatory conditions. Macrophages remove
dying cells which allows for the fast "clean up" of the infected area, e.g. phagocytosis of dying
neutrophils', and this also accelerates the healing processes. Propanil exposure, which inhibits
phagocytosis of pathogenic bacteria, might also suppress the removal of apoptotic cells resulting
in prolongation of inflammatory condition.
The studies of an anti-inflammatory potential of propanil yield very promising results,
demonstrating an inhibition of PGE2 production by 1-5 μM concentrations of propanil. This low
micromolar concentration of propanil does not affect cell viability and did not appear to be toxic
during the time-points observed (up to 48 hr); however, there are no data available yet on a longterm toxicity of propanil.
Changes in NF-κB activation profile could lead to a large number of effects. NF-κB is
one of the most ubiquitous transcription factors responsible for the transcription of 150 genes in
many cell types. Almost all inflammatory mediators discussed in the dissertation are NF-κBinducible, e.g. iNOS, COX-2, TNF-α, IL-6. Macrophages have to be fully activated in order to
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fulfill their bactericidal potential; therefore, NF-κB activation enables them to express
inflammatory cytokines and upregulates respiratory burst molecules.
The oscillatory behavior of NF-κB is an important part of the activation process. More
studies are needed to describe this novel process in order to learn how NF-κB activation can be
altered or adjusted through the modification of the oscillations. These fine adjustments of the
NF-κB may help to manage many inflammatory and autoimmune conditions because the
complete inhibition of this transcription factor may affect other normal biological functions.
An important part of any toxicological study would be an investigation of the effects of
metabolites of the toxic compound. Most of the studies were done in vitro, where propanil was
applied directly to macrophages.

Upon entry into the human body, propanil is rapidly

metabolized by the liver; therefore, macrophages would probably encounter propanil’s
metabolite, DCA. Future studies need to examine the effects of DCA on macrophages and other
cell types of immune system.
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